KR101729373B1 - Organic compound and organic electroluminescent device comprising the same - Google Patents
Organic compound and organic electroluminescent device comprising the same Download PDFInfo
- Publication number
- KR101729373B1 KR101729373B1 KR1020140025643A KR20140025643A KR101729373B1 KR 101729373 B1 KR101729373 B1 KR 101729373B1 KR 1020140025643 A KR1020140025643 A KR 1020140025643A KR 20140025643 A KR20140025643 A KR 20140025643A KR 101729373 B1 KR101729373 B1 KR 101729373B1
- Authority
- KR
- South Korea
- Prior art keywords
- mmol
- group
- synthesis
- mol
- yield
- Prior art date
Links
- 0 C*CCc1cccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4cc(Cl)ccc4)c3)n2)c1 Chemical compound C*CCc1cccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4cc(Cl)ccc4)c3)n2)c1 0.000 description 4
- TYQPJXDSAHTWRO-UHFFFAOYSA-N CCc1nc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound CCc1nc(-c2ccccc2)nc(-c2ccccc2)n1 TYQPJXDSAHTWRO-UHFFFAOYSA-N 0.000 description 2
- OVNPUJOZNPAVJQ-UHFFFAOYSA-N Clc1cc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)ccc1 Chemical compound Clc1cc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)ccc1 OVNPUJOZNPAVJQ-UHFFFAOYSA-N 0.000 description 2
- ORPVVAKYSXQCJI-UHFFFAOYSA-N [O-][N+](c(cccc1)c1Br)=O Chemical compound [O-][N+](c(cccc1)c1Br)=O ORPVVAKYSXQCJI-UHFFFAOYSA-N 0.000 description 2
- IIDVKUIDWHFUAT-UHFFFAOYSA-N c(cc1)ccc1N1c2ccc3[nH]c4ccccc4c3c2C=Cc2ccccc12 Chemical compound c(cc1)ccc1N1c2ccc3[nH]c4ccccc4c3c2C=Cc2ccccc12 IIDVKUIDWHFUAT-UHFFFAOYSA-N 0.000 description 2
- AYQZGHPXIKKZHF-UHFFFAOYSA-N c(cc12)ccc1[nH]c(cc1)c2c2c1C=Cc1ccccc1S2 Chemical compound c(cc12)ccc1[nH]c(cc1)c2c2c1C=Cc1ccccc1S2 AYQZGHPXIKKZHF-UHFFFAOYSA-N 0.000 description 2
- SCNJASLQQLBHLU-UHFFFAOYSA-N c(cc12)ccc1[nH]c(cc1)c2c2c1Sc1ccccc1C=C2 Chemical compound c(cc12)ccc1[nH]c(cc1)c2c2c1Sc1ccccc1C=C2 SCNJASLQQLBHLU-UHFFFAOYSA-N 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C Chemical compound CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- AJUJMORRHNUGOQ-UHFFFAOYSA-N CC1(C)OB(c(cc2)cc3c2C=Cc2ccccc2S3)OC1(C)C Chemical compound CC1(C)OB(c(cc2)cc3c2C=Cc2ccccc2S3)OC1(C)C AJUJMORRHNUGOQ-UHFFFAOYSA-N 0.000 description 1
- GSHKYTCNZPBLGB-UHFFFAOYSA-N CC1(C)OB(c2c(C=Cc3ccccc3N3)c3ccc2)OC1(C)C Chemical compound CC1(C)OB(c2c(C=Cc3ccccc3N3)c3ccc2)OC1(C)C GSHKYTCNZPBLGB-UHFFFAOYSA-N 0.000 description 1
- FNXOJKLRHYFBBQ-UHFFFAOYSA-N CC1(C)OB(c2c(C=Cc3ccccc3S3)c3ccc2)OC1(C)C Chemical compound CC1(C)OB(c2c(C=Cc3ccccc3S3)c3ccc2)OC1(C)C FNXOJKLRHYFBBQ-UHFFFAOYSA-N 0.000 description 1
- BRTNACKFELUKGA-UHFFFAOYSA-N CCc1cc(-c2ccccc2)cc(-c2ccccc2)n1 Chemical compound CCc1cc(-c2ccccc2)cc(-c2ccccc2)n1 BRTNACKFELUKGA-UHFFFAOYSA-N 0.000 description 1
- LZQBKGPVNBKIPR-UHFFFAOYSA-N CNc1nc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound CNc1nc(-c2ccccc2)nc(-c2ccccc2)n1 LZQBKGPVNBKIPR-UHFFFAOYSA-N 0.000 description 1
- VZFHZGBGZSCHCE-UHFFFAOYSA-N Cc(cc1C=Cc2c3c4ccccc44)ccc1Sc2ccc3[n]4-c1nc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound Cc(cc1C=Cc2c3c4ccccc44)ccc1Sc2ccc3[n]4-c1nc(-c2ccccc2)nc(-c2ccccc2)n1 VZFHZGBGZSCHCE-UHFFFAOYSA-N 0.000 description 1
- ZLMBAXQKCVBGFF-UHFFFAOYSA-N Cc1cccc(-c2cc(-c3ccccc3)nc(-c3ccccc3)n2)c1 Chemical compound Cc1cccc(-c2cc(-c3ccccc3)nc(-c3ccccc3)n2)c1 ZLMBAXQKCVBGFF-UHFFFAOYSA-N 0.000 description 1
- ROTVYQUGLYGYKI-UHFFFAOYSA-N Clc1cc(-c2ccccc2)cc(-c2ccccc2)n1 Chemical compound Clc1cc(-c2ccccc2)cc(-c2ccccc2)n1 ROTVYQUGLYGYKI-UHFFFAOYSA-N 0.000 description 1
- MJDDVTZXYXHTRY-UHFFFAOYSA-N Clc1cc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound Clc1cc(-c2ccccc2)nc(-c2ccccc2)n1 MJDDVTZXYXHTRY-UHFFFAOYSA-N 0.000 description 1
- DDGPPAMADXTGTN-UHFFFAOYSA-N Clc1nc(-c2ccccc2)nc(-c2ccccc2)n1 Chemical compound Clc1nc(-c2ccccc2)nc(-c2ccccc2)n1 DDGPPAMADXTGTN-UHFFFAOYSA-N 0.000 description 1
- SFKMVPQJJGJCMI-UHFFFAOYSA-N Clc1nc2ccccc2c(-c2ccccc2)n1 Chemical compound Clc1nc2ccccc2c(-c2ccccc2)n1 SFKMVPQJJGJCMI-UHFFFAOYSA-N 0.000 description 1
- BBXHKLFYVKBQMA-UHFFFAOYSA-N [O-][N+](c(cccc1)c1-c1c(C=Cc2ccccc2N2)c2ccc1)=O Chemical compound [O-][N+](c(cccc1)c1-c1c(C=Cc2ccccc2N2)c2ccc1)=O BBXHKLFYVKBQMA-UHFFFAOYSA-N 0.000 description 1
- GCVYTXKVMPFVQU-UHFFFAOYSA-N [O-][N+](c1ccccc1-c1c(C=Cc2ccccc2S2)c2ccc1)=O Chemical compound [O-][N+](c1ccccc1-c1c(C=Cc2ccccc2S2)c2ccc1)=O GCVYTXKVMPFVQU-UHFFFAOYSA-N 0.000 description 1
- VOQRPCXPZOPOSE-UHFFFAOYSA-N [O-][N+](c1ccccc1-c1cccc2c1N(c1ccccc1)c1ccccc1C=C2)=O Chemical compound [O-][N+](c1ccccc1-c1cccc2c1N(c1ccccc1)c1ccccc1C=C2)=O VOQRPCXPZOPOSE-UHFFFAOYSA-N 0.000 description 1
- KDFHIPYAIBHJIS-UHFFFAOYSA-N [O-][N+](c1ccccc1-c1cccc2c1Nc1ccccc1C=C2)=O Chemical compound [O-][N+](c1ccccc1-c1cccc2c1Nc1ccccc1C=C2)=O KDFHIPYAIBHJIS-UHFFFAOYSA-N 0.000 description 1
- QMEJNEMHHYVMLJ-UHFFFAOYSA-N c(cc1)cc2c1[nH]c1c2ccc2c1C=Cc1ccccc1S2 Chemical compound c(cc1)cc2c1[nH]c1c2ccc2c1C=Cc1ccccc1S2 QMEJNEMHHYVMLJ-UHFFFAOYSA-N 0.000 description 1
- UYUOOPOXZSPUAZ-UHFFFAOYSA-N c(cc1)ccc1-[n]1c(cc(cc2)-c(cc3)cc(C=Cc4c5)c3Nc4cc3c5[o]c4ccccc34)c2c2ccccc12 Chemical compound c(cc1)ccc1-[n]1c(cc(cc2)-c(cc3)cc(C=Cc4c5)c3Nc4cc3c5[o]c4ccccc34)c2c2ccccc12 UYUOOPOXZSPUAZ-UHFFFAOYSA-N 0.000 description 1
- SAWKBIRVSPSCFJ-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-[n]2c3ccc4N(c5ccccc5)c5ccccc5C=Cc4c3c3ccccc23)nc(-c2ccccc2)c1 Chemical compound c(cc1)ccc1-c1cc(-[n]2c3ccc4N(c5ccccc5)c5ccccc5C=Cc4c3c3ccccc23)nc(-c2ccccc2)c1 SAWKBIRVSPSCFJ-UHFFFAOYSA-N 0.000 description 1
- HFSSYLPDTPDRDF-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-c2cccc(-[n](c3ccccc33)c(cc4)c3c3c4C=Cc4ccccc4S3)c2)nc(-c2ccccc2)n1 Chemical compound c(cc1)ccc1-c1cc(-c2cccc(-[n](c3ccccc33)c(cc4)c3c3c4C=Cc4ccccc4S3)c2)nc(-c2ccccc2)n1 HFSSYLPDTPDRDF-UHFFFAOYSA-N 0.000 description 1
- QUQXCRQTVPLASF-UHFFFAOYSA-N c(cc1)ccc1-c1cc(-c2ccccc2)nc(-[n]2c(c3c(cc4)N(c5ccccc5)c5ccccc5C=C3)c4c3c2cccc3)c1 Chemical compound c(cc1)ccc1-c1cc(-c2ccccc2)nc(-[n]2c(c3c(cc4)N(c5ccccc5)c5ccccc5C=C3)c4c3c2cccc3)c1 QUQXCRQTVPLASF-UHFFFAOYSA-N 0.000 description 1
- UMMCZSCTVHYWNA-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-[n]2c3ccc(C=Cc(cccc4)c4S4)c4c3c3c2cccc3)nc(-c2ccccc2)n1 Chemical compound c(cc1)ccc1-c1nc(-[n]2c3ccc(C=Cc(cccc4)c4S4)c4c3c3c2cccc3)nc(-c2ccccc2)n1 UMMCZSCTVHYWNA-UHFFFAOYSA-N 0.000 description 1
- KLHPCNGJFLWVTO-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-c2cc(-[n]3c(c4c(cc5)Sc6ccccc6C=C4)c5c4c3cccc4)ccc2)nc(-c2ccccc2)n1 Chemical compound c(cc1)ccc1-c1nc(-c2cc(-[n]3c(c4c(cc5)Sc6ccccc6C=C4)c5c4c3cccc4)ccc2)nc(-c2ccccc2)n1 KLHPCNGJFLWVTO-UHFFFAOYSA-N 0.000 description 1
- CRARRYFFNQYVEC-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-c2ccccc2)nc(-[n]2c3ccc(C=Cc(cccc4)c4N4c5ccccc5)c4c3c3c2cccc3)c1 Chemical compound c(cc1)ccc1-c1nc(-c2ccccc2)nc(-[n]2c3ccc(C=Cc(cccc4)c4N4c5ccccc5)c4c3c3c2cccc3)c1 CRARRYFFNQYVEC-UHFFFAOYSA-N 0.000 description 1
- JVVKHBZTHQJERH-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2cc(-c3cc(-[n](c4c5cccc4)c(cc4)c5c5c4N(c4ccccc4)c4ccccc4C=C5)ccc3)ccc2)n1 Chemical compound c(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2cc(-c3cc(-[n](c4c5cccc4)c(cc4)c5c5c4N(c4ccccc4)c4ccccc4C=C5)ccc3)ccc2)n1 JVVKHBZTHQJERH-UHFFFAOYSA-N 0.000 description 1
- RIVYAMGYHGMXTM-UHFFFAOYSA-N c(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2cccc(-[n](c3ccccc33)c(cc4)c3c3c4Sc4ccccc4C=C3)c2)n1 Chemical compound c(cc1)ccc1-c1nc(-c2ccccc2)nc(-c2cccc(-[n](c3ccccc33)c(cc4)c3c3c4Sc4ccccc4C=C3)c2)n1 RIVYAMGYHGMXTM-UHFFFAOYSA-N 0.000 description 1
- FEILGOMISBHXFE-UHFFFAOYSA-N c(cc1)ccc1-c1nc(N2c(cc(c3ccccc3[o]3)c3c3)c3C=Cc3cc(-c(cc4)cc5c4c(cccc4)c4[n]5-c4ccccc4)ccc23)nc2ccccc12 Chemical compound c(cc1)ccc1-c1nc(N2c(cc(c3ccccc3[o]3)c3c3)c3C=Cc3cc(-c(cc4)cc5c4c(cccc4)c4[n]5-c4ccccc4)ccc23)nc2ccccc12 FEILGOMISBHXFE-UHFFFAOYSA-N 0.000 description 1
- OXNDGLQMAHNCBE-UHFFFAOYSA-N c(cc1)ccc1N(c1ccccc1C=C1)c(cc2)c1c1c2c(cccc2)c2[nH]1 Chemical compound c(cc1)ccc1N(c1ccccc1C=C1)c(cc2)c1c1c2c(cccc2)c2[nH]1 OXNDGLQMAHNCBE-UHFFFAOYSA-N 0.000 description 1
- VKAVARIJVIVZDE-UHFFFAOYSA-N c(cc1)ccc1N1c(c2c(cc3)[nH]c4ccccc24)c3C=Cc2ccccc12 Chemical compound c(cc1)ccc1N1c(c2c(cc3)[nH]c4ccccc24)c3C=Cc2ccccc12 VKAVARIJVIVZDE-UHFFFAOYSA-N 0.000 description 1
- NDLBBMKGFRGSHD-UHFFFAOYSA-N c(cc1c2c3)ccc1[nH]c2cc1c3C=Cc2ccccc2O1 Chemical compound c(cc1c2c3)ccc1[nH]c2cc1c3C=Cc2ccccc2O1 NDLBBMKGFRGSHD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6576—Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1033—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1037—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1059—Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
Abstract
본 발명은 유기 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것으로서, 본 발명에 따른 화합물은 유기 전계 발광 소자의 유기물층, 바람직하게는 발광층에 사용됨에 따라 유기 전계 발광 소자의 발광효율, 구동전압, 수명 등을 향상시킬 수 있다.BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an organic compound and an organic electroluminescent device including the organic compound, wherein the compound according to the present invention is used in an organic compound layer of an organic electroluminescent device, And the like can be improved.
Description
본 발명은 신규한 유기 화합물 및 상기 화합물을 포함하는 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic compound and an organic electroluminescent device comprising the compound.
유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 유기물층으로 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 상기 유기물층에 포함되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다.In the organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the organic layer in the anode, and electrons are injected into the organic layer in the cathode. When the injected holes and electrons meet, an exciton is formed. When the exciton falls to the ground state, light is emitted. The material contained in the organic material layer may be classified into a light emitting material, a hole injecting material, a hole transporting material, an electron transporting material, an electron injecting material, or the like depending on its function.
상기 발광 물질은 발광색에 따라 청색, 녹색, 적색의 발광 물질과, 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색의 발광 물질로 구분될 수 있다. 또한 색순도의 증가와 에너지 전이를 통해 발광 효율을 증가시키기 위하여 발광 물질로서 호스트/도판트 계를 사용할 수 있다.The luminescent material may be classified into blue, green, and red luminescent materials according to luminescent colors, and yellow and orange luminescent materials necessary to realize better natural colors. A host / dopant system can be used as a luminescent material to increase the luminous efficiency through increase of color purity and energy transfer.
도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이때 인광 도판트는 이론적으로 형광 도판트에 비해 최대 4배의 발광 효율을 향상시킬 수 있기 때문에 인광 도판트 뿐만 아니라 인광 호스트에 대한 연구가 많이 진행되고 있다.The dopant material can be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. Since the phosphorescent dopant can theoretically improve the luminous efficiency up to 4 times as compared with the fluorescent dopant, studies on the phosphorescent dopant as well as the phosphorescent host have been conducted.
현재 발광층에 사용되는 형광 도판트/호스트 물질로는 안트라센 유도체들이 알려져 있다. 또한 발광층에 사용되는 인광 도판트 물질로는 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등의 Ir을 포함하는 금속 착체 화합물이 알려져 있고, 인광 호스트 물질로는 4,4-dicarbazolybiphenyl(CBP)가 알려져 있다.Currently, anthracene derivatives are known as fluorescent dopant / host materials used in the light emitting layer. As phosphorescent dopant materials used for the light emitting layer, metal complex compounds including Ir such as Firpic, Ir (ppy) 3 , (acac) Ir (btp) 2 and the like are known. As phosphorescent host materials, 4,4-dicarbazolybiphenyl (CBP) is known.
그러나 기존의 재료들은 유리전이온도가 낮고 열적 안정성이 좋지 않아 유기 전계 발광 소자에서의 수명 측면에서 만족할만한 수준이 되지 못하고 있으며, 발광 특성 측면에서도 여전히 개선이 필요하다.However, since the conventional materials have low glass transition temperature and poor thermal stability, they are not satisfactory in terms of lifetime in organic electroluminescent devices, and still need improvement in terms of luminescent properties.
상기한 문제점을 해결하기 위해 본 발명은 유리 전이온도가 높으며 열적 안정성이 우수하고, 발광 특성이 개선된 신규 유기 화합물을 제공하는 것을 목적으로 한다.In order to solve the above problems, it is an object of the present invention to provide a novel organic compound having a high glass transition temperature, excellent thermal stability, and improved luminescence properties.
또 본 발명은 상기 유기 화합물을 포함하는 유기 전계 발광 소자를 제공하는 것을 목적으로 한다.Another object of the present invention is to provide an organic electroluminescent device comprising the organic compound.
상기한 목적을 달성하기 위해 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.In order to accomplish the above object, the present invention provides a compound represented by the following general formula (1).
[화학식 1][Chemical Formula 1]
상기 화학식 1에서,In Formula 1,
X1은 O, S 및 N(Ar1)으로 이루어진 군에서 선택되고,X 1 is selected from the group consisting of O, S and N (Ar 1 )
Ar1은 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고,Ar 1 represents a C 1 to C 40 alkyl group, a C 2 to C 40 alkenyl group, a C 2 to C 40 alkynyl group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C An aryl group having 6 to 60 carbon atoms, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, a C 3 to C 40 alkylsilyl group, a C 6 ~ C 60 aryl silyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C of the group 60 arylboronic of, C 6 ~ C 60 aryl phosphine group, C 6 ~ aryl phosphine oxide of the C 60 group And an arylamine group of C 6 to C 60 ,
R1 내지 R10은 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되며,R 1 to R 10 each independently represent hydrogen, deuterium, a halogen, a cyano group, a nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ of C 40 cycloalkyl group, the number of nuclear atoms of 3 to 40 of the heterocycloalkyl of the alkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, C 1 ~ alkyloxy group of C 40, C 6 ~ aryloxy group of C 60, C 3 ~ C 40 alkylsilyl group, C group 6 ~ C 60 aryl silyl, C 1 ~ arylboronic of C 40 group of an alkyl boron, C 6 ~ C 60 group, C 6 ~ C 60 groups of the aryl phosphine group, an aryl amine of the C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 of is selected from the group consisting of,
R1과 R2, R2와 R3 및 R3와 R4 중 적어도 하나는 서로 결합하여 하기 화학식 2로 표시되는 축합 고리를 형성하고,At least one of R 1 and R 2 , R 2 and R 3, and R 3 and R 4 is bonded to each other to form a condensed ring represented by the following formula (2)
[화학식 2](2)
상기 화학식 2에서,In Formula 2,
점선은 상기 화학식 1과 결합되는 부분이고,The dotted line is a moiety bonded to the above formula (1)
X2는 O, S, N(R31), C(R32)(R33) 및 Si(R34)(R35)로 이루어진 군에서 선택되며,X 2 is selected from the group consisting of O, S, N (R 31 ), C (R 32) (R 33) and Si (R 34) (R 35 ),
R11 내지R14 및 R31내지 R35는 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되며,R 11 to R 14 and R 31 to R 35 each independently represent hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 2 to C 40 alkenyl, C 2 to C 40 An alkynyl group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyl aryloxy group, C 6 ~ aryloxy C 60, C group 3 ~ C 40 alkylsilyl, C 6 ~ C aryl silyl group of 60, C 1 ~ C 40 group of an alkyl boron, C 6 ~ aryl of C 60 boron group, C 6 ~ C 60 aryl phosphine group, and selected from the group consisting of an aryl amine of the C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 of,
상기 Ar1, R1 내지 R14 및 R31 내지 R35의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있으며, 상기 치환기는 인접한 기와 결합하여 축합 고리를 형성할 수 있다.Wherein Ar 1, R 1 to R 14 and R 31 to R 35 an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, alkyloxy group, aryloxy group, alkyl silyl group, A halogen atom, a cyano group, a nitro group, a C 1 to C 40 alkyl group, a C 2 to C 40 alkyl group, an aryl group, an aryl group, A C 2 to C 40 alkynyl group, a C 3 to C 40 cycloalkyl group, a heterocyclic cycloalkyl group having 3 to 40 nuclear atoms, an aryl group having 6 to 60 carbon atoms, an aryl group having 5 to 60 nuclear atoms a heteroaryl group, C 1 ~ C 40 of the alkyloxy group, C 6 ~ C 60 of the aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C aryl silyl group of 60, C 1 ~ C 40 boron alkyl group, C 6 ~ C 60 aryl group of boron, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ selected from the group consisting of an arylamine C in 60 1 may be unsubstituted or substituted by at least one substituent, and the substituent may form a condensed ring by combining adjacent tile.
상기 Ar1, R1 내지 R14 및 R31 내지 R35가 복수개의 치환기로 치환될 경우, 복수개의 치환기는 서로 동일하거나 상이할 수 있다.When Ar 1 , R 1 to R 14, and R 31 to R 35 are substituted with a plurality of substituents, the plurality of substituents may be the same as or different from each other.
한편 본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.According to another aspect of the present invention, there is provided an organic electroluminescent device comprising a positive electrode, a negative electrode, and at least one organic material layer interposed between the positive electrode and the negative electrode, wherein at least one of the one or more organic material layers contains a compound represented by the above formula An organic electroluminescent device is provided.
본 발명에 따른 화합물은 내열성, 캐리어 수송능, 발광능 등이 우수하기 때문에 유기 전계 발광 소자의 유기물층 재료로 사용될 수 있다.Since the compound according to the present invention is excellent in heat resistance, carrier transport ability, and light emitting ability, it can be used as an organic material layer material of an organic electroluminescent device.
또한, 본 발명에 따른 화합물을 유기물층에 포함하는 유기 전계 발광 소자는 발광성능, 구동전압, 수명, 효율 등의 측면이 크게 향상될 수 있고, 이에 따라 풀 칼라 디스플레이 패널 등에 효과적으로 적용될 수 있다.In addition, the organic electroluminescent device including the compound according to the present invention in the organic material layer can significantly improve aspects such as light emitting performance, driving voltage, lifetime, and efficiency, and thus can be effectively applied to a full color display panel and the like.
이하, 본 발명을 설명한다.
Hereinafter, the present invention will be described.
1. 유기 화합물1. Organic compounds
본 발명에 따른 신규 유기 화합물은 디벤조아제핀(5H-dibenzo[b,f]azepine), 디벤조옥세핀(dibenzo[b,f]oxepine) 또는 디벤조싸이에핀(dibenzo[b,f]thiepine)에 벤젠이 축합된 5원 헤테로방향족환 모이어티, 인덴 모이어티(indene moiety), 또는 인돌 모이어티(indole moiety)가 축합되어 기본 골격을 이루는 것으로, 상기 화학식 1로 표시된다.The novel organic compounds according to the present invention can be prepared by reacting dibenzo [b, f] azepine, dibenzo [b, f] oxepine or dibenzo [b, a 5-membered heteroaromatic ring moiety, an indene moiety, or an indole moiety is condensed with thiepine to form a basic skeleton.
이러한 본 발명의 화학식 1로 표시되는 화합물은 상기 기본 골격에 도입되는 치환기의 종류에 따라 HOMO 및 LUMO 에너지 레벨을 조절할 수 있어, 넓은 밴드갭을 가질 수 있고, 높은 캐리어 수송성을 가질 수 있다. 예를 들어, 상기 화학식 1로 표시되는 화합물은 상기 기본 골격에 질소-함유 헤테로환(예컨대, 피리딘기, 피리미딘기, 트리아진기등)과 같이 전자 흡수성이 큰 전자 끌개기(EWG)가 결합될 경우, 분자 전체가 바이폴라(bipolar) 특성을 갖기 때문에 정공과 전자의 결합력을 높일 수 있다. 이와 같이 EWG가 도입된 상기 화학식 1로 표시되는 화합물은 캐리어 수송성 및 발광 특성이 우수하기 때문에 유기 전계 발광 소자의 발광층 재료뿐만 아니라, 캐리어 수송층 재료로도 사용될 수 있다.The compound represented by Formula 1 of the present invention can control the HOMO and LUMO energy levels according to the type of substituent introduced into the basic skeleton, and can have a wide band gap and a high carrier transporting property. For example, the compound represented by Formula 1 may have an electron-withdrawing group (EWG) such as a nitrogen-containing heterocycle (e.g., pyridine group, pyrimidine group, triazine group, etc.) , Since the entire molecule has a bipolar characteristic, the bonding force between holes and electrons can be increased. Since the compound represented by the formula (1) introduced with EWG is excellent in carrier transporting property and light emitting property, it can be used not only as a light emitting layer material of an organic electroluminescence device but also as a carrier transporting layer material.
한편, 상기 화학식 1의 화합물은 상기 기본 골격에 아릴아민기, 카바졸기, 터페닐기, 트리페닐렌기 등과 같이 전자 공여성이 큰 전자 주게기(EDG)가 결합될 경우, 정공의 주입 및 수송이 원활하게 이루어지기 때문에 정공주입/수송층 또는 발광 보조층 재료로도 유용하게 사용될 수 있다.On the other hand, when a large electron donor (EDG) such as an arylamine group, a carbazole group, a terphenyl group, and a triphenylene group is bonded to the basic skeleton of the compound of Formula 1, injection and transport of holes are smooth The hole injecting / transporting layer or the light emitting auxiliary layer material can be effectively used.
또한 본 발명의 화학식 1로 표시되는 화합물은 상기 기본 골격에 다양한 치환체, 특히 아릴기 및/또는 헤테로아릴기가 도입되어 화합물의 분자량이 유의적으로 증대됨으로써 유리 전이 온도가 높아 종래의 유기물층 재료(예를 들어, CBP)보다 높은 열적 안정성을 가질 수 있다. 또한, 본 발명의 화학식 1로 표시되는 화합물은 유기물층의 결정화 억제에도 효과가 있다.In addition, the compound represented by the formula (1) of the present invention has various substituents, particularly aryl groups and / or heteroaryl groups, introduced into the basic skeleton and the molecular weight of the compound is significantly increased, For example, CBP may have higher thermal stability. Further, the compound represented by the general formula (1) of the present invention is also effective for inhibiting crystallization of the organic material layer.
또 본 발명의 화학식 1로 표시되는 화합물은 넓은 일중항 에너지 준위와 높은 삼중항 에너지 준위를 가지는 인돌 모이어티가 축합되어 있고, 다양한 치환체가 도입되어 있어 에너지 준위가 높기 때문에 유기물층에서도 발광층의 인광 호스트로 유용하게 적용될 수 있다.In addition, the compound represented by the formula (1) of the present invention has an indole moiety having a broad singlet energy level and a high triplet energy level condensed therein, and various substituents are introduced, Can be usefully applied.
따라서 본 발명의 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 유기물층(구체적으로, 정공 수송층, 정공 주입층, 전자수송층 또는 발광층)에 적용할 경우 유기 전계 발광 소자의 구동전압, 발광효율 및 수명을 향상시킬 수 있다. 이와 같이 성능 및 수명 특성이 향상된 유기 전계 발광 소자는 결과적으로 풀 칼라 유기 발광 패널의 성능을 극대화시킬 수 있다.Accordingly, when the compound represented by Formula 1 of the present invention is applied to an organic compound layer (specifically, a hole transport layer, a hole injection layer, an electron transport layer, or a light emitting layer) of an organic electroluminescent device, the driving voltage, Can be improved. As a result, the organic light emitting device having improved performance and lifetime characteristics can maximize the performance of the full color organic light emitting panel.
이러한 본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택될 수 있다.The compound represented by the formula (1) of the present invention may be selected from the group consisting of compounds represented by the following formulas (1a) to (1f).
[화학식 1a][Formula 1a]
[화학식 1b][Chemical Formula 1b]
[화학식 1c][Chemical Formula 1c]
[화학식 1d]≪ RTI ID = 0.0 &
[화학식 1e][Formula 1e]
[화학식 1f](1f)
상기 화학식 1a 내지 1f에서, X1, X2, R1 내지 R14는 상기 화학식 1에서 정의된 바와 같다.In the above formulas (1a) to (1f), X 1 , X 2 and R 1 to R 14 are as defined in the above formula (1).
한편 상기 화학식 2로 표시되는 축합 고리가 결합된 화학식 1로 표시되는 화합물에서, R1 내지 R14 중 적어도 하나는 하기 화학식 3으로 표시될 수 있는데, 그 중에서도 R7 내지 R14 중 하나가 하기 화학식 3으로 표시되는 것이 바람직하며, R7 내지 R10 중 하나가 하기 화학식 3으로 표시되는 것이 더욱 바람직하다.Meanwhile, in the fused ring compound represented by the above formula (2) represented by the combined formula 1, R 1 to R 14 At least one of R < 7 > to R < 7 > R < 14 > is preferably represented by the following formula (3), and R < 7 & R 10 Is more preferably represented by the following formula (3).
[화학식 3](3)
상기 화학식 3에서, L1은 단일결합, C6~C60의 아릴렌기 및 핵원자수 5 내지 60의 헤테로아릴렌기로 이루어진 군에서 선택되고, *는 상기 화학식 1과 결합되는 부분이며,In Formula 3, L 1 is selected from the group consisting of a single bond, an arylene group having 6 to 60 carbon atoms, and a heteroarylene group having 5 to 60 nuclear atoms, * is a moiety bonded to Formula 1,
X3는 O, S, N(R31), C(R32)(R33) 및 Si(R34)(R35)로 이루어진 군에서 선택되고,X 3 is selected from the group consisting of O, S, N (R 31 ), C (R 32) (R 33) and Si (R 34) (R 35 ),
L1과 연결되지 않은 상기 R21 내지 R28 및 R31 내지 R35는 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고,R 21 to R 28 and R 31 to R 35 which are not connected to L 1 are each independently hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 2 to C 40 alkenyl , A C 2 to C 40 alkynyl group, a C 3 to C 40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, A C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, a C 1 to C 40 alkylsilyl group, a C 6 to C 60 arylsilyl group, a C 1 to C 40 alkylboron group, is selected from the group C 6 ~ C 60 aryl group of boron, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl amine, consisting of,
상기 R21 내지 R28 및 R31 내지 R35의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기와, 상기L1의 아릴렌기 및 헤테로아릴렌기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있으며, 상기 치환기는 인접한 기와 결합하여 축합 고리를 형성할 수 있다.The alkyl group, alkenyl group, alkynyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group and arylsilyl group of R 21 to R 28 and R 31 to R 35 , alkyl boron group, an aryl boron group, an aryl phosphine group, aryl phosphine oxide group and an arylamine group, arylene group and heteroarylene group each independently selected from deuterium, halogen, a cyano group of the L 1, a nitro group, C 1 ~ alkyl group of C 40, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 of the alkynyl group, C of 3 ~ C 40 heterocycloalkyl group, C 6 ~ C 60 cycloalkyl in the group, a number of nuclear atoms of 3 to 40 aryl , A heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, a C 1 to C 40 alkylsilyl group, a C 6 to C 60 aryl silyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C group 60 arylboronic of, C 6 ~ C 60 aryl phosphine group, C 6 ~ aryl phosphine oxide of a C 60 group, and a C 6 ~ C 60 May be unsubstituted or substituted by one or more substituents selected from the group consisting of aryl amines, and the substituents may be bonded to the adjacent groups can form a condensed ring.
상기 R21 내지 R28 및 R31 내지 R35이 복수개의 치환기로 치환될 경우, 복수개의 치환기는 서로 동일하거나 상이할 수 있다.When R 21 to R 28 and R 31 to R 35 are substituted with a plurality of substituents, the plurality of substituents may be the same or different from each other.
여기서, 유기 전계 발광 소자의 특성을 고려할 때, 상기 화학식 3에서 L1은 단일결합이거나 페닐렌기이며, X2는 O 또는 N(R31)인 것이 바람직하다.Here, considering the characteristics of the organic electroluminescent device, it is preferable that L 1 in Formula 3 is a single bond or a phenylene group, and X 2 is O or N (R 31 ).
또한, 유기 전계 발광 소자의 특성을 고려할 때, 본 발명의 화학식 1로 표시되는 화합물에서, Ar1및 R31은 각각 독립적으로 C1~C40의 알킬기, C6~C60의 아릴기 및 핵원자수 5 내지 60의 헤테로아릴기로 이루어진 군에서 선택되는 것이 바람직하며, 페닐기 또는 하기 화학식 4로 표시되는 치환기인 것이 더 바람직하다.In the compound represented by the formula (1) of the present invention, Ar 1 and R 31 each independently represent a C 1 to C 40 alkyl group, a C 6 to C 60 aryl group, and a nucleus And a heteroaryl group having 5 to 60 atoms, and more preferably a phenyl group or a substituent represented by the following general formula (4).
[화학식 4][Chemical Formula 4]
상기 화학식 4에서,In Formula 4,
L2는 단일결합, C6~C18의 아릴렌기 및 핵원자수 5 내지 18의 헤테로아릴렌기로 이루어진 군에서 선택되고,L 2 is selected from the group consisting of a single bond, a C 6 to C 18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms,
Z1 내지 Z5는 각각 독립적으로 N 또는 C(R15)이며, 이때, Z1 내지 Z5 중 적어도 하나는 N이고,Each of Z 1 to Z 5 is independently N or C (R 15 ), wherein at least one of Z 1 to Z 5 is N,
상기 R15는 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C6~C60의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되거나, 인접하는 기와 결합하여 축합 고리를 형성할 수 있고,Wherein R 15 is selected from the group consisting of hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 2 to C 40 alkenyl, C 2 to C 40 alkynyl, C 3 to C 40 cycloalkyl , A heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group A C 6 to C 60 arylamine group, a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, a C 6 to C 60 arylphosphine pingi, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ selected from the group consisting of C 60 or aryl silyl, by combining groups of adjacent, may form a condensed ring,
상기 R15의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있다. 이때, R15가 복수개의 치환기로 치환될 경우, 복수개의 치환기는 서로 동일하거나 상이할 수 있다.Alkyl group of the R 15, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, an arylamine group, an alkylsilyl group, an alkyl boron group, an aryl boron group, The arylphosphine group, arylphosphine oxide group and arylsilyl group are each independently selected from the group consisting of deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkoxy A C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 6 to C 60 aryloxy group, a C 1 to C 40 alkyloxy group, a C 6 to C 60 arylamine group, aryl boron group, C 3 ~ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 60 of the group, substituted by C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide groups and one or more substituents selected from the group consisting of aryl silyl C 6 ~ C 60 of It may be unsubstituted. When R 15 is substituted with a plurality of substituents, a plurality of substituents may be the same as or different from each other.
여기서, 유기 전계 발광 소자의 특성을 고려할 때, 상기 화학식 4의 L2는 단일결합, 페닐렌기 또는 비페닐렌기인 것이 바람직하다.Here, considering the characteristics of the organic electroluminescent device, it is preferable that L 2 in Formula 4 is a single bond, a phenylene group or a biphenylene group.
또한, Z1 내지 Z5는 중 둘 이상이 C(R15)이어서 C(R15)가 복수개일 경우, 복수개의 C(R15)는 서로 동일하거나 상이할 수 있다.Furthermore, Z 1 to Z 5 or more than one is C (R 15) Then C (R 15) when the plurality of the plurality of C (R 15) of which may be the same or different from each other.
구체적으로, 상기 화학식 4로 표시되는 치환기는 하기 A1 내지 A15로 표시되는 구조로 이루어진 군에서 선택될 수 있다.Specifically, the substituent represented by the formula (4) may be selected from the group consisting of the structures represented by the following formulas A1 to A15.
상기 화학식 A1 내지 A15에서, L2 및 R15는 상기 화학식 4에서 정의한 바와 같고,In the formulas (A1) to (A15), L 2 and R 15 are the same as defined in the formula (4)
R41은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C6~C60의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되거나, 인접하는 기와 결합하여 축합 고리를 형성할 수 있고,R 41 is selected from the group consisting of hydrogen, deuterium, halogen, cyano, nitro, C 1 to C 40 alkyl, C 2 to C 40 alkenyl, C 2 to C 40 alkynyl, C 3 to C 40 cycloalkyl, nuclear atoms of 3 to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, a nuclear atoms of 5 to 60 heteroaryl group, C 1 ~ alkyloxy group of C 40 of the, aryloxy of C 6 ~ C 60 , An arylamine group of C 6 to C 60 , a C 1 to C 40 alkylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, a C 6 to C 60 arylphosphine group , C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ selected from the group consisting of C 60 or aryl silyl, by combining groups of adjacent, may form a condensed ring,
n은 1 내지 4의 정수이며,n is an integer of 1 to 4,
상기 R41의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있다. 이때, R15가 복수개의 치환기로 치환될 경우, 복수개의 치환기는 서로 동일하거나 상이할 수 있다.Alkyl group of the R 41, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, an arylamine group, an alkylsilyl group, an alkyl boron group, an aryl boron group, The arylphosphine group, arylphosphine oxide group and arylsilyl group are each independently selected from the group consisting of deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkoxy A C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 6 to C 60 aryloxy group, a C 1 to C 40 alkyloxy group, a C 6 to C 60 arylamine group, aryl boron group, C 3 ~ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 60 of the group, substituted by C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide groups and one or more substituents selected from the group consisting of aryl silyl C 6 ~ C 60 of It may be unsubstituted. When R 15 is substituted with a plurality of substituents, a plurality of substituents may be the same as or different from each other.
본 발명의 화합물은 보다 구체적으로 하기 화학식으로 나타낼 수 있으나, 이에 한정되는 것은 아니다.The compounds of the present invention can be represented more specifically by the following formulas, but are not limited thereto.
본 발명에서의 알킬은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미하며, 이의 비제한적인 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등이 있다.The alkyl in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a linear or branched saturated hydrocarbon having 1 to 40 carbon atoms, and examples thereof include methyl, ethyl, propyl, isobutyl, sec-butyl, Pentyl, iso-amyl, hexyl, and the like.
본 발명에서의 알케닐(alkenyl)은 탄소-탄소 이중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등이 있다.The alkenyl in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a linear or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond. Non-limiting examples thereof include vinyl, allyl, isopropenyl, 2-butenyl, and the like.
본 발명에서의 알키닐(alkynyl)은 탄소-탄소 삼중 결합을 1개 이상 가진 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 에타인일(ethynyl), 2-프로파인일(2-propynyl) 등이 있다.The alkynyl in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a linear or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon triple bond. Non-limiting examples thereof include ethynyl, 2-propynyl, and the like.
본 발명에서의 시클로알킬은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소(포화 고리형 탄화수소)로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 시클로프로필, 시클로펜틸, 시클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine)등이 있다.The cycloalkyl in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms (saturated cyclic hydrocarbon). Non-limiting examples thereof include cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
본 발명에서의 헤테로시클로알킬은 핵원자수 3 내지 40의 비-방향족 탄화수소(포화 고리형 탄화수소)로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 질소(N), 산소(O), 황(S) 또는 셀레늄(Se)와 같은 헤테로원자로 치환된다. 이의 비제한적인 예로는 모르폴린, 피페라진 등이 있다.In the present invention, heterocycloalkyl means a monovalent functional group obtained by removing a hydrogen atom from a non-aromatic hydrocarbon (saturated cyclic hydrocarbon) having 3 to 40 nuclear atoms, and includes at least one carbon atom in the ring, The three carbons are replaced by a heteroatom such as nitrogen (N), oxygen (O), sulfur (S) or selenium (Se). Non-limiting examples thereof include morpholine, piperazine, and the like.
본 발명에서의 아릴은 단독 고리 또는 2 이상의 고리가 조합된, 탄소수 6 내지 60의 방향족 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이때, 2 이상의 고리는 서로 단순 부착되거나 축합된 형태로 부착될 수 있다. 이의 비제한적인 예로는 페닐, 비페닐, 터페닐(terphenyl), 나프틸, 페난트릴, 안트릴 등이 있다.The aryl in the present invention means a monovalent functional group obtained by removing a hydrogen atom from an aromatic hydrocarbon having 6 to 60 carbon atoms in which a single ring or two or more rings are combined. At this time, the two or more rings may be attached to each other in a simple attached or condensed form. Non-limiting examples thereof include phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthryl, and the like.
본 발명에서의 헤테로아릴은 핵원자수 5 내지 60의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기로서, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 질소(N), 산소(O), 황(S) 또는 셀레늄(Se)과 같은 헤테로원자로 치환된다. 이때, 헤테로아릴은 2 이상의 고리가 서로 단순 부착되거나 축합된 형태로 부착될 수 있고, 나아가 아릴기와의 축합된 형태도 포함할 수 있다. 이러한 헤테로아릴의 비제한적인 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리; 및 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등을 들 수 있다.The heteroaryl in the present invention is a monovalent functional group obtained by removing a hydrogen atom from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms, and includes at least one carbon atom, preferably 1 to 3 carbon atoms in the ring Carbon is replaced by a heteroatom such as nitrogen (N), oxygen (O), sulfur (S) or selenium (Se). At this time, the heteroaryl may be attached in a form in which two or more rings are attached or condensed to each other, and may further include a condensed form with an aryl group. Non-limiting examples of such heteroaryls include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, and triazinyl; Such as phenoxathienyl, indolizinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl, and the like. ring; And 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl and the like.
본 발명에서의 알킬옥시는 RO-로 표시되는 1가의 작용기를 의미하며, 상기 R은 탄소수 1 내지 40개의 알킬로서, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 이러한 알킬옥시의 비제한적인 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있다.The alkyloxy in the present invention means a monovalent functional group represented by RO-, wherein R is an alkyl having 1 to 40 carbon atoms and may include a linear, branched or cyclic structure have. Non-limiting examples of such alkyloxy include methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
본 발명에서의 아릴옥시는 R'O-로 표시되는 1가의 작용기를 의미하며, 상기 R'는 탄소수 6 내지 60의 아릴이다. 이러한 아릴옥시의 비제한적인 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등이 있다.In the present invention, aryloxy means a monovalent functional group represented by R'O-, and R 'is aryl having 6 to 60 carbon atoms. Non-limiting examples of such aryloxy include phenyloxy, naphthyloxy, diphenyloxy, and the like.
본 발명에서의 알킬실릴은 탄소수 1 내지 40의 알킬로 치환된 실릴을 의미하며, 아릴실릴은 탄소수 6 내지 60의 아릴로 치환된 실릴을 의미하고, 아릴아민은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다.In the present invention, alkylsilyl means silyl substituted with alkyl having 1 to 40 carbon atoms, arylsilyl means silyl substituted with aryl having 6 to 60 carbon atoms, and arylamine means silyl substituted with aryl having 6 to 60 carbon atoms Amines.
본 발명에서의 축합 고리는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.
The condensed ring in the present invention means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.
2. 유기 전계 발광 소자2. Organic electroluminescent device
본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 1종 이상 포함하는 유기 전계 발광 소자를 제공한다.The present invention relates to an organic electroluminescent device comprising a cathode, a cathode, and at least one organic layer interposed between the anode and the cathode, wherein at least one of the organic layers includes at least one compound represented by Formula 1 to provide.
상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 전자 주입층 중 어느 하나 이상일 수 있다. 바람직하게는 상기 화학식 1로 표시되는 화합물은 정공 주입층, 정공 수송층 및 발광층 물질로서 유기 전계 발광 소자에 포함될 수 있다. 이 경우 유기 전계 발광 소자는 발광효율, 휘도, 전력효율, 열적 안정성 및 소자 수명이 향상될 수 있다.The organic material layer containing the compound represented by Formula 1 may be at least one of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. Preferably, the compound represented by Formula 1 may be included in an organic electroluminescent device as a hole injecting layer, a hole transporting layer, and a light emitting layer material. In this case, the light emitting efficiency, brightness, power efficiency, thermal stability, and device lifetime of the organic electroluminescent device can be improved.
특히 본 발명의 화학식 1로 표시되는 화합물은 발광층의 인광 호스트, 형광 호스트 또는 도펀트인 것이 바람직하며, 발광층의 인광 호스트인 것이 더욱 바람직하다.In particular, the compound represented by the general formula (1) of the present invention is preferably a phosphorescent host, a fluorescent host or a dopant of a light emitting layer, and more preferably a phosphorescent host of a light emitting layer.
이러한 본 발명의 유기 전계 발광 소자의 구조는 특별히 한정되지 않으나, 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 음극이 순차적으로 적층된 것일 수 있다. 상기 전자 수송층 위에는 전자 주입층이 위치할 수도 있다.The structure of the organic electroluminescent device of the present invention is not particularly limited, but may be a substrate, an anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and a cathode sequentially laminated. An electron injection layer may be disposed on the electron transport layer.
또한 본 발명의 유기 전계 발광 소자는 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조로 이루어질 수도 있다.Also, the organic electroluminescent device of the present invention may have a structure in which an insulating layer or an adhesive layer is interposed between the electrode and the organic layer interface.
본 발명의 유기 전계 발광 소자에서 상기 화학식 1로 표시되는 화합물을 포함하는 유기물층은 진공증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이들에 한정되지는 않는다.In the organic electroluminescent device of the present invention, the organic material layer containing the compound represented by Formula 1 may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.
본 발명의 유기 전계 발광 소자는 유기물층 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는 당업계에 알려져 있는 재료 및 방법을 이용하여 유기물층 및 전극을 형성함으로써 제조될 수 있다.The organic electroluminescent device of the present invention can be manufactured by forming an organic material layer and an electrode using materials and methods known in the art, except that one or more of the organic material layers include the compound represented by Formula 1 have.
예컨대, 기판으로는 실리콘 웨이퍼, 석영 또는 유리판, 금속판, 플라스틱 필름 등이 사용될 수 있다.For example, the substrate may be a silicon wafer, quartz or glass plate, a metal plate, a plastic film, or the like.
양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자; 또는 카본블랙 등이 있으나, 이들에 한정되는 것은 아니다.Examples of the positive electrode material include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole and polyaniline; Or carbon black, but are not limited thereto.
음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에 한정되는 것은 아니다.Examples of the negative electrode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin or lead or alloys thereof; Layer structure materials such as LiF / Al or LiO 2 / Al, but are not limited thereto.
정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층으로 사용되는 물질은 당업계에 알려진 통상의 물질이라면 특별히 한정되지 않는다.
The material used for the hole injecting layer, the hole transporting layer, the electron injecting layer and the electron transporting layer is not particularly limited as long as it is a conventional material known in the art.
이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited by the following examples.
[준비예 1] IIC-1 의 합성[Preparation Example 1] Synthesis of IIC-1
<단계 1> 1-(2-bromophenyl)-1H-indole의 합성<Step 1> Synthesis of 1- (2-bromophenyl) -1H-indole
질소 기류 하에서 Indole (80 g, 683 mmol), 2-Bromoiodobenzene (290 g, 1.02 mol), Cu powder(21.7 g, 341 mmol), K2CO3(189 g, 1.37 mol), nitrobenzene(1000 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 9:1 (v/v))로 정제하여 1-(2-bromophenyl)-1H-indole (103.7 g, 수율 56%)을 얻었다.2-Bromoiodobenzene (290 g, 1.02 mol), Cu powder (21.7 g, 341 mmol), K 2 CO 3 (189 g, 1.37 mol), nitrobenzene (1000 mL) under a nitrogen stream, Were mixed and stirred at 190 占 폚 for 12 hours. After the reaction was terminated, the nitrobenzene was removed, extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer, and the residue was purified by column chromatography (Hexane: EA = 9: 1 (v / v)) to obtain 1- (2-bromophenyl) -1H-indole (103.7 g, yield 56%).
1H-NMR: δ 6.69 (d, 1H), 7.21 (m, 4H), 7.28 (d, 1H), 7.38 (d, 1H), 7.52 (d, 1H), 7.66 (m, 2H) 1 H-NMR: δ 6.69 ( d, 1H), 7.21 (m, 4H), 7.28 (d, 1H), 7.38 (d, 1H), 7.52 (d, 1H), 7.66 (m, 2H)
<단계 2> 4-bromo-5H-dibenzo[b,f]azepine의 합성<Step 2> Synthesis of 4-bromo-5H-dibenzo [b, f] azepine
질소 기류 하에서 1-(2-bromophenyl)-1H-indole (103.7 g, 381 mmol)에 PPA 1000 g을 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 차가운 물에 반응 용액을 부은 후 교반시키며 NaOH 수용액으로 중화시켰다. 이후, 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 4-bromo-5H-dibenzo[b,f]azepine (35.2 g, 수율 34 %)을 얻었다.1000 g of PPA was added to 1- (2-bromophenyl) -1H-indole (103.7 g, 381 mmol) under a nitrogen stream and stirred for 12 hours. After the reaction was completed, the reaction solution was poured into cold water, stirred and neutralized with aqueous NaOH solution. Then, the mixture was extracted with dichloromethane, added with MgSO 4 and filtered. The solvent was removed from the resulting organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain 4-bromo-5H-dibenzo [b, f] azepine (35.2 g, yield 34% .
1H-NMR : δ 4.21 (brs, 1H), 6.70(t, 1H), 6.81(t, 1H), 6.99 (s, 2H), 7.24 (m, 4H), 8.21 (d, 1H) 1 H-NMR: δ 4.21 ( brs, 1H), 6.70 (t, 1H), 6.81 (t, 1H), 6.99 (s, 2H), 7.24 (m, 4H), 8.21 (d, 1H)
<단계 3> 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine의 합성Synthesis of 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine
질소 기류 하에서 4-bromo-5H-dibenzo[b,f]azepine (35.2 g, 130 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (36.1 g, 142 mmol), Pd(dppf)Cl2 (11.3 g, 13.0 mmol), KOAc (36.5 g, 388 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine (25.6 g, 수율 62 %)을 얻었다.(35.2 g, 130 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-dibenzo [b, dioxane (36.1 g, 142 mmol), Pd (dppf) Cl 2 (11.3 g, 13.0 mmol), KOAc (36.5 g, 388 mmol) and 1,4- ) Were mixed and stirred at 130 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 4- (4,4,5,5- -1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine (25.6 g, yield 62%).
1H-NMR: δ 1.21 (s, 12H), 4.23 (brs, 1H), 6.74(t, 1H), 6.83(t, 1H), 6.99 (s, 2H), 7.24 (m, 4H), 8.20 (d, 1H) 1 H-NMR: δ 1.21 ( s, 12H), 4.23 (brs, 1H), 6.74 (t, 1H), 6.83 (t, 1H), 6.99 (s, 2H), 7.24 (m, 4H), 8.20 ( d, 1 H)
<단계 4> 4-(2-nitrophenyl)-5H-dibenzo[b,f]azepine의 합성<Step 4> Synthesis of 4- (2-nitrophenyl) -5H-dibenzo [b, f] azepine
질소 기류 하에서 2-bromo-1-nitrobenzene (16.2 g, 80.2 mmol), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine (25.6 g, 80.2 mmol), K2CO3 (33.3 g, 241 mmol) 및 THF/H2O (200 ml/50 ml)를 혼합한 다음, Pd(PPh3)4 (4.63 g, 3 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 4-(2-nitrophenyl)-5H-dibenzo[b,f]azepine (18.4 g, 수율 73%)을 얻었다.(16.2 g, 80.2 mmol), 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine (25.6 g, 80.2 mmol), K 2 CO 3 (33.3 g, 241 mmol) and a mixture of THF / H 2 O (200 ml / 50 ml) , and then, Pd (PPh 3) 4 ( 4.63 g, 3 mmol), which was stirred for 12 hours at 80 ° C. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 4- (2-nitrophenyl) -5H-dibenzo [b, f] azepine %).
1H-NMR: δ 4.26 (brs, 1H), 6.80(t, 1H), 6.88(t, 1H), 6.96 (s, 2H), 7.27 (m, 4H), 7.67 (d, 1H), 8.07 (m, 3H), 8.22(d, 1H) 1 H-NMR: δ 4.26 ( brs, 1H), 6.80 (t, 1H), 6.88 (t, 1H), 6.96 (s, 2H), 7.27 (m, 4H), 7.67 (d, 1H), 8.07 ( m, 3 H), 8.22 (d, 1 H)
<단계 5> 4-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine의 합성Step 5 Synthesis of 4- (2-nitrophenyl) -5-phenyl-5H-dibenzo [b, f] azepine
질소 기류 하에서 4-(2-nitrophenyl)-5H-dibenzo[b,f]azepine (18.4 g, 58.6 mmol), iodobenzene (7.21 mL, 64.4 mmol), Cu powder (1.86 g, 29.3 mmol), K2CO3 (16.2 g, 117 mmol), nitrobenzene(200 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 4-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine (14.9 g, 수율 65%)을 얻었다. 5-dibenzo [b, f] azepine (18.4 g, 58.6 mmol), iodobenzene (7.21 mL, 64.4 mmol), Cu powder (1.86 g, 29.3 mmol), K 2 CO 3 (16.2 g, 117 mmol) and nitrobenzene (200 ml) were mixed and stirred at 190 ° C for 12 hours. After the reaction was terminated, the nitrobenzene was removed, extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and the residue was purified by column chromatography (hexane: EA = 20: 1 (v / v)) to obtain 4- (2-nitrophenyl) -5-phenyl-5H-dibenzo [ g, yield 65%).
1H-NMR: δ 6.71-6.88 (m, 6H), 6.96 (s, 2H), 7.12-7.23 (m, 6H), 7.67 (t, 1H), 8.03 (m, 3H) 1 H-NMR: δ 6.71-6.88 ( m, 6H), 6.96 (s, 2H), 7.12-7.23 (m, 6H), 7.67 (t, 1H), 8.03 (m, 3H)
<단계 6> IIC-1의 합성<Step 6> Synthesis of IIC-1
질소 기류 하에서 4-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine (14.9 g, 38.1 mmol), triphenylphosphine (25.0 g, 95.4 mmol), 1,2-dichlorobenzene (150 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-1 (4.78 g, 수율 35 %)을 얻었다.Dibenzo [b, f] azepine (14.9 g, 38.1 mmol), triphenylphosphine (25.0 g, 95.4 mmol), 1,2-dichlorobenzene (150 mL) under nitrogen atmosphere, And the mixture was stirred for 12 hours. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain compound IIC-1 (4.78 g, yield 35%).
1H-NMR: δ 6.68-6.73(m, 5H), 6.99(m, 3H), 7.14-7.20(m, 4H), 7.34-7.41(m, 4H), 8.12(d, 1H), 8.51(brs, 1H)
1 H-NMR: δ 6.68-6.73 ( m, 5H), 6.99 (m, 3H), 7.14-7.20 (m, 4H), 7.34-7.41 (m, 4H), 8.12 (d, 1H), 8.51 (brs , 1H)
[준비예 2] IIC-2 & IIC-3의 합성[Preparation Example 2] Synthesis of IIC-2 & IIC-3
<단계 1> 1-(3-bromophenyl)-1H-indole의 합성<Step 1> Synthesis of 1- (3-bromophenyl) -1H-indole
질소 기류 하에서 Indole (80 g, 683 mmol), 3-Bromoiodobenzene (290 g, 1.02 mol), Cu powder (21.7 g, 341 mmol), K2CO3 (189 g, 1.37 mol), nitrobenzene (1000 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 9:1 (v/v))로 정제하여 1-(3-bromophenyl)-1H-indole (103.7 g, 수율 56%)을 얻었다.Indole (80 g, 683 mmol), 3-bromoiodobenzene (290 g, 1.02 mol), Cu powder (21.7 g, 341 mmol), K 2 CO 3 (189 g, 1.37 mol), nitrobenzene (1000 mL) Were mixed and stirred at 190 占 폚 for 12 hours. After the reaction was completed, nitrobenzene was removed, and the residue was extracted with methylene chloride, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer, and the residue was purified by column chromatography (Hexane: EA = 9: 1 (v / v)) to obtain 1- (3-bromophenyl) -1H-indole (103.7 g, yield 56%).
1H-NMR: δ 6.67 (d, 1H), 7.24 (m, 4H), 7.25 (d, 1H), 7.43 (d, 1H), 7.50 (d, 1H), 7.63 (m, 2H) 1 H-NMR: δ 6.67 ( d, 1H), 7.24 (m, 4H), 7.25 (d, 1H), 7.43 (d, 1H), 7.50 (d, 1H), 7.63 (m, 2H)
<단계 2> 3-bromo-5H-dibenzo[b,f]azepine의 합성<Step 2> Synthesis of 3-bromo-5H-dibenzo [b, f] azepine
질소 기류 하에서 1-(3-bromophenyl)-1H-indole (103.7 g, 381 mmol)에 PPA 1000 g을 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 차가운 물에 반응 용액을 부은 후 교반시키며 NaOH 수용액으로 중화시켰다. 이후, 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 3-bromo-5H-dibenzo[b,f]azepine (35.2 g, 수율 34 %)을 얻었다.1000 g of PPA was added to 1- (3-bromophenyl) -1H-indole (103.7 g, 381 mmol) under a nitrogen stream and stirred for 12 hours. After the reaction was completed, the reaction solution was poured into cold water, stirred and neutralized with aqueous NaOH solution. Then, the mixture was extracted with dichloromethane, added with MgSO 4 and filtered. The solvent was removed from the resulting organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain 35.2 g (yield: 34%) of 3-bromo-5H-dibenzo [b, f] azepine .
1H-NMR: δ 4.18 (brs, 1H), 6.70(t, 1H), 6.81(t, 1H), 6.95 (s, 2H), 7.21 (m, 4H), 8.18 (d, 1H) 1 H-NMR: δ 4.18 ( brs, 1H), 6.70 (t, 1H), 6.81 (t, 1H), 6.95 (s, 2H), 7.21 (m, 4H), 8.18 (d, 1H)
<단계 3> 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine의 합성Synthesis of 3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine
질소 기류 하에서 3-bromo-5H-dibenzo[b,f]azepine (35.2 g, 130 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (36.1 g, 142 mmol), Pd(dppf)Cl2 (11.3 g, 13.0 mmol), KOAc (36.5 g, 388 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine (25.6 g, 수율 62%)을 얻었다.(35.2 g, 130 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-dibenzo [b, dioxane (36.1 g, 142 mmol), Pd (dppf) Cl 2 (11.3 g, 13.0 mmol), KOAc (36.5 g, 388 mmol) and 1,4- ) Were mixed and stirred at 130 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 3- (4,4,5,5-tetramethyl -1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine (25.6 g, yield 62%).
1H-NMR: δ 1.20 (s, 12H), 4.20 (brs, 1H), 6.71(t, 1H), 6.80(t, 1H), 6.98 (s, 2H), 7.22 (m, 4H), 8.20 (d, 1H) 1 H-NMR: δ 1.20 ( s, 12H), 4.20 (brs, 1H), 6.71 (t, 1H), 6.80 (t, 1H), 6.98 (s, 2H), 7.22 (m, 4H), 8.20 ( d, 1 H)
<단계 4> 3-(2-nitrophenyl)-5H-dibenzo[b,f]azepine의 합성<Step 4> Synthesis of 3- (2-nitrophenyl) -5H-dibenzo [b, f] azepine
질소 기류 하에서 2-bromo-1-nitrobenzene (16.2 g, 80.2 mmol), 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine (25.6 g, 80.2 mmol), K2CO3 (33.3 g, 241 mmol) 및 THF/H2O(200 ml/50 ml)를 혼합한 다음, Pd(PPh3)4 (4.63 g, 3 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 3-(2-nitrophenyl)-5H-dibenzo[b,f]azepine (18.4 g, 수율 73%)을 얻었다.(16.2 g, 80.2 mmol), 3- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine (25.6 g, 80.2 mmol), K 2 CO 3 (33.3 g, 241 mmol) and a mixture of THF / H 2 O (200 ml / 50 ml) , and then, Pd (PPh 3) 4 ( 4.63 g, 3 mmol), which was stirred for 12 hours at 80 ° C. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then the residue was purified by column chromatography (hexane: EA = 20: 1 (v / v)) to obtain 18.4 g of 3- (2-nitrophenyl) -5H-dibenzo [b, f] azepine %).
1H-NMR: δ 4.22 (brs, 1H), 6.80(t, 1H), 6.88(t, 1H), 6.96 (s, 2H), 7.27 (m, 4H), 7.67 (d, 1H), 8.07 (m, 3H), 8.22(d, 1H) 1 H-NMR: δ 4.22 ( brs, 1H), 6.80 (t, 1H), 6.88 (t, 1H), 6.96 (s, 2H), 7.27 (m, 4H), 7.67 (d, 1H), 8.07 ( m, 3 H), 8.22 (d, 1 H)
<단계 5> 3-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine의 합성Step 5 Synthesis of 3- (2-nitrophenyl) -5-phenyl-5H-dibenzo [b, f] azepine
질소 기류 하에서 3-(2-nitrophenyl)-5H-dibenzo[b,f]azepine (18.4 g, 58.6 mmol), iodobenzene (7.21 mL, 64.4 mmol), Cu powder(1.86 g, 29.3 mmol), K2CO3(16.2 g, 117 mmol), nitrobenzene (200 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 3-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine (14.9 g, 수율 65%)을 얻었다.(18.4 g, 58.6 mmol), iodobenzene (7.21 mL, 64.4 mmol), Cu powder (1.86 g, 29.3 mmol), K 2 CO 3 (16.2 g, 117 mmol) and nitrobenzene (200 ml) were mixed and stirred at 190 ° C for 12 hours. After the reaction was terminated, the nitrobenzene was removed, extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and the residue was purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 3- (2-nitrophenyl) -5-phenyl-5H-dibenzo [b, f] azepine g, yield 65%).
1H-NMR: δ 6.68-6.84 (m, 6H), 6.98 (s, 2H), 7.15-7.23 (m, 6H), 7.66 (t, 1H), 8.01 (m, 3H) 1 H-NMR: δ 6.68-6.84 ( m, 6H), 6.98 (s, 2H), 7.15-7.23 (m, 6H), 7.66 (t, 1H), 8.01 (m, 3H)
<단계 6> IIC-2 & IIC-3의 합성<Step 6> Synthesis of IIC-2 & IIC-3
질소 기류 하에서 3-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine (14.9 g, 38.1 mmol), triphenylphosphine (25.0 g, 95.4 mmol), 1,2-dichlorobenzene (150 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-2 (4.78 g, 수율 35 %)과, 화합물 IIC-3 (4.78g, 수율 35 %)을 얻었다.Dibenzo [b, f] azepine (14.9 g, 38.1 mmol), triphenylphosphine (25.0 g, 95.4 mmol), 1,2-dichlorobenzene (150 mL) under nitrogen atmosphere, And the mixture was stirred for 12 hours. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain 4.78 g of compound IIC-2 (4.78 g, yield 35% 35%).
IIC-2의 1H-NMR: δ 6.68-6.73(m, 5H), 6.99(m, 3H), 7.14-7.20(m, 3H), 7.34-7.41(m, 4H), 8.08(d, 1H), 8.12(d, 1H), 8.50(brs, 1H)Of IIC-2 1 H-NMR: δ 6.68-6.73 (m, 5H), 6.99 (m, 3H), 7.14-7.20 (m, 3H), 7.34-7.41 (m, 4H), 8.08 (d, 1H) , 8.12 (d, 1 H), 8.50 (brs, 1 H)
IIC-3의 1H-NMR: δ 6.70-6.74(m, 5H), 6.97(m, 3H), 7.12-7.20(m, 3H), 7.38-7.42(m, 4H), 7.99(s, 1H), 8.10(d, 1H), 8.53(brs, 1H)
Of IIC-3 1 H-NMR: δ 6.70-6.74 (m, 5H), 6.97 (m, 3H), 7.12-7.20 (m, 3H), 7.38-7.42 (m, 4H), 7.99 (s, 1H) , 8.10 (d, 1 H), 8.53 (brs, 1 H)
[준비예 3] IIC-4의 합성[Preparation Example 3] Synthesis of IIC-4
<단계 1> 1-(3-bromophenyl)-1H-indole의 합성<Step 1> Synthesis of 1- (3-bromophenyl) -1H-indole
질소 기류 하에서 Indole (80 g, 683 mmol), 3-Bromoiodobenzene (290 g, 1.02 mol), Cu powder(21.7 g, 341 mmol), K2CO3 (189 g, 1.37 mol), nitrobenzene (1000 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 9:1 (v/v))로 정제하여 1-(3-bromophenyl)-1H-indole (103.7 g, 수율 56%)을 얻었다.Indole (80 g, 683 mmol), 3-bromoiodobenzene (290 g, 1.02 mol), Cu powder (21.7 g, 341 mmol), K 2 CO 3 (189 g, 1.37 mol), nitrobenzene (1000 mL) Were mixed and stirred at 190 占 폚 for 12 hours. After the reaction was terminated, the nitrobenzene was removed, extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer, and the residue was purified by column chromatography (Hexane: EA = 9: 1 (v / v)) to obtain 1- (3-bromophenyl) -1H-indole (103.7 g, yield 56%).
1H-NMR: δ 6.67 (d, 1H), 7.24 (m, 4H), 7.25 (d, 1H), 7.43 (d, 1H), 7.50 (d, 1H), 7.63 (m, 2H) 1 H-NMR: δ 6.67 ( d, 1H), 7.24 (m, 4H), 7.25 (d, 1H), 7.43 (d, 1H), 7.50 (d, 1H), 7.63 (m, 2H)
<단계 2> 1-bromo-5H-dibenzo[b,f]azepine의 합성<Step 2> Synthesis of 1-bromo-5H-dibenzo [b, f] azepine
질소 기류 하에서 1-(3-bromophenyl)-1H-indole (103.7 g 381 mmol)에 PPA 1000 g을 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 차가운 물에 반응 용액을 부은 후 교반시키며 NaOH 수용액으로 중화시켰다. 이후, 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 1-bromo-5H-dibenzo[b,f]azepine (35.2 g, 수율 34 %)을 얻었다.1000 g of PPA was added to 1- (3-bromophenyl) -1H-indole (103.7 g, 381 mmol) under nitrogen flow, and the mixture was stirred for 12 hours. After the reaction was completed, the reaction solution was poured into cold water, stirred and neutralized with aqueous NaOH solution. Then, the mixture was extracted with dichloromethane, added with MgSO 4 and filtered. The solvent was removed from the resulting organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain 1-bromo-5H-dibenzo [b, f] azepine (35.2 g, yield 34% .
1H-NMR: δ 4.17 (brs, 1H), 6.76(t, 1H), 6.83(t, 1H), 6.98 (s, 2H), 7.25 (m, 4H), 8.04 (d, 1H) 1 H-NMR: δ 4.17 ( brs, 1H), 6.76 (t, 1H), 6.83 (t, 1H), 6.98 (s, 2H), 7.25 (m, 4H), 8.04 (d, 1H)
<단계 3> 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine의 합성Synthesis of 1- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine
질소 기류 하에서 1-bromo-5H-dibenzo[b,f]azepine (35.2 g, 130 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (36.1 g, 142 mmol), Pd(dppf)Cl2 (11.3 g, 13.0 mmol), KOAc (36.5 g, 388 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine (25.6 g, 수율 62%)을 얻었다.(35.2 g, 130 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-dibenzo [b, dioxane (36.1 g, 142 mmol), Pd (dppf) Cl 2 (11.3 g, 13.0 mmol), KOAc (36.5 g, 388 mmol) and 1,4- ) Were mixed and stirred at 130 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 1- (4,4,5,5- -1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine (25.6 g, yield 62%).
1H-NMR: δ 1.25 (s, 12H), 4.23 (brs, 1H), 6.75(t, 1H), 6.83(t, 1H), 6.98 (s, 2H), 7.20 (m, 4H), 8.02 (d, 1H) 1 H-NMR: δ 1.25 ( s, 12H), 4.23 (brs, 1H), 6.75 (t, 1H), 6.83 (t, 1H), 6.98 (s, 2H), 7.20 (m, 4H), 8.02 ( d, 1 H)
<단계 4> 1-(2-nitrophenyl)-5H-dibenzo[b,f]azepine의 합성<Step 4> Synthesis of 1- (2-nitrophenyl) -5H-dibenzo [b, f] azepine
질소 기류 하에서 2-bromo-1-nitrobenzene (16.2 g, 80.2 mmol), 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine (25.6 g, 80.2 mmol), K2CO3 (33.3 g, 241 mmol) 및 THF/H2O(200 ml/50 ml)를 혼합한 다음, Pd(PPh3)4 (4.63 g, 3 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 1-(2-nitrophenyl)-5H-dibenzo[b,f]azepine (18.4 g, 수율 73%)을 얻었다.(16.2 g, 80.2 mmol), 1- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine (25.6 g, 80.2 mmol), K 2 CO 3 (33.3 g, 241 mmol) and a mixture of THF / H 2 O (200 ml / 50 ml) , and then, Pd (PPh 3) 4 ( 4.63 g, 3 mmol), which was stirred for 12 hours at 80 ° C. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then the residue was purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 1- (2-nitrophenyl) -5H-dibenzo [b, f] azepine %).
1H-NMR: δ 4.22 (brs, 1H), 6.73(t, 1H), 6.83(t, 1H), 6.98 (s, 2H), 7.23 (m, 4H), 7.67 (d, 1H), 8.05 (m, 3H), 8.10(d, 1H) 1 H-NMR: δ 4.22 ( brs, 1H), 6.73 (t, 1H), 6.83 (t, 1H), 6.98 (s, 2H), 7.23 (m, 4H), 7.67 (d, 1H), 8.05 ( m, 3H), 8.10 (d, 1 H)
<단계 5> 1-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine의 합성Step 5 Synthesis of 1- (2-nitrophenyl) -5-phenyl-5H-dibenzo [b, f] azepine
질소 기류 하에서 1-(2-nitrophenyl)-5H-dibenzo[b,f]azepine (18.4 g, 58.6 mmol), iodobenzene (7.21 mL, 64.4 mmol), Cu powder(1.86 g, 29.3 mmol), K2CO3 (16.2 g, 117 mmol), nitrobenzene (200 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 1-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine (14.9 g, 수율 65 %)을 얻었다.5-dibenzo [b, f] azepine (18.4 g, 58.6 mmol), iodobenzene (7.21 mL, 64.4 mmol), Cu powder (1.86 g, 29.3 mmol), K 2 CO 3 (16.2 g, 117 mmol) and nitrobenzene (200 ml) were mixed and stirred at 190 ° C for 12 hours. After the reaction was completed, nitrobenzene was removed, and the residue was extracted with methylene chloride, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and the residue was purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 1- (2-nitrophenyl) -5-phenyl-5H-dibenzo [b, f] azepine g, yield 65%).
1H-NMR: δ 6.69-6.81 (m, 6H), 6.97 (s, 2H), 7.15-7.20 (m, 6H), 7.62 (t, 1H), 8.07 (m, 3H) 1 H-NMR:? 6.69-6.81 (m, 6H), 6.97 (s, 2H), 7.15-7. 20 (m,
<단계 6> IIC-4의 합성<Step 6> Synthesis of IIC-4
질소 기류 하에서 1-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine (14.9 g, 38.1 mmol), triphenylphosphine (25.0 g, 95.4 mmol), 1,2-dichlorobenzene (150 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-4 (4.78 g, 수율 35 %) 을 얻었다.5-dibenzo [b, f] azepine (14.9 g, 38.1 mmol), triphenylphosphine (25.0 g, 95.4 mmol), 1,2-dichlorobenzene (150 mL) And the mixture was stirred for 12 hours. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain compound IIC-4 (4.78 g, yield 35%).
1H-NMR: δ 6.68-6.76(m, 5H), 6.99(m, 3H), 7.20-7.25(m, 4H), 7.35-7.40(m, 4H), 8.10(d, 1H), 8.46(brs, 1H)
1 H-NMR:? 6.68-6.76 (m, 5H), 6.99 (m, 3H), 7.20-7.25 (m, 4H), 7.35-7.40 , 1H)
[준비예 4] IIC-5 & IIC-6의 합성[Preparation Example 4] Synthesis of IIC-5 & IIC-6
<단계 1> 1-(4-bromophenyl)-1H-indole의 합성<Step 1> Synthesis of 1- (4-bromophenyl) -1H-indole
질소 기류 하에서 Indole (80 g, 683 mmol), 4-Bromoiodobenzene (290 g, 1.02 mol), Cu powder (21.7 g, 341 mmol), K2CO3 (189 g, 1.37 mol), nitrobenzene(1000 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 9:1 (v/v))로 정제하여 1-(4-bromophenyl)-1H-indole (103.7 g, 수율 56 %)을 얻었다.(80 g, 683 mmol), 4-bromoiodobenzene (290 g, 1.02 mol), Cu powder (21.7 g, 341 mmol), K 2 CO 3 (189 g, 1.37 mol), nitrobenzene (1000 mL) Were mixed and stirred at 190 占 폚 for 12 hours. After the reaction was completed, nitrobenzene was removed, and the residue was extracted with methylene chloride, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer, and the residue was purified by column chromatography (Hexane: EA = 9: 1 (v / v)) to obtain 1- (4-bromophenyl) -1H-indole (103.7 g, yield 56%).
1H-NMR: δ 6.54 (d, 1H), 7.01(t, 1H), 7.28 (d, 1H), 7.33 (t, 1H), 7.50 (d, 2H), 7.62 (d, 2H), 7.93(m, 2H) 1 H-NMR: δ 6.54 ( d, 1H), 7.01 (t, 1H), 7.28 (d, 1H), 7.33 (t, 1H), 7.50 (d, 2H), 7.62 (d, 2H), 7.93 ( m, 2H)
<단계 2> 2-bromo-5H-dibenzo[b,f]azepine의 합성<Step 2> Synthesis of 2-bromo-5H-dibenzo [b, f] azepine
질소 기류 하에서 1-(4-bromophenyl)-1H-indole (103.7 g 381 mmol)에 PPA 1000 g을 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 차가운 물에 반응 용액을 부은 후 교반시키며 NaOH 수용액으로 중화시켰다. 이후, 디클로로메탄으로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 2-bromo-5H-dibenzo[b,f]azepine (35.2g, 수율 34 %)을 얻었다.1000 g of PPA was added to 1- (4-bromophenyl) -1H-indole (103.7 g, 381 mmol) under a nitrogen stream, followed by stirring for 12 hours. After the reaction was completed, the reaction solution was poured into cold water, stirred and neutralized with aqueous NaOH solution. Then, the mixture was extracted with dichloromethane, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain 2-bromo-5H-dibenzo [b, f] azepine (35.2 g, yield 34% .
1H-NMR: δ 4.16 (brs, 1H), 6.73(t, 1H), 6.82(t, 1H), 6.97 (s, 2H), 7.23 (m, 4H), 8.01 (d, 1H) 1 H-NMR: δ 4.16 ( brs, 1H), 6.73 (t, 1H), 6.82 (t, 1H), 6.97 (s, 2H), 7.23 (m, 4H), 8.01 (d, 1H)
<단계 3> 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine의 합성Synthesis of 2- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine
질소 기류 하에서 2-bromo-5H-dibenzo[b,f]azepine (35.2 g, 130 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (36.1 g, 142 mmol), Pd(dppf)Cl2 (11.3 g, 13.0 mmol), KOAc (36.5 g, 388 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine (25.6 g, 수율 62 %)을 얻었다.(35.2 g, 130 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-dibenzo [b, f] azepine dioxane (36.1 g, 142 mmol), Pd (dppf) Cl 2 (11.3 g, 13.0 mmol), KOAc (36.5 g, 388 mmol) and 1,4- ) Were mixed and stirred at 130 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 2- (4,4,5,5-tetramethyl -1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine (25.6 g, yield 62%).
1H-NMR: δ 1.20 (s, 12H), 4.18 (brs, 1H), 6.73(t, 1H), 6.81(t, 1H), 6.98 (s, 2H), 7.20 (m, 4H), 8.00 (d, 1H) 1 H-NMR: δ 1.20 ( s, 12H), 4.18 (brs, 1H), 6.73 (t, 1H), 6.81 (t, 1H), 6.98 (s, 2H), 7.20 (m, 4H), 8.00 ( d, 1 H)
<단계 4> 2-(2-nitrophenyl)-5H-dibenzo[b,f]azepine의 합성<Step 4> Synthesis of 2- (2-nitrophenyl) -5H-dibenzo [b, f] azepine
질소 기류 하에서 2-bromo-1-nitrobenzene (16.2 g, 80.2 mmol), 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,f]azepine (25.6 g, 80.2 mmol), K2CO3 (33.3 g, 241 mmol) 및 THF/H2O (200 ml/50 ml)를 혼합한 다음, Pd(PPh3)4 (4.63 g, 3 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 2-(2-nitrophenyl)-5H-dibenzo[b,f]azepine (18.4 g, 수율 73%)을 얻었다.(16.2 g, 80.2 mmol), 2- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -5H-dibenzo [b, f] azepine (25.6 g, 80.2 mmol), K 2 CO 3 (33.3 g, 241 mmol) and a mixture of THF / H 2 O (200 ml / 50 ml) , and then, Pd (PPh 3) 4 ( 4.63 g, 3 mmol), which was stirred for 12 hours at 80 ° C. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then the residue was purified by column chromatography (hexane: EA = 20: 1 (v / v)) to obtain 2- (2-nitrophenyl) -5H- dibenzo [b, f] azepine %).
1H-NMR: δ 4.20 (brs, 1H), 6.80(t, 1H), 6.86(t, 1H), 6.98 (s, 2H), 7.25 (m, 4H), 7.66 (d, 1H), 8.02 (m, 3H), 8.18(d, 1H) 1 H-NMR: δ 4.20 ( brs, 1H), 6.80 (t, 1H), 6.86 (t, 1H), 6.98 (s, 2H), 7.25 (m, 4H), 7.66 (d, 1H), 8.02 ( m, 3 H), 8.18 (d, 1 H)
<단계 5> 2-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine의 합성Step 5 Synthesis of 2- (2-nitrophenyl) -5-phenyl-5H-dibenzo [b, f] azepine
질소 기류 하에서 2-(2-nitrophenyl)-5H-dibenzo[b,f]azepine (18.4 g, 58.6 mmol), iodobenzene (7.21 mL, 64.4 mmol), Cu powder(1.86 g, 29.3 mmol), K2CO3 (16.2 g, 117 mmol), nitrobenzene (200 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. 반응이 종결된 후 nitrobenzene을 제거하고 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 2-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine (14.9 g, 수율 65%)을 얻었다.5-dibenzo [b, f] azepine (18.4 g, 58.6 mmol), iodobenzene (7.21 mL, 64.4 mmol), Cu powder (1.86 g, 29.3 mmol), K 2 CO 3 (16.2 g, 117 mmol) and nitrobenzene (200 ml) were mixed and stirred at 190 ° C for 12 hours. After the reaction was terminated, the nitrobenzene was removed, extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and the residue was purified by column chromatography (hexane: EA = 20: 1 (v / v)) to obtain 2- (2-nitrophenyl) -5-phenyl-5H-dibenzo [b, f] azepine g, yield 65%).
1H-NMR: δ 6.65-6.80 (m, 6H), 6.96 (s, 2H), 7.11-7.17 (m, 6H), 7.66 (t, 1H), 7.98 (m, 3H) 1 H-NMR: δ 6.65-6.80 ( m, 6H), 6.96 (s, 2H), 7.11-7.17 (m, 6H), 7.66 (t, 1H), 7.98 (m, 3H)
<단계 6> IIC-5 & IIC-6의 합성<Step 6> Synthesis of IIC-5 & IIC-6
질소 기류 하에서 2-(2-nitrophenyl)-5-phenyl-5H-dibenzo[b,f]azepine (14.9 g, 38.1mmol), triphenylphosphine (25.0 g, 95.4 mmol), 1,2-dichlorobenzene (150 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-5 (4.78 g, 수율 35 %)와, 화합물 IIC-6 (4.78 g, 수율 35 %)을 얻었다.Dibenzo [b, f] azepine (14.9 g, 38.1 mmol), triphenylphosphine (25.0 g, 95.4 mmol), 1,2-dichlorobenzene (150 mL) under a nitrogen atmosphere, And the mixture was stirred for 12 hours. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain 4.78 g of compound IIC-5 (4.78 g, yield 35% 35%).
IIC-5의 1H-NMR: δ 6.63-6.70(m, 5H), 6.97(m, 3H), 7.14-7.23(m, 3H), 7.34-7.38(m, 4H), 8.04(d, 1H), 8.09(d, 1H), 8.52(brs, 1H)Of IIC-5 1 H-NMR: δ 6.63-6.70 (m, 5H), 6.97 (m, 3H), 7.14-7.23 (m, 3H), 7.34-7.38 (m, 4H), 8.04 (d, 1H) , 8.09 (d, 1 H), 8.52 (brs, 1 H)
IIC-6의 1H-NMR: δ 6.67-6.71(m, 5H), 6.96(m, 3H), 7.12-7.16(m, 3H), 7.35-7.40(m, 4H), 7.99(s, 1H), 8.11(d, 1H), 8.53(brs, 1H)
Of IIC-6 1 H-NMR: δ 6.67-6.71 (m, 5H), 6.96 (m, 3H), 7.12-7.16 (m, 3H), 7.35-7.40 (m, 4H), 7.99 (s, 1H) , 8.11 (d, 1 H), 8.53 (brs, 1 H)
[준비예 5] IIC-7 & IIC-8의 합성[Preparation Example 5] Synthesis of IIC-7 & IIC-8
<단계 1> 2-(dibenzo[b,f]thiepin-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성<Step 1> Synthesis of 2- (dibenzo [b, f] thiepin-2-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
질소 기류 하에서 2-bromodibenzo[b,f]thiepine (50 g, 173 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.3 g, 190 mmol), Pd(dppf)Cl2 (14.1 g, 17.3 mmol), KOAc (50.9 g, 519 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(dibenzo[b,f]thiepin-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, 수율 62%)을 얻었다.(50 g, 173 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1 Dioxaborolane (48.3 g, 190 mmol), Pd (dppf) Cl 2 (14.1 g, 17.3 mmol), KOAc (50.9 g, 519 mmol) and 1,4-dioxane And the mixture was stirred at 130 DEG C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 2- (dibenzo [b, f] thiepin-2 -yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, yield 62%).
1H-NMR: δ 1.24 (s, 12H), 6.99(s, 2H), 7.10(t, 1H), 7.18(t, 1H), 7.30(d, 1H), 7.40(m, 4H) 1 H-NMR: δ 1.24 ( s, 12H), 6.99 (s, 2H), 7.10 (t, 1H), 7.18 (t, 1H), 7.30 (d, 1H), 7.40 (m, 4H)
<단계 2> 2-(2-nitrophenyl)dibenzo[b,f]thiepine의 합성<Step 2> Synthesis of 2- (2-nitrophenyl) dibenzo [b, f] thiepine
질소 기류 하에서 2-bromo-1-nitrobenzene (21.6 g, 107 mmol), 2-(dibenzo[b,f]thiepin-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, 107 mmol), K2CO3 (44.4 g, 321 mmol) 및 THF/H2O(400 ml/100 ml)를 혼합한 다음, Pd(PPh3)4 (6.18 g, 5mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 2-(2-nitrophenyl)dibenzo[b,f]thiepine (25.9 g, 수율 73%)을 얻었다.(21.6 g, 107 mmol), 2- (dibenzo [b, f] thiepin-2-yl) -4,4,5,5-tetramethyl- 1,3,2- dioxaborolane (36.0 g, 107 mmol), K 2 CO 3 (44.4 g, 321 mmol) and THF / H 2 O (400 ml / 100 ml) were mixed and Pd (PPh 3 ) 4 (6.18 g, And the mixture was stirred at 80 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 2- (2-nitrophenyl) dibenzo [b, f] thiepine (25.9 g, yield 73% .
1H-NMR: δ 6.99(s, 2H), 7.10(t, 1H), 7.18(t, 1H), 7.30(d, 1H), 7.42-7.47(m, 3H), 7.67(t, 1H), 7.86(m, 2H), 8.02(m, 2H) 1 H-NMR:? 6.99 (s, 2H), 7.10 (t, IH), 7.18 (t, IH), 7.30 (d, IH), 7.42-7.47 7.86 (m, 2 H), 8.02 (m, 2 H)
<단계 3> IIC-7 & IIC-8의 합성<Step 3> Synthesis of IIC-7 & IIC-8
질소 기류 하에서 2-(2-nitrophenyl)dibenzo[b,f]thiepine (25.9 g, 78.3 mmol), triphenylphosphine (51.2 g, 195 mmol), 1,2-dichlorobenzene (250 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-7 (8.20 g, 수율 35 %)와, 화합물 IIC-8 (8.20 g, 수율 35 %)을 얻었다.(25.9 g, 78.3 mmol), triphenylphosphine (51.2 g, 195 mmol) and 1,2-dichlorobenzene (250 ml) were added under a nitrogen atmosphere and stirred for 12 hours. Respectively. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the resulting organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain 8.20 g of compound IIC-7 (yield: 35% 35%).
IIC-7의 1H-NMR: δ 6.97(m, 3H), 7.10(t, 1H), 7.18(t, 1H), 7.30(m, 2H), 7.42(d, 1H), 7.50(t, 1H), 7.63(d, 1H), 7.77(d, 1H), 8.08(d, 1H), 8.52(brs, 1H)Of IIC-7 1 H-NMR: δ 6.97 (m, 3H), 7.10 (t, 1H), 7.18 (t, 1H), 7.30 (m, 2H), 7.42 (d, 1H), 7.50 (t, 1H ), 7.63 (d, IH), 7.77 (d, IH), 8.08
IIC-8의 1H-NMR: δ 6.98(s, 2H), 7.10(t, 1H), 7.18(t, 1H), 7.28(m, 2H), 7.34(s, 1H), 7.40(d, 1H), 7.50(t, 1H), 7.63(d, 1H), 8.04(d, 1H), 8.15(s, 1H), 8.50(brs, 1H)
1 of the IIC-8 H-NMR: δ 6.98 (s, 2H), 7.10 (t, 1H), 7.18 (t, 1H), 7.28 (m, 2H), 7.34 (s, 1H), 7.40 (d, 1H ), 7.50 (t, IH), 7.63 (d, IH), 8.04
[준비예 6] IIC-9 & IIC-10의 합성[Preparation Example 6] Synthesis of IIC-9 & IIC-10
<단계 1> 2-(dibenzo[b,f]thiepin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성<Step 1> Synthesis of 2- (dibenzo [b, f] thiepin-3-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
질소 기류 하에서 3-bromodibenzo[b,f]thiepine (50 g, 173 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.3 g, 190 mmol), Pd(dppf)Cl2 (14.1 g, 17.3 mmol), KOAc (50.9 g, 519 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(dibenzo[b,f]thiepin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, 수율 62 %)을 얻었다.(50 g, 173 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1 Dioxaborolane (48.3 g, 190 mmol), Pd (dppf) Cl 2 (14.1 g, 17.3 mmol), KOAc (50.9 g, 519 mmol) and 1,4-dioxane And the mixture was stirred at 130 DEG C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 2- (dibenzo [b, f] thiepin-3 -yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, yield 62%).
1H-NMR: δ 1.24 (s, 12H), 6.99(s, 2H), 7.10(t, 1H), 7.18(t, 1H), 7.34(m, 3H), 7.45(d, 1H), 7.49(d, 1H) 1 H-NMR:? 1.24 (s, 12H), 6.99 (s, 2H), 7.10 (t, d, 1 H)
<단계 2> 3-(2-nitrophenyl)dibenzo[b,f]thiepine의 합성<Step 2> Synthesis of 3- (2-nitrophenyl) dibenzo [b, f] thiepine
질소 기류 하에서 2-bromo-1-nitrobenzene (21.6 g, 107 mmol), 2-(dibenzo[b,f]thiepin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, 107 mmol), K2CO3 (44.4 g, 321 mmol) 및 THF/H2O (400 ml/100 ml)를 혼합한 다음, Pd(PPh3)4 (6.18 g, 5 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 3-(2-nitrophenyl)dibenzo[b,f]thiepine (25.9 g, 수율 73%)을 얻었다.(21.6 g, 107 mmol), 2- (dibenzo [b, f] thiepin-3-yl) -4,4,5,5-tetramethyl- 1,3,2- dioxaborolane (36.0 g, 107 mmol) , K 2 CO 3 (44.4 g, 321 mmol) and a mixture of THF / H 2 O (400 ml / 100 ml) , and then, Pd (PPh 3) 4 ( 6.18 g, 5 mmol ) And the mixture was stirred at 80 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 3- (2-nitrophenyl) dibenzo [b, f] thiepine (25.9 g, yield 73% .
1H-NMR: δ 6.99(s, 2H), 7.10(t, 1H), 7.18(t, 1H), 7.36(m, 3H), 7.41(m, 2H), 7.67(t, 1H), 7.89(t, 1H), 8.03(m, 2H) 1 H-NMR: δ 6.99 ( s, 2H), 7.10 (t, 1H), 7.18 (t, 1H), 7.36 (m, 3H), 7.41 (m, 2H), 7.67 (t, 1H), 7.89 ( t, 1 H), 8.03 (m, 2 H)
<단계 3> IIC-9 & IIC-10의 합성<Step 3> Synthesis of IIC-9 & IIC-10
질소 기류 하에서 3-(2-nitrophenyl)dibenzo[b,f]thiepine (25.9 g, 78.3 mmol), triphenylphosphine (51.2 g, 195 mmol), 1,2-dichlorobenzene (250 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물인 IIC-9 (8.20 g, 수율 35 %)와, 화합물 IIC-10 (8.20 g, 수율 35 %)을 얻었다.(25.9 g, 78.3 mmol), triphenylphosphine (51.2 g, 195 mmol) and 1,2-dichlorobenzene (250 ml) were added thereto under nitrogen atmosphere and stirred for 12 hours. Respectively. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . Compound IIC-9 (8.20 g, yield 35%) and compound IIC-10 (8.20 g, yield 35%) were purified by column chromatography (Hexane: MC = 2: 1 (v / v) Yield: 35%).
IIC-9의 1H-NMR: δ 6.98(s, 2H), 7.10(t, 1H), 7.18(t, 1H), 7.28(m, 2H), 7.42(m, 2H), 7.50(t, 1H), 7.63(d, 1H), 8.07(d, 1H), 8.12(d, 1H), 8.52(brs, 1H)Of IIC-9 1 H-NMR: δ 6.98 (s, 2H), 7.10 (t, 1H), 7.18 (t, 1H), 7.28 (m, 2H), 7.42 (m, 2H), 7.50 (t, 1H ), 7.63 (d, IH), 8.07 (d, IH), 8.12
IIC-10의 1H-NMR: δ 6.99(s, 2H), 7.10(t, 1H), 7.18(t, 1H), 7.34(m, 3H), 7.38(s, 1H), 7.53(t, 1H), 7.63(d, 1H), 8.09(s, 1H), 8.12(d, 1H), 8.50(brs, 1H)
Of IIC-10 1 H-NMR: δ 6.99 (s, 2H), 7.10 (t, 1H), 7.18 (t, 1H), 7.34 (m, 3H), 7.38 (s, 1H), 7.53 (t, 1H ), 7.63 (d, IH), 8.09 (s, IH), 8.12
[준비예 7] IIC-11의 합성[Preparation Example 7] Synthesis of IIC-11
<단계 1> 2-(dibenzo[b,f]thiepin-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성<Step 1> Synthesis of 2- (dibenzo [b, f] thiepin-4-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
질소 기류 하에서 4-bromodibenzo[b,f]thiepine (50 g, 173 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.3 g, 190 mmol), Pd(dppf)Cl2 (14.1 g, 17.3 mmol), KOAc (50.9 g, 519 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(dibenzo[b,f]thiepin-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, 수율 62%)을 얻었다.(50 g, 173 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1 Dioxaborolane (48.3 g, 190 mmol), Pd (dppf) Cl 2 (14.1 g, 17.3 mmol), KOAc (50.9 g, 519 mmol) and 1,4-dioxane And the mixture was stirred at 130 DEG C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 2- (dibenzo [b, f] thiepin-4 -yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, yield 62%).
1H-NMR: δ 1.24 (s, 12H), 6.99(s, 2H), 7.10(t, 1H), 7.18(m, 2H), 7.34(m, 2H), 7.41(m, 2H) 1 H-NMR: δ 1.24 ( s, 12H), 6.99 (s, 2H), 7.10 (t, 1H), 7.18 (m, 2H), 7.34 (m, 2H), 7.41 (m, 2H)
<단계 2> 4-(2-nitrophenyl)dibenzo[b,f]thiepine의 합성<Step 2> Synthesis of 4- (2-nitrophenyl) dibenzo [b, f] thiepine
질소 기류 하에서 2-bromo-1-nitrobenzene (21.6 g, 107 mmol), 2-(dibenzo[b,f]thiepin-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, 107 mmol), K2CO3 (44.4 g, 321 mmol) 및 THF/H2O (400 ml/100 ml)를 혼합한 다음, Pd(PPh3)4 (6.18 g, 5 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 4-(2-nitrophenyl)dibenzo[b,f]thiepine (25.9 g, 수율 73 %)을 얻었다.(21.6 g, 107 mmol), 2- (dibenzo [b, f] thiepin-4-yl) -4,4,5,5-tetramethyl- 1,3,2- dioxaborolane (36.0 g, 107 mmol) , K 2 CO 3 (44.4 g, 321 mmol) and a mixture of THF / H 2 O (400 ml / 100 ml) , and then, Pd (PPh 3) 4 ( 6.18 g, 5 mmol ) And the mixture was stirred at 80 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 4- (2-nitrophenyl) dibenzo [b, f] thiepine (25.9 g, yield 73% .
1H-NMR: δ 6.99(s, 2H), 7.10(t, 1H), 7.18(t, 1H), 7.28(m, 3H), 7.43(m, 2H), 7.67(t, 1H), 7.90(t, 1H), 8.03(m, 2H) 1 H-NMR: δ 6.99 ( s, 2H), 7.10 (t, 1H), 7.18 (t, 1H), 7.28 (m, 3H), 7.43 (m, 2H), 7.67 (t, 1H), 7.90 ( t, 1 H), 8.03 (m, 2 H)
<단계 3> IIC-11의 합성<Step 3> Synthesis of IIC-11
질소 기류 하에서 4-(2-nitrophenyl)dibenzo[b,f]thiepine (25.9 g, 78.3mmol), triphenylphosphine (51.2 g, 195 mmol), 1,2-dichlorobenzene (250 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-11 (8.20 g, 수율 35 %)을 얻었다.(25.9 g, 78.3 mmol), triphenylphosphine (51.2 g, 195 mmol) and 1,2-dichlorobenzene (250 ml) were added thereto under a nitrogen atmosphere and stirred for 12 hours. Respectively. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain compound IIC-11 (8.20 g, yield 35%).
IIC-11의 1H-NMR: δ 6.98(s, 2H), 7.10(t, 1H), 7.18(t, 1H), 7.30(m, 2H), 7.39(m, 2H), 7.50(m, 2H), 7.63(d, 1H), 8.12(d, 1H), 8.51(brs, 1H)
1 of the IIC-11 H-NMR: δ 6.98 (s, 2H), 7.10 (t, 1H), 7.18 (t, 1H), 7.30 (m, 2H), 7.39 (m, 2H), 7.50 (m, 2H ), 7.63 (d, 1 H), 8.12 (d, 1 H), 8.51 (br s,
[준비예 8] IIC-12의 합성[Preparation Example 8] Synthesis of IIC-12
<단계 1> 2-(dibenzo[b,f]thiepin-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성<Step 1> Synthesis of 2- (dibenzo [b, f] thiepin-1-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
질소 기류 하에서 1-bromodibenzo[b,f]thiepine (50 g, 173 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.3 g, 190 mmol), Pd(dppf)Cl2 (14.1 g, 17.3 mmol), KOAc (50.9 g, 519 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(dibenzo[b,f]thiepin-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, 수율 62 %)을 얻었다.(50 g, 173 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1 Dioxaborolane (48.3 g, 190 mmol), Pd (dppf) Cl 2 (14.1 g, 17.3 mmol), KOAc (50.9 g, 519 mmol) and 1,4-dioxane And the mixture was stirred at 130 DEG C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 2- (dibenzo [b, f] thiepin-1 -yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, yield 62%).
1H-NMR: δ 1.24 (s, 12H), 6.99(s, 2H), 7.10(m, 2H), 7.18(t, 1H), 7.31(d, 1H), 7.41(m, 2H), 7.49(d, 1H) 1 H-NMR: δ 1.24 ( s, 12H), 6.99 (s, 2H), 7.10 (m, 2H), 7.18 (t, 1H), 7.31 (d, 1H), 7.41 (m, 2H), 7.49 ( d, 1 H)
<단계 2> 1-(2-nitrophenyl)dibenzo[b,f]thiepine의 합성<Step 2> Synthesis of 1- (2-nitrophenyl) dibenzo [b, f] thiepine
질소 기류 하에서 2-bromo-1-nitrobenzene (21.6 g, 107 mmol), 2-(dibenzo[b,f]thiepin-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.0 g, 107 mmol), K2CO3 (44.4 g, 321 mmol) 및 THF/H2O (400 ml/100 ml)를 혼합한 다음, Pd(PPh3)4 (6.18 g, 5 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 1-(2-nitrophenyl)dibenzo[b,f]thiepine (25.9 g, 수율 73%)을 얻었다.(21.6 g, 107 mmol), 2- (dibenzo [b, f] thiepin-1-yl) -4,4,5,5-tetramethyl- 1,3,2- dioxaborolane (36.0 g, 107 mmol) , K 2 CO 3 (44.4 g, 321 mmol) and a mixture of THF / H 2 O (400 ml / 100 ml) , and then, Pd (PPh 3) 4 ( 6.18 g, 5 mmol ) And the mixture was stirred at 80 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 1- (2-nitrophenyl) dibenzo [b, f] thiepine (25.9 g, yield 73% .
1H-NMR: δ 6.99(s, 2H), 7.14-7.18(m, 3H), 7.31(d, 1H), 7.37(d, 1H), 7.41(d, 1H), 7.67(t, 1H), 7.90(t, 1H), 8.02-8.06(m, 3H) 1 H-NMR: δ 6.99 ( s, 2H), 7.14-7.18 (m, 3H), 7.31 (d, 1H), 7.37 (d, 1H), 7.41 (d, 1H), 7.67 (t, 1H), 7.90 (t, 1 H), 8.02-8.06 (m, 3 H)
<단계 3> IIC-12의 합성<Step 3> Synthesis of IIC-12
질소 기류 하에서 1-(2-nitrophenyl)dibenzo[b,f]thiepine (25.9 g, 78.3 mmol), triphenylphosphine (51.2 g, 195 mmol), 1,2-dichlorobenzene (250 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-12 (8.20g, 수율 35 %)을 얻었다.(25.9 g, 78.3 mmol), triphenylphosphine (51.2 g, 195 mmol) and 1,2-dichlorobenzene (250 ml) were added thereto under nitrogen atmosphere and stirred for 12 hours. Respectively. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain compound IIC-12 (8.20 g, yield 35%).
IIC-12의 1H-NMR: δ 6.98(s, 2H), 7.02(d, 1H), 7.10(t, 1H), 7.18(t, 1H), 7.30(m, 3H), 7.39(d, 1H), 7.50(t, 1H), 7.63(d, 1H), 8.06(d, 1H), 8.53(brs, 1H)
Of IIC-12 1 H-NMR: δ 6.98 (s, 2H), 7.02 (d, 1H), 7.10 (t, 1H), 7.18 (t, 1H), 7.30 (m, 3H), 7.39 (d, 1H ), 7.50 (t, IH), 7.63 (d, IH), 8.06
[준비예 9] IIC-13 & IIC-14의 합성[Preparation Example 9] Synthesis of IIC-13 & IIC-14
<단계 1> 2-(dibenzo[b,f]oxepin-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성<Step 1> Synthesis of 2- (dibenzo [b, f] oxepin-2-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
질소 기류 하에서 2-bromodibenzo[b,f]oxepine (50 g, 183 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (51.1 g, 201 mmol), Pd(dppf)Cl2 (14.9 g, 18.3 mmol), KOAc (53.9 g, 549 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(dibenzo[b,f]oxepin-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, 수율 62%)을 얻었다.(50 g, 183 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1 Dioxaborolane (51.1 g, 201 mmol), Pd (dppf) Cl 2 (14.9 g, 18.3 mmol), KOAc (53.9 g, 549 mmol) and 1,4-dioxane And the mixture was stirred at 130 DEG C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 2- (dibenzo [b, f] oxepin-2 -yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, yield 62%).
1H-NMR: δ 1.24 (s, 12H), 6.99(s, 2H), 7.15(m, 2H), 7.26(t, 1H), 7.30(d, 1H), 7.56(m, 2H), 7.85(d, 1H) 1 H-NMR: δ 1.24 ( s, 12H), 6.99 (s, 2H), 7.15 (m, 2H), 7.26 (t, 1H), 7.30 (d, 1H), 7.56 (m, 2H), 7.85 ( d, 1 H)
<단계 2> 2-(2-nitrophenyl)dibenzo[b,f]oxepine의 합성<Step 2> Synthesis of 2- (2-nitrophenyl) dibenzo [b, f] oxepine
질소 기류 하에서 2-bromo-1-nitrobenzene (22.9 g, 114 mmol), 2-(dibenzo[b,f]oxepin-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, 114 mmol), K2CO3 (47.0 g, 340 mmol) 및 THF/H2O (400 ml/100 ml)를 혼합한 다음, Pd(PPh3)4 (6.59 g, 6 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 2-(2-nitrophenyl)dibenzo[b,f]oxepine (26.1 g, 수율 73%)을 얻었다.(22.9 g, 114 mmol), 2- (dibenzo [b, f] oxepin-2-yl) -4,4,5,5-tetramethyl- 1,3,2- dioxaborolane (36.3 g, 114 mmol) , K 2 CO 3 (47.0 g, 340 mmol) and a mixture of THF / H 2 O (400 ml / 100 ml) , and then, Pd (PPh 3) 4 ( 6.59 g, 6 mmol ) And the mixture was stirred at 80 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer, and the residue was purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 26.1 g of 2- (2-nitrophenyl) dibenzo [b, f] oxepine .
1H-NMR: δ 6.99(s, 2H), 7.19(m, 2H), 7.26(t, 1H), 7.32(d, 1H), 7.64(m, 2H), 7.88(m, 2H), 8.04(m, 3H) 1 H-NMR: δ 6.99 ( s, 2H), 7.19 (m, 2H), 7.26 (t, 1H), 7.32 (d, 1H), 7.64 (m, 2H), 7.88 (m, 2H), 8.04 ( m, 3H)
<단계 3> IIC-13 & IIC-14의 합성<Step 3> Synthesis of IIC-13 & IIC-14
질소 기류 하에서 2-(2-nitrophenyl)dibenzo[b,f]oxepine (26.1 g, 82.9mmol), triphenylphosphine (54.4 g, 207 mmol), 1,2-dichlorobenzene (250 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종료된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-13 (8.22g, 수율 35 %)와, 화합물 IIC-14 (8.22g, 수율 35 %)을 얻었다.Dibenzo [b, f] oxepine (26.1 g, 82.9 mmol), triphenylphosphine (54.4 g, 207 mmol) and 1,2-dichlorobenzene (250 ml) were added thereto under a nitrogen stream. Respectively. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain Compound IIC-13 (8.22 g, yield 35%) and Compound IIC- 35%).
IIC-13의 1H-NMR: δ 6.98(s, 2H), 7.18(t, 1H), 7.30(m, 4H), 7.50(t, 1H), 7.63(d, 1H), 7.85(d, 1H), 8.03(d, 1H), 8.09(d, 1H), 8.50(brs, 1H) 1 H-NMR of the IIC-13: δ 6.98 (s , 2H), 7.18 (t, 1H), 7.30 (m, 4H), 7.50 (t, 1H), 7.63 (d, 1H), 7.85 (d, 1H ), 8.03 (d, IH), 8.09 (d, IH), 8.50 (brs, IH)
IIC-14의 1H-NMR: δ 6.99(s, 2H), 7.06(s, 1H), 7.18(t, 1H), 7.30(m, 3H), 7.50(t, 1H), 7.63(d, 1H), 7.85(d, 1H), 8.10(s, 1H), 8.12(d, 1H), 8.51(brs, 1H)
1 H-NMR of the IIC-14: δ 6.99 (s , 2H), 7.06 (s, 1H), 7.18 (t, 1H), 7.30 (m, 3H), 7.50 (t, 1H), 7.63 (d, 1H ), 7.85 (d, IH), 8.10 (s, IH), 8.12
[준비예 10] IIC-15 & IIC-16의 합성[Preparation Example 10] Synthesis of IIC-15 & IIC-16
<단계 1> 2-(dibenzo[b,f]oxepin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성<Step 1> Synthesis of 2- (dibenzo [b, f] oxepin-3-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
질소 기류 하에서 3-bromodibenzo[b,f]oxepine (50 g, 183 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (51.1 g, 201 mmol), Pd(dppf)Cl2 (14.9 g, 18.3 mmol), KOAc (53.9 g, 549 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(dibenzo[b,f]oxepin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, 수율 62 %)을 얻었다.A solution of 3-bromodibenzo [b, f] oxepine (50 g, 183 mmol), 4,4,4 ', 4,5,5,5,5-octamethyl- 2,2'- Dioxaborolane (51.1 g, 201 mmol), Pd (dppf) Cl 2 (14.9 g, 18.3 mmol), KOAc (53.9 g, 549 mmol) and 1,4-dioxane And the mixture was stirred at 130 DEG C for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 2- (dibenzo [b, f] oxepin- -yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, yield 62%).
1H-NMR: δ 1.24 (s, 12H), 6.99(s, 2H), 7.10(s, 1H), 7.17(t, 1H), 7.28(m, 2H), 7.47(m, 2H), 7.85(d, 1H) 1 H-NMR: δ 1.24 ( s, 12H), 6.99 (s, 2H), 7.10 (s, 1H), 7.17 (t, 1H), 7.28 (m, 2H), 7.47 (m, 2H), 7.85 ( d, 1 H)
<단계 2> 3-(2-nitrophenyl)dibenzo[b,f]oxepine의 합성<Step 2> Synthesis of 3- (2-nitrophenyl) dibenzo [b, f] oxepine
질소 기류 하에서 2-bromo-1-nitrobenzene (22.9 g, 114 mmol), 2-(dibenzo[b,f]oxepin-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, 114 mmol), K2CO3 (47.0 g, 340 mmol) 및 THF/H2O(400 ml/100 ml)를 혼합한 다음, Pd(PPh3)4 (6.59 g, 6 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 3-(2-nitrophenyl)dibenzo[b,f]oxepine (26.1 g, 수율 73%)을 얻었다.(22.9 g, 114 mmol), 2- (dibenzo [b, f] oxepin-3-yl) -4,4,5,5-tetramethyl- 1,3,2- dioxaborolane (36.3 g, 114 mmol) , K 2 CO 3 (47.0 g, 340 mmol) and a mixture of THF / H 2 O (400 ml / 100 ml) , and then, Pd (PPh 3) 4 ( 6.59 g, 6 mmol ) And the mixture was stirred at 80 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 3- (2-nitrophenyl) dibenzo [b, f] oxepine (26.1 g, yield 73% .
1H-NMR: δ 6.99(s, 2H), 7.17(t, 1H), 7.30(m, 3H), 7.52(m, 2H), 7.67(t, 1H), 7.88(m, 2H), 8.02(m, 2H) 1 H-NMR: δ 6.99 ( s, 2H), 7.17 (t, 1H), 7.30 (m, 3H), 7.52 (m, 2H), 7.67 (t, 1H), 7.88 (m, 2H), 8.02 ( m, 2H)
<단계 3> IIC-15 & IIC-16의 합성<Step 3> Synthesis of IIC-15 & IIC-16
질소 기류 하에서 3-(2-nitrophenyl)dibenzo[b,f]oxepine (26.1 g, 82.9mmol), triphenylphosphine (54.4 g, 207 mmol), 1,2-dichlorobenzene (250 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-15 (8.22g, 수율 35 %)와, 화합물 IIC-16 (8.22g, 수율 35 %)을 얻었다.Dibenzo [b, f] oxepine (26.1 g, 82.9 mmol), triphenylphosphine (54.4 g, 207 mmol) and 1,2-dichlorobenzene (250 ml) were added thereto under a nitrogen stream. Respectively. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain Compound IIC-15 (8.22 g, yield 35%) and Compound IIC- 35%).
IIC-15의 1H-NMR: δ 6.98(s, 2H), 7.18(t, 1H), 7.30(m, 3H), 7.50(t, 1H), 7.60(m, 2H), 7.85(d, 1H), 8.03(d, 1H), 8.09(d, 1H), 8.50(brs, 1H)Of IIC-15 1 H-NMR: δ 6.98 (s, 2H), 7.18 (t, 1H), 7.30 (m, 3H), 7.50 (t, 1H), 7.60 (m, 2H), 7.85 (d, 1H ), 8.03 (d, IH), 8.09 (d, IH), 8.50 (brs, IH)
IIC-16의 1H-NMR: δ 6.99(s, 2H), 7.18(t, 1H), 7.28(m, 3H), 7.50(m, 2H), 7.63(d, 1H), 7.85(d, 1H), 8.09(s, 1H), 8.12(d, 1H), 8.51(brs, 1H)
Of IIC-16 1 H-NMR: δ 6.99 (s, 2H), 7.18 (t, 1H), 7.28 (m, 3H), 7.50 (m, 2H), 7.63 (d, 1H), 7.85 (d, 1H ), 8.09 (s, IH), 8.12 (d, IH), 8.51 (brs, IH)
[준비예 11] IIC-17의 합성[Preparation Example 11] Synthesis of IIC-17
<단계 1> 2-(dibenzo[b,f]oxepin-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성<Step 1> Synthesis of 2- (dibenzo [b, f] oxepin-4-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
질소 기류 하에서 4-bromodibenzo[b,f]oxepine (50 g, 183 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (51.1 g, 201 mmol), Pd(dppf)Cl2 (14.9 g, 18.3 mmol), KOAc (53.9 g, 549 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(dibenzo[b,f]oxepin-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, 수율 62%)을 얻었다.A solution of 4-bromodibenzo [b, f] oxepine (50 g, 183 mmol), 4,4,4 ', 4,5,5,5,5-octamethyl-2,2'- Dioxaborolane (51.1 g, 201 mmol), Pd (dppf) Cl 2 (14.9 g, 18.3 mmol), KOAc (53.9 g, 549 mmol) and 1,4-dioxane And the mixture was stirred at 130 DEG C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 2- (dibenzo [b, f] oxepin- -yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, yield 62%).
1H-NMR: δ 1.24 (s, 12H), 6.99(s, 2H), 7.17(m, 2H), 7.29(m, 2H), 7.56(d, 1H), 7.85(m, 2H) 1 H-NMR: δ 1.24 ( s, 12H), 6.99 (s, 2H), 7.17 (m, 2H), 7.29 (m, 2H), 7.56 (d, 1H), 7.85 (m, 2H)
<단계 2> 4-(2-nitrophenyl)dibenzo[b,f]oxepine의 합성<Step 2> Synthesis of 4- (2-nitrophenyl) dibenzo [b, f] oxepine
질소 기류 하에서 2-bromo-1-nitrobenzene (22.9 g, 114 mmol), 2-(dibenzo[b,f]oxepin-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, 114 mmol), K2CO3 (47.0 g, 340 mmol) 및 THF/H2O (400 ml/100 ml)를 혼합한 다음, Pd(PPh3)4 (6.59 g, 6 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 4-(2-nitrophenyl)dibenzo[b,f]oxepine (26.1 g, 수율 73 %)을 얻었다.(22.9 g, 114 mmol), 2- (dibenzo [b, f] oxepin-4-yl) -4,4,5,5-tetramethyl- 1,3,2- dioxaborolane (36.3 g, 114 mmol) , K 2 CO 3 (47.0 g, 340 mmol) and a mixture of THF / H 2 O (400 ml / 100 ml) , and then, Pd (PPh 3) 4 ( 6.59 g, 6 mmol ) And the mixture was stirred at 80 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 4- (2-nitrophenyl) dibenzo [b, f] oxepine (26.1 g, yield 73% .
1H-NMR: δ 6.99(s, 2H), 7.23(m, 3H), 7.32(d, 1H), 7.63(m, 2H), 7.86(m, 3H), 8.02(m, 2H) 1 H-NMR: δ 6.99 ( s, 2H), 7.23 (m, 3H), 7.32 (d, 1H), 7.63 (m, 2H), 7.86 (m, 3H), 8.02 (m, 2H)
<단계 3> IIC-17의 합성<Step 3> Synthesis of IIC-17
질소 기류 하에서 4-(2-nitrophenyl)dibenzo[b,f]oxepine (26.1 g, 82.9mmol), triphenylphosphine (54.4 g, 207 mmol), 1,2-dichlorobenzene (250 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-17 (8.22g, 수율 35 %)을 얻었다.(26.1 g, 82.9 mmol), triphenylphosphine (54.4 g, 207 mmol) and 1,2-dichlorobenzene (250 ml) were placed under a nitrogen atmosphere and stirred for 12 hours. Respectively. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain compound IIC-17 (8.22 g, yield 35%).
IIC-17의 1H-NMR: δ 6.99(s, 2H), 7.18(t, 1H), 7.26-7.34(m, 4H), 7.50(d, 1H), 7.65(m, 2H), 7.85(d, 1H), 8.11(d, 1H), 8.51(brs, 1H)
Of IIC-17 1 H-NMR: δ 6.99 (s, 2H), 7.18 (t, 1H), 7.26-7.34 (m, 4H), 7.50 (d, 1H), 7.65 (m, 2H), 7.85 (d , 8.11 (d, 1 H), 8.51 (brs, 1 H)
[준비예 12] IIC-18의 합성[Preparation Example 12] Synthesis of IIC-18
<단계 1> 2-(dibenzo[b,f]oxepin-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane의 합성<Step 1> Synthesis of 2- (dibenzo [b, f] oxepin-1-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane
질소 기류 하에서 1-bromodibenzo[b,f]oxepine (50 g, 183 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (51.1 g, 201 mmol), Pd(dppf)Cl2 (14.9 g, 18.3 mmol), KOAc (53.9 g, 549 mmol) 및 1,4-Dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(dibenzo[b,f]oxepin-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, 수율 62%)을 얻었다.(50 g, 183 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1 Dioxaborolane (51.1 g, 201 mmol), Pd (dppf) Cl 2 (14.9 g, 18.3 mmol), KOAc (53.9 g, 549 mmol) and 1,4-dioxane And the mixture was stirred at 130 DEG C for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, and then dried over MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 2- (dibenzo [b, f] oxepin-1 -yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, yield 62%).
1H-NMR: δ 1.24 (s, 12H), 6.99(s, 2H), 7.17(t, 1H), 7.27(m, 2H), 7.32(m, 2H), 7.47(d, 1H), 7.85(d, 1H) 1 H-NMR: δ 1.24 ( s, 12H), 6.99 (s, 2H), 7.17 (t, 1H), 7.27 (m, 2H), 7.32 (m, 2H), 7.47 (d, 1H), 7.85 ( d, 1 H)
<단계 2> 1-(2-nitrophenyl)dibenzo[b,f]oxepine의 합성<Step 2> Synthesis of 1- (2-nitrophenyl) dibenzo [b, f] oxepine
질소 기류 하에서 2-bromo-1-nitrobenzene (22.9 g, 114 mmol), 2-(dibenzo[b,f]oxepin-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (36.3 g, 114 mmol), K2CO3 (47.0 g, 340 mmol) 및 THF/H2O (400 ml/100 ml)를 혼합한 다음, Pd(PPh3)4 (6.59 g, 6 mmol)를 넣고 80℃에서 12시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 20:1 (v/v))로 정제하여 1-(2-nitrophenyl)dibenzo[b,f]oxepine (26.1 g, 수율 73 %)을 얻었다.(22.9 g, 114 mmol), 2- (dibenzo [b, f] oxepin-1-yl) -4,4,5,5-tetramethyl- 1,3,2- dioxaborolane (36.3 g, 114 mmol) , K 2 CO 3 (47.0 g, 340 mmol) and a mixture of THF / H 2 O (400 ml / 100 ml) , and then, Pd (PPh 3) 4 ( 6.59 g, 6 mmol ) And the mixture was stirred at 80 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 20: 1 (v / v)) to obtain 1- (2-nitrophenyl) dibenzo [b, f] oxepine (26.1 g, yield 73% .
1H-NMR: δ 6.99(s, 2H), 7.17(t, 1H), 7.30(m, 4H), 7.67(t, 1H), 7.88(m, 2H), 8.03(m, 3H) 1 H-NMR: δ 6.99 ( s, 2H), 7.17 (t, 1H), 7.30 (m, 4H), 7.67 (t, 1H), 7.88 (m, 2H), 8.03 (m, 3H)
<단계 3> IIC-18의 합성<Step 3> Synthesis of IIC-18
질소 기류 하에서 1-(2-nitrophenyl)dibenzo[b,f]oxepine (26.1 g, 82.9 mmol), triphenylphosphine (54.4 g, 207 mmol), 1,2-dichlorobenzene (250 ml)를 넣은 후 12시간 동안 교반하였다. 반응이 종결된 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출한 후 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:MC = 2:1 (v/v))로 정제하여 화합물 IIC-18 (8.22 g, 수율 35 %)을 얻었다.(26.1 g, 82.9 mmol), triphenylphosphine (54.4 g, 207 mmol) and 1,2-dichlorobenzene (250 ml) were placed under a nitrogen atmosphere and stirred for 12 hours. Respectively. After the reaction was completed, 1,2-dichlorobenzene was removed, and the mixture was extracted with dichloromethane, followed by addition of MgSO 4 . The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: MC = 2: 1 (v / v)) to obtain compound IIC-18 (8.22 g, yield 35%).
IIC-18의 1H-NMR: δ 6.99(s, 2H), 7.16(t, 1H), 7.26-7.32(m, 4H), 7.44(d, 1H), 7.50(t, 1H), 7.63(d, 1H), 7.85(d, 1H), 8.11(d, 1H), 8.51(brs, 1H)
Of IIC-18 1 H-NMR: δ 6.99 (s, 2H), 7.16 (t, 1H), 7.26-7.32 (m, 4H), 7.44 (d, 1H), 7.50 (t, 1H), 7.63 (d , 7.85 (d, IH), 8.11 (d, IH), 8.51 (brs, IH)
[준비예 13] PCB-1의 합성[Preparation Example 13] Synthesis of PCB-1
질소 기류 하에서 2-bromo-9-phenyl-9H-carbazole (174.0 g, 540.0 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd(dppf)Cl2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) 및 1,4-Dioxane (2800 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 화합물 PCB-1 (169.5 g, 수율 85 %)을 얻었다.2-bromo-9-phenyl-9H-carbazole (174.0 g, 540.0 mmol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi Dioxaborolane (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4- And the mixture was stirred at 130 DEG C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 4: 1 (v / v)) to obtain 169.5 g (yield: 85% ≪ / RTI >
1H-NMR: δ 1.24 (s, 12H), 7.25-7.33 (m, 2H), 7.43-7.58 (m, 6H), 7.83 (s, 1H), 7.94 (d, 1H), 8.12 (d, 1H), 8.55 (d, 1H)
1 H-NMR: δ 1.24 ( s, 12H), 7.25-7.33 (m, 2H), 7.43-7.58 (m, 6H), 7.83 (s, 1H), 7.94 (d, 1H), 8.12 (d, 1H ), 8.55 (d, 1 H)
[준비예 14] PCB-2의 합성[Preparation Example 14] Synthesis of PCB-2
질소 기류 하에서 3-bromo-9-phenyl-9H-carbazole (174.0 g, 540.0 mmol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (150.8 g, 594.0 mmol), Pd(dppf)Cl2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) 및 1,4-Dioxane (2800 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 화합물 PCB-2 (161.5 g, 수율 81 %)를 얻었다.(174.0 g, 540.0 mmol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi Dioxaborolane (150.8 g, 594.0 mmol), Pd (dppf) Cl 2 (62.4 g, 54.0 mmol), KOAc (152.5 g, 1.62 mol) and 1,4- And the mixture was stirred at 130 DEG C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 4: 1 (v / v)) to obtain 161.5 g of compound PCB- .
1H-NMR: δ 1.24 (s, 12H), 7.25-7.33 (m, 2H), 7.45-7.63 (m, 7H), 7.94-7.98 (m, 2H), 8.55 (d, 1H)
1 H-NMR: δ 1.24 ( s, 12H), 7.25-7.33 (m, 2H), 7.45-7.63 (m, 7H), 7.94-7.98 (m, 2H), 8.55 (d, 1H)
[준비예 15] AzC-1의 합성[Preparation Example 15] Synthesis of AzC-1
<단계 1> 2-(1H-indol-5-yl)-9-phenyl-9H-carbazole의 합성<Step 1> Synthesis of 2- (1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 5-bromo-1H-indole (100 g, 439.2 mmol), PCB-1 (194.6 g, 527.0 mmol), Pd(PPh3)4 (25.4 g, 22.0 mmol), K2CO3 (121.4 g, 878 mmol), 1,4-dioxane/H2O (200 ml/50 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 2-(1H-indol-5-yl)-9-phenyl-9H-carbazole (118.1 g, 수율 75 %)을 얻었다.5-bromo-1H-indole ( 100 g, 439.2 mmol), PCB-1 (194.6 g, 527.0 mmol), Pd (PPh 3) 4 (25.4 g, 22.0 mmol), K 2 CO 3 (121.4 g in a nitrogen atmosphere , 878 mmol) and 1,4-dioxane / H 2 O (200 ml / 50 ml) were mixed and stirred at 120 ° C for 4 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer, and the residue was purified by column chromatography (Hexane: EA = 4: 1 (v / v)) to obtain 118.1 g of 2- (1H-indol- Yield: 75%).
1H-NMR: δ 6.45 (d, 1H), 7.27-7.29 (m, 2H), 7.45-7.77 (m, 10H), 7.87 (d, 1H), 8.10-8.12 (m, 2H), 8.49 (d, 1H), 10.1 (b, 1H) 1 H-NMR:? 6.45 (d, 1H), 7.27-7.29 (m, 2H), 7.45-7.77 (m, 10H), 7.87 , 1 H), 10.1 (b, 1 H)
<단계 2> 2-(1-(9,9-dimethyl-9H-fluoren-3-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole의 합성Synthesis of 2- (1- (9,9-dimethyl-9H-fluoren-3-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 2-(1H-indol-5-yl)-9-phenyl-9H-carbazole (118.1 g, 329.4 mmol), 3-bromo-9,9-dimethyl-9H-fluorene (108.0 g, 395.3 mmol), Cu (10.5 g, 164.7 mmol), K2CO3 (91.1 g, 658.8 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 6:1 (v/v))로 정제하여 2-(1-(9,9-dimethyl-9H-fluoren-3-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (146.9 g, 수율 81 %)을 얻었다.3-bromo-9,9-dimethyl-9H-fluorene (108.0 g, 395.3 mmol) was added to a solution of 2- (1H-indol-5-yl) -9- , Cu (10.5 g, 164.7 mmol), K 2 CO 3 (91.1 g, 658.8 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4, and the residue was purified by column chromatography (Hexane: EA = 6: 1 (v / v) 9H-fluoren-3-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole (146.9 g, yield 81%).
1H-NMR: δ 1.72 (s, 6H), 6.52 (d, 1H), 7.06-7.07 (m, 2H), 7.17-7.34 (m, 5H), 7.45-7.60 (m, 8H), 7.77-7.79 (m, 2H), 7.87-8.00 (m, 3H), 8.16-8.18 (m, 2H), 8.55 (d, 1H) 1 H-NMR: δ 1.72 ( s, 6H), 6.52 (d, 1H), 7.06-7.07 (m, 2H), 7.17-7.34 (m, 5H), 7.45-7.60 (m, 8H), 7.77-7.79 (m, 2H), 7.87-8.00 (m, 3H), 8.16-8.18 (m, 2H), 8.55
<단계 3> AzC-1의 합성<Step 3> Synthesis of AzC-1
질소 기류 하에서 2-(1-(9,9-dimethyl-9H-fluoren-3-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (146.9 g, 266.8 mmol), polyphosphoric acid (734.6 g)를 혼합하고 100℃ 에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-1 (45.5 g, 수율 31 %)을 얻었다.9H-fluoren-3-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole (146.9 g, 266.8 mmol), polyphosphoric acid (734.6 g) were mixed and stirred at 100 ° C for 12 hours. After completion of the reaction, the reaction product was extracted from water and then filtered to obtain a compound AzC-1 (45.5 g, yield: 31%).
1H-NMR: δ 1.72 (s, 6H), 6.69 (d, 1H), 6.99-7.04 (m, 3H), 7.28-7.63 (m, 14H), 7.82-7.87 (m, 2H), 8.10-8.12 (m, 2H), 8.42 (b, 1H), 8.49 (d, 1H)
1 H-NMR: δ 1.72 ( s, 6H), 6.69 (d, 1H), 6.99-7.04 (m, 3H), 7.28-7.63 (m, 14H), 7.82-7.87 (m, 2H), 8.10-8.12 (m, 2H), 8.42 (b, IH), 8.49 (d, IH)
[준비예 16] AzC-2의 합성[Preparation Example 16] Synthesis of AzC-2
<단계 1> 2-(1-(dibenzo[b,d]furan-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole의 합성Synthesis of 2- (1- (dibenzo [b, d] furan-2-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 2-(1H-indol-5-yl)-9-phenyl-9H-carbazole (150.0 g, 418.5 mmol), 2-bromodibenzo[b,d]furan (124.1 g, 502.2 mmol), Cu (13.3 g, 209.2 mmol), K2CO3 (115.7 g, 837.0 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 2-(1-(dibenzo[b,d]furan-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (171.2 g, 수율 78 %)을 얻었다.2-bromodibenzo [b, d] furan (124.1 g, 502.2 mmol), Cu (13.3 g, g, 209.2 mmol), K 2 CO 3 (115.7 g, 837.0 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, and then dried over MgSO 4 and purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 2- (1- (dibenzo [ furan-2-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole (171.2 g, yield 78%).
1H-NMR: δ 6.52 (d, 1H), 7.25-7.66 (m, 14H), 7.77-7.80 (m, 3H), 7.89-8.00 (m, 3H), 8.16-8.18 (m, 2H), 8.55 (d, 1H) 1 H-NMR: δ 6.52 ( d, 1H), 7.25-7.66 (m, 14H), 7.77-7.80 (m, 3H), 7.89-8.00 (m, 3H), 8.16-8.18 (m, 2H), 8.55 (d, 1 H)
<단계 2> AzC-2의 합성<Step 2> Synthesis of AzC-2
질소 기류 하에서 2-(1-(dibenzo[b,d]furan-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (171.2 g, 326.4 mmol), polyphosphoric acid (856.2 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 AzC-2 (47.9 g, 수율 28 %)을 얻었다.5-yl) -9-phenyl-9H-carbazole (171.2 g, 326.4 mmol), polyphosphoric acid (856.2 g) were mixed and stirred at 100 占 폚 for 12 hours. After the reaction was completed, the reaction product was extracted from water and then filtered to obtain AzC-2 (47.9 g, yield: 28%).
1H-NMR: δ 6.69 (d, 1H), 6.99-7.01 (m, 2H), 7.29-7.66 (m, 15H), 7.82 (s, 1H), 7.89 (d, 1H), 8.10-8.12 (m, 2H), 8.42 (b, 1H), 8.49 (d, 1H)
1 H-NMR: δ 6.69 ( d, 1H), 6.99-7.01 (m, 2H), 7.29-7.66 (m, 15H), 7.82 (s, 1H), 7.89 (d, 1H), 8.10-8.12 (m , 2H), 8.42 (b, IH), 8.49 (d, IH)
[준비예 17] AzC-3의 합성[Preparation Example 17] Synthesis of AzC-3
<단계 1> 2-(1-(dibenzo[b,d]thiophen-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole의 합성Synthesis of 2- (1- (dibenzo [b, d] thiophen-2-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 2-(1H-indol-5-yl)-9-phenyl-9H-carbazole (150.0 g, 418.5 mmol), 2-bromodibenzo[b,d]thiophene (132.2 g, 502.2 mmol), Cu (13.3 g, 209.2 mmol), K2CO3 (115.7 g, 837.0 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 2-(1-(dibenzo[b,d]thiophen-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (169.7 g, 수율 75 %)을 얻었다.2-bromodibenzo [b, d] thiophene (132.2 g, 502.2 mmol), Cu (13.3 g, g, 209.2 mmol), K 2 CO 3 (115.7 g, 837.0 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, and then dried over MgSO 4 and purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 2- (1- (dibenzo [ 2-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole (169.7 g, yield 75%).
1H-NMR: δ 6.52 (d, 1H), 7.25-7.33 (m, 2H), 7.45-7.62 (m, 10H), 7.77-7.79 (m, 2H), 7.94-8.00 (m, 5H), 8.16-8.18 (m, 2H), 8.45 (d, 1H), 8.55 (d, 1H) 1 H-NMR: δ 6.52 ( d, 1H), 7.25-7.33 (m, 2H), 7.45-7.62 (m, 10H), 7.77-7.79 (m, 2H), 7.94-8.00 (m, 5H), 8.16 -8.18 (m, 2H), 8.45 (d, IH), 8.55 (d, IH)
<단계 2> AzC-3의 합성<Step 2> Synthesis of AzC-3
질소 기류 하에서 2-(1-(dibenzo[b,d]thiophen-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (169.7 g, 418.5 mmol), polyphosphoric acid (848.5 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-3 (56.0 g, 수율 33 %)을 얻었다.9-phenyl-9H-carbazole (169.7 g, 418.5 mmol), polyphosphoric acid (848.5 g, g) were mixed and stirred at 100 占 폚 for 12 hours. After completion of the reaction, the reaction mixture was extracted with water and then filtered to obtain Compound AzC-3 (56.0 g, yield 33%).
1H-NMR: δ 6.69 (d, 1H), 6.99-7.01 (m, 2H), 7.29 (dd, 1H), 7.39-7.63 (m, 12H), 7.77-7.82 (m, 2H), 7.98 (d, 1H), 8.10-8.12 (m, 2H), 8.42-8.49 (m, 3H)
1 H-NMR: δ 6.69 ( d, 1H), 6.99-7.01 (m, 2H), 7.29 (dd, 1H), 7.39-7.63 (m, 12H), 7.77-7.82 (m, 2H), 7.98 (d , 1H), 8.10-8.12 (m, 2H), 8.42-8. 49 (m, 3H)
[준비예 18] AzC-4의 합성[Preparation Example 18] Synthesis of AzC-4
<단계 1> 3-(1H-indol-5-yl)-9-phenyl-9H-carbazole의 합성<Step 1> Synthesis of 3- (1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 5-bromo-1H-indole (100 g, 439.2 mmol), PCB-2 (194.6 g, 527.0 mmol), Pd(PPh3)4 (25.4 g, 22.0 mmol), K2CO3 (121.4 g, 878 mmol), 1,4-dioxane/H2O (200 ml/50 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 3-(1H-indol-5-yl)-9-phenyl-9H-carbazole (127.5 g, 수율 81 %)을 얻었다.5-bromo-1H-indole ( 100 g, 439.2 mmol), PCB-2 (194.6 g, 527.0 mmol), Pd (PPh 3) 4 (25.4 g, 22.0 mmol), K 2 CO 3 (121.4 g in a nitrogen atmosphere , 878 mmol) and 1,4-dioxane / H 2 O (200 ml / 50 ml) were mixed and stirred at 120 ° C for 4 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer, and the residue was purified by column chromatography (Hexane: EA = 4: 1 (v / v)) to obtain 127.5 g of 3- (1H-indol- Yield: 81%).
1H-NMR: δ 6.45 (d, 1H), 7.27-7.29 (m, 2H), 7.45-7.77 (m, 10H), 7.87 (d, 1H), 8.00 (d, 1H), 8.12-8.18 (m, 2H), 10.1 (b, 1H) 1 H-NMR:? 6.45 (d, 1H), 7.27-7.29 (m, 2H), 7.45-7.77 (m, 10H), 7.87 , 2H), 10.1 (b, 1 H)
<단계 2> 3-(1-(9,9-dimethyl-9H-fluoren-3-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole의 합성Synthesis of 3- (1- (9,9-dimethyl-9H-fluoren-3-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 3-(1H-indol-5-yl)-9-phenyl-9H-carbazole (127.5 g, 355.7 mmol), 3-bromo-9,9-dimethyl-9H-fluorene (116.6 g, 426.9 mmol), Cu (11.3 g, 177.9 mmol), K2CO3 (98.3 g, 711.5 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 6:1 (v/v))로 정제하여 3-(1-(9,9-dimethyl-9H-fluoren-3-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (156.7 g, 수율 80 %)을 얻었다.3-bromo-9,9-dimethyl-9H-fluorene (116.6 g, 426.9 mmol) was added to a solution of 3- (1H-indol-5-yl) -9- , Cu (11.3 g, 177.9 mmol), K 2 CO 3 (98.3 g, 711.5 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4, and the residue was purified by column chromatography (Hexane: EA = 6: 1 (v / v) 9H-fluoren-3-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole (156.7 g, yield 80%).
1H-NMR: δ 1.72 (s, 6H), 6.52 (d, 1H), 7.06-7.07 (m, 2H), 7.17-7.34 (m, 5H), 7.45-7.69 (m, 8H), 7.77-7.79 (m, 2H), 7.87-8.00 (m, 4H), 8.18 (d, 1H), 8.55 (d, 1H) 1 H-NMR: δ 1.72 ( s, 6H), 6.52 (d, 1H), 7.06-7.07 (m, 2H), 7.17-7.34 (m, 5H), 7.45-7.69 (m, 8H), 7.77-7.79 (m, 2H), 7.87-8.00 (m, 4H), 8.18 (d,
<단계 3> AzC-4의 합성<Step 3> Synthesis of AzC-4
질소 기류 하에서 3-(1-(9,9-dimethyl-9H-fluoren-3-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (156.7 g, 284.6 mmol), polyphosphoric acid (783.6 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 AzC-4 (51.7 g, 수율 33 %)를 얻었다.9H-fluoren-3-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole (156.7 g, 284.6 mmol), polyphosphoric acid (783.6 g) were mixed and stirred at 100 ° C for 12 hours. After completion of the reaction, the reaction product was extracted with water and then filtered to obtain AzC-4 (51.7 g, yield 33%).
1H-NMR: δ 1.72 (s, 6H), 6.69 (d, 1H), 6.99-7.04 (m, 3H), 7.28-7.63 (m, 13H), 7.77 (s, 1H), 7.82-7.87 (m, 2H), 8.00-8.12 (m, 3H), 8.42 (b, 1H)
1 H-NMR: δ 1.72 ( s, 6H), 6.69 (d, 1H), 6.99-7.04 (m, 3H), 7.28-7.63 (m, 13H), 7.77 (s, 1H), 7.82-7.87 (m , 2H), 8.00-8.12 (m, 3H), 8.42 (b, IH)
[준비예 19] AzC-5의 합성[Preparation Example 19] Synthesis of AzC-5
<단계 1> 3-(1-(dibenzo[b,d]furan-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole 의 합성Synthesis of 3- (1- (dibenzo [b, d] furan-2-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 3-(1H-indol-5-yl)-9-phenyl-9H-carbazole (150.0 g, 418.5 mmol), 2-bromodibenzo[b,d]furan (124.1 g, 502.2 mmol), Cu (13.3 g, 209.2 mmol), K2CO3 (115.7 g, 837.0 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 3-(1-(dibenzo[b,d]furan-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (160.1 g, 수율 73 %)을 얻었다.B, d] furan (124.1 g, 502.2 mmol), Cu (13.3 g, 418.5 mmol), 2- g, 209.2 mmol), K 2 CO 3 (115.7 g, 837.0 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 3- (1- (dibenzo [ furan-2-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole (160.1 g, yield 73%).
1H-NMR: δ 6.52 (d, 1H), 7.25-8.00 (m, 21H), 8.18 (d, 1H), 8.55 (d, 1H) 1 H-NMR:? 6.52 (d, 1H), 7.25-8.00 (m, 21H), 8.18
<단계 2> AzC-5의 합성<Step 2> Synthesis of AzC-5
질소 기류 하에서 3-(1-(dibenzo[b,d]furan-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (160.1 g, 305.5 mmol), polyphosphoric acid (800.7 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-5 (48.0 g, 수율 30 %)을 얻었다.9-phenyl-9H-carbazole (160.1 g, 305.5 mmol), polyphosphoric acid (800.7 g, g) were mixed and stirred at 100 占 폚 for 12 hours. After completion of the reaction, the reaction product was extracted from water and then filtered to obtain a compound AzC-5 (48.0 g, yield 30%).
1H-NMR: δ 6.69 (d, 1H), 6.99-7.01 (m, 2H), 7.29-7.66 (m, 14H), 7.77-7.89 (m, 3H), 8.00 (d, 1H), 8.10-8.12 (m, 2H), 8.42 (b, 1H)
1 H-NMR: δ 6.69 ( d, 1H), 6.99-7.01 (m, 2H), 7.29-7.66 (m, 14H), 7.77-7.89 (m, 3H), 8.00 (d, 1H), 8.10-8.12 (m, 2 H), 8.42 (b, 1 H)
[준비예 20] AzC-6의 합성[Preparation Example 20] Synthesis of AzC-6
<단계 1> 3-(1-(dibenzo[b,d]thiophen-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole의 합성Synthesis of 3- (1- (dibenzo [b, d] thiophen-2-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 3-(1H-indol-5-yl)-9-phenyl-9H-carbazole (150.0 g, 418.5 mmol), 2-bromodibenzo[b,d]thiophene (132.2 g, 502.2 mmol), Cu (13.3 g, 209.2 mmol), K2CO3 (115.7 g, 837.0 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 3-(1-(dibenzo[b,d]thiophen-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (172.0 g, 수율 76 %)을 얻었다.B, d] thiophene (132.2 g, 502.2 mmol), Cu (13.3 g, 418.5 mmol), 2- g, 209.2 mmol), K 2 CO 3 (115.7 g, 837.0 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 3- (1- (dibenzo [ 2-yl) -1H-indol-5-yl) -9-phenyl-9H-carbazole (172.0 g, yield 76%).
1H-NMR: δ 6.52 (d, 1H), 7.25-7.33 (m, 2H), 7.45-7.58 (m, 9H), 7.69 (d, 1H), 7.77-7.79 (m, 2H), 7.87-8.00 (m, 6H), 8.18 (d, 1H), 8.45 (d, 1H), 8.55 (d, 1H) 1 H-NMR: δ 6.52 ( d, 1H), 7.25-7.33 (m, 2H), 7.45-7.58 (m, 9H), 7.69 (d, 1H), 7.77-7.79 (m, 2H), 7.87-8.00 (m, 6H), 8.18 (d, IH), 8.45 (d, IH), 8.55
<단계 2> AzC-6의 합성<Step 2> Synthesis of AzC-6
질소 기류 하에서 3-(1-(dibenzo[b,d]thiophen-2-yl)-1H-indol-5-yl)-9-phenyl-9H-carbazole (172.0 g, 318.0 mmol), polyphosphoric acid (859.8 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-6 (43.0 g, 수율 25 %)을 얻었다.9-phenyl-9H-carbazole (172.0 g, 318.0 mmol), polyphosphoric acid (859.8 mmol) was added to a solution of 3- (1- g) were mixed and stirred at 100 占 폚 for 12 hours. After completion of the reaction, the reaction mixture was extracted from water and then filtered to obtain Compound AzC-6 (43.0 g, yield 25%).
1H-NMR: δ 6.69 (d, 1H), 6.99-7.01 (m, 2H), 7.29 (dd, 1H), 7.39-7.63 (m, 11H), 7.77-7.82 (m, 3H), 7.98-8.00 (m, 2H), 8.12-8.18 (m, 2H), 8.42 (b, 1H), 8.45 (d, 1H)
1 H-NMR: δ 6.69 ( d, 1H), 6.99-7.01 (m, 2H), 7.29 (dd, 1H), 7.39-7.63 (m, 11H), 7.77-7.82 (m, 3H), 7.98-8.00 (m, 2H), 8.12-8.18 (m, 2H), 8.42 (b, 1H), 8.45
[준비예 21] AzC-7의 합성[Preparation Example 21] Synthesis of AzC-7
<단계 1> 2-(1H-indol-5-yl)-9-phenyl-9H-carbazole의 합성<Step 1> Synthesis of 2- (1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 5-bromo-1H-indole (100 g, 439.2 mmol), PCB-1 (194.6 g, 527.0 mmol), Pd(PPh3)4 (25.4 g, 22.0 mmol), K2CO3 (121.4 g, 878 mmol), 1,4-dioxane/H2O (200 ml/50 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 2-(1H-indol-5-yl)-9-phenyl-9H-carbazole (132.2 g, 수율 84 %)을 얻었다.5-bromo-1H-indole ( 100 g, 439.2 mmol), PCB-1 (194.6 g, 527.0 mmol), Pd (PPh 3) 4 (25.4 g, 22.0 mmol), K 2 CO 3 (121.4 g in a nitrogen atmosphere , 878 mmol) and 1,4-dioxane / H 2 O (200 ml / 50 ml) were mixed and stirred at 120 ° C for 4 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then the residue was purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to obtain 132.2 g of 2- (1H- Yield: 84%).
1H-NMR: δ 6.45 (d, 1H), 7.25-7.33 (m, 3H), 7.45-7.94 (m, 11H), 8.18 (d, 1H), 8.55 (d, 1H), 10.1 (b, 1H) 1 H-NMR:? 6.45 (d, 1H), 7.25-7.33 (m, 3H), 7.45-7.94 (m, 11H), 8.18 )
<단계 2> 9-phenyl-2-(1-(9-phenyl-9H-carbazol-3-yl)-1H-indol-5-yl)-9H-carbazole의 합성Synthesis of 9-phenyl-2- (1- (9-phenyl-9H-carbazol-3-yl) -1H-indol-5-yl) -9H-carbazole
질소 기류 하에서 2-(1H-indol-5-yl)-9-phenyl-9H-carbazole (132.2 g, 368.9 mmol), 3-bromo-9-phenyl-9H-carbazole (142.6 g, 442.7 mmol), Cu (11.7 g, 184.5 mmol), K2CO3 (102.0 g, 737.8 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 9-phenyl-2-(1-(9-phenyl-9H-carbazol-3-yl)-1H-indol-5-yl)-9H-carbazole (192.5 g, 수율 87 %)을 얻었다.9-phenyl-9H-carbazole (142.6 g, 442.7 mmol), Cu (3-bromo-9- (11.7 g, 184.5 mmol), K 2 CO 3 (102.0 g, 737.8 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to obtain 9- phenyl-9H-carbazol-3-yl) -1H-indol-5-yl) -9H-carbazole (192.5 g, yield 87%).
1H-NMR: δ 6.52 (d, 1H), 7.25-7.7.33 (m, 5H), 7.45-7.63 (m, 13H), 7.77-7.79 (m, 2H), 7.94-8.00 (m, 4H), 8.14-8.17 (m, 2H), 8.54-8.56 (m, 2H) 1 H-NMR: δ 6.52 ( d, 1H), 7.25-7.7.33 (m, 5H), 7.45-7.63 (m, 13H), 7.77-7.79 (m, 2H), 7.94-8.00 (m, 4H) , 8.14-8.17 (m, 2H), 8.54-8.56 (m, 2H)
<단계 3> AzC-7의 합성<Step 3> Synthesis of AzC-7
질소 기류 하에서 9-phenyl-2-(1-(9-phenyl-9H-carbazol-3-yl)-1H-indol-5-yl)-9H-carbazole (192.5 g, 321.0 mmol), polyphosphoric acid (962.4 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-7 (65.4 g, 수율 34 %)를 얻었다.9H-carbazol-3-yl) -1H-indol-5-yl) -9H-carbazole (192.5 g, 321.0 mmol), polyphosphoric acid (962.4 g) were mixed and stirred at 100 占 폚 for 12 hours. After completion of the reaction, the reaction product was extracted from water and then filtered to obtain a compound AzC-7 (65.4 g, yield 34%).
1H-NMR: δ 6.69 (d, 1H), 6.99-7.01 (m, 2H), 7.29-7.63 (m, 19H), 7.79-7.82 (m, 2H), 7.94 (d, 1H), 8.12-8.18 (m, 2H), 8.42 (b, 1H), 8.55 (d, 1H)
1 H-NMR: δ 6.69 ( d, 1H), 6.99-7.01 (m, 2H), 7.29-7.63 (m, 19H), 7.79-7.82 (m, 2H), 7.94 (d, 1H), 8.12-8.18 (m, 2H), 8.42 (b, IH), 8.55 (d, IH)
[준비예 22] AzC-8의 합성[Preparation Example 22] Synthesis of AzC-8
<단계 1> 3-(1H-indol-5-yl)-9-phenyl-9H-carbazole의 합성<Step 1> Synthesis of 3- (1H-indol-5-yl) -9-phenyl-9H-carbazole
질소 기류 하에서 5-bromo-1H-indole (100 g, 439.2 mmol), PCB-2 (194.6 g, 527.0 mmol), Pd(PPh3)4 (25.4 g, 22.0 mmol), K2CO3 (121.4 g, 878 mmol), 1,4-dioxane/H2O (200 ml/50 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 3-(1H-indol-5-yl)-9-phenyl-9H-carbazole (125.9 g, 수율 80%)을 얻었다.5-bromo-1H-indole ( 100 g, 439.2 mmol), PCB-2 (194.6 g, 527.0 mmol), Pd (PPh 3) 4 (25.4 g, 22.0 mmol), K 2 CO 3 (121.4 g in a nitrogen atmosphere , 878 mmol) and 1,4-dioxane / H 2 O (200 ml / 50 ml) were mixed and stirred at 120 ° C for 4 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer, and the residue was purified by column chromatography (Hexane: EA = 7: 1 (v / v)) to obtain 3- (1H- indol- Yield: 80%).
1H-NMR: δ 6.45 (d, 1H), 7.25-7.33 (m, 3H), 7.45-7.94 (m, 12H), 8.55 (d, 1H), 10.1 (b, 1H) 1 H-NMR:? 6.45 (d, 1H), 7.25-7.33 (m, 3H), 7.45-7.94 (m, 12H), 8.55
<단계 2> 3,3'-(1H-indole-1,5-diyl)bis(9-phenyl-9H-carbazole)의 합성<Step 2> Synthesis of 3,3 '- (1H-indole-1,5-diyl) bis (9-phenyl-9H-carbazole)
질소 기류 하에서 3-(1H-indol-5-yl)-9-phenyl-9H-carbazole (125.9 g, 351.3 mmol), 3-bromo-9-phenyl-9H-carbazole (135.8 g, 421.6 mmol), Cu (11.2 g, 175.7 mmol), K2CO3 (97.1 g, 702.7 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 8:1 (v/v))로 정제하여 3,3'-(1H-indole-1,5-diyl)bis(9-phenyl-9H-carbazole) (174.9 g, 수율 83 %)을 얻었다.(125.8 g, 351.3 mmol), 3-bromo-9-phenyl-9H-carbazole (135.8 g, 421.6 mmol), Cu (11.2 g, 175.7 mmol), K 2 CO 3 (97.1 g, 702.7 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then remove the water with MgSO 4 and purified by column chromatography (Hexane: EA = 8: 1 (v / v)) to give 3,3 '- (1H-indole- 1, 5-diyl) bis (9-phenyl-9H-carbazole) (174.9 g, yield 83%).
1H-NMR: δ 6.52 (d, 1H), 7.25-7.7.33 (m, 5H), 7.45-7.69 (m, 13H), 7.77-7.79 (m, 2H), 7.94-8.00 (m, 5H), 8.18 (d, 1H), 8.54-8.56 (m, 2H) 1 H-NMR: δ 6.52 ( d, 1H), 7.25-7.7.33 (m, 5H), 7.45-7.69 (m, 13H), 7.77-7.79 (m, 2H), 7.94-8.00 (m, 5H) , 8.18 (d, 1 H), 8.54 - 8.56 (m, 2 H)
<단계 3> AzC-8의 합성<Step 3> Synthesis of AzC-8
질소 기류 하에서 3,3'-(1H-indole-1,5-diyl)bis(9-phenyl-9H-carbazole) (174.9 g, 291.6 mmol), polyphosphoric acid (874.5 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-8 (52.5 g, 수율 30%)를 얻었다.9-phenyl-9H-carbazole (174.9 g, 291.6 mmol) and polyphosphoric acid (874.5 g) were mixed in a nitrogen stream at 100 ° C and 12 Lt; / RTI > After the reaction was completed, the reaction product was extracted from water and then filtered to obtain a compound AzC-8 (52.5 g, yield 30%).
1H-NMR: δ 6.69 (d, 1H), 6.99-7.01 (m, 2H), 7.25-7.69 (m, 19H), 7.77-7.94 (m, 4H), 8.12 (d, 1H), 8.42 (b, 1H), 8.55 (d, 1H)
1 H-NMR:? 6.69 (d, 1H), 6.99-7.01 (m, 2H), 7.25-7.69 (m, 19H), 7.77-7.94 , ≪ / RTI > 1H), 8.55 (d, 1H)
[준비예 23] AzC-9의 합성[Preparation Example 23] Synthesis of AzC-9
<단계 1> 5-(dibenzo[b,d]furan-4-yl)-1H-indole의 합성<Step 1> Synthesis of 5- (dibenzo [b, d] furan-4-yl) -1H-indole
질소 기류 하에서 5-bromo-1H-indole (100 g, 439.2 mmol), 2-(dibenzo[b,d]furan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (155.0 g, 527.0 mmol), Pd(PPh3)4 (25.4 g, 22.0 mmol), K2CO3 (121.4 g, 878 mmol), 1,4-dioxane/H2O (200 ml/50 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 7:1 (v/v))로 정제하여 5-(dibenzo[b,d]furan-4-yl)-1H-indole (104.5 g, 수율 84 %)을 얻었다.(100 g, 439.2 mmol), 2- (dibenzo [b, d] furan-4-yl) -4,4,5,5-tetramethyl-1,3,2- dioxane / H 2 O (200 mL / 50 mL) was added to a solution of the title compound (155.0 g, 527.0 mmol), Pd (PPh 3 ) 4 (25.4 g, 22.0 mmol), K 2 CO 3 ) Were mixed and stirred at 120 ° C for 4 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. Dibenzo [b, d] furan-4-yl) -1H-indole (104.5 g, yielded as a colorless powder) was obtained by removing the solvent from the obtained organic layer and then purifying by column chromatography (Hexane: EA = 7: Yield: 84%).
1H-NMR: δ 6.45 (d, 1H), 7.27-7.38 (m, 4H), 7.66-7.89 (m, 7H), 10.1 (b, 1H) 1 H-NMR: δ 6.45 ( d, 1H), 7.27-7.38 (m, 4H), 7.66-7.89 (m, 7H), 10.1 (b, 1H)
<단계 2> 3-(5-(dibenzo[b,d]furan-4-yl)-1H-indol-1-yl)-9-phenyl-9H-carbazole의 합성Synthesis of 3- (5- (dibenzo [b, d] furan-4-yl) -1H-indol-1-yl) -9-phenyl-9H-
질소 기류 하에서 5-(dibenzo[b,d]furan-4-yl)-1H-indole (104.5 g, 368.9 mmol), 3-bromo-9-phenyl-9H-carbazole (142.6 g, 442.7 mmol), Cu (11.7 g, 184.5 mmol), K2CO3 (102.0 g, 737.8 mmol) 및 nitrobenzene (1000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 3-(5-(dibenzo[b,d]furan-4-yl)-1H-indol-1-yl)-9-phenyl-9H-carbazole (145.2 g, 수율 75 %)을 얻었다.3-bromo-9-phenyl-9H-carbazole (142.6 g, 442.7 mmol), Cu (dibenzo [b, d] furan-4-yl) -1H- indole (104.5 g, 368.9 mmol) (11.7 g, 184.5 mmol), K 2 CO 3 (102.0 g, 737.8 mmol) and nitrobenzene (1000 ml) were mixed and stirred at 210 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 4: 1 (v / v)) to obtain 3- (5- (dibenzo [ furan-4-yl) -1H-indol-1-yl) -9-phenyl-9H-carbazole (145.2 g, yield 75%).
1H-NMR: δ 6.52 (d, 1H), 7.25-7.67 (m, 14H), 7.77-8.00 (m, 7H), 8.18 (d, 1H), 8.55 (b, 1H) 1 H-NMR: δ 6.52 ( d, 1H), 7.25-7.67 (m, 14H), 7.77-8.00 (m, 7H), 8.18 (d, 1H), 8.55 (b, 1H)
<단계 3> AzC-9의 합성<Step 3> Synthesis of AzC-9
질소 기류 하에서 3-(5-(dibenzo[b,d]furan-4-yl)-1H-indol-1-yl)-9-phenyl-9H-carbazole (145.2 g, 276.7 mmol), polyphosphoric acid (725.8 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-9 (47.9 g, 수율 33 %)을 얻었다.9-phenyl-9H-carbazole (145.2 g, 276.7 mmol), polyphosphoric acid (725.8 g, g) were mixed and stirred at 100 占 폚 for 12 hours. After the reaction was completed, the reaction product was extracted from water and then filtered to obtain a compound AzC-9 (47.9 g, yield 33%).
1H-NMR: δ 6.69 (d, 1H), 6.99-7.00 (m, 2H), 7.31-7.66 (m, 15H), 7.81-7.89 (m, 4H), 8.12 (d, 1H), 8.49 (b, 1H)
1 H-NMR:? 6.69 (d, 1 H), 6.99-7.00 (m, 2H), 7.31-7.66 (m, 15H), 7.81-7.89 , 1H)
[준비예 24] AzC-10의 합성[Preparation Example 24] Synthesis of AzC-10
<단계 1> 5-(dibenzo[b,d]furan-4-yl)-1H-indole의 합성<Step 1> Synthesis of 5- (dibenzo [b, d] furan-4-yl) -1H-indole
질소 기류 하에서 5-bromo-1H-indole (100 g, 439.2 mmol), 2-(dibenzo[b,d]furan-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (155.0 g, 527.0 mmol), Pd(PPh3)4 (25.4 g, 22.0 mmol), K2CO3 (121.4 g, 878 mmol), 1,4-dioxane/H2O (200 ml/50 ml)를 혼합하고 120℃에서 4시간 동안 교반하였다. 반응이 종결된 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA = 5:1 (v/v))로 정제하여 5-(dibenzo[b,d]furan-4-yl)-1H-indole (94.6 g, 수율 76%)을 얻었다.(100 g, 439.2 mmol), 2- (dibenzo [b, d] furan-4-yl) -4,4,5,5-tetramethyl-1,3,2- dioxane / H 2 O (200 mL / 50 mL) was added to a solution of the title compound (155.0 g, 527.0 mmol), Pd (PPh 3 ) 4 (25.4 g, 22.0 mmol), K 2 CO 3 ) Were mixed and stirred at 120 ° C for 4 hours. After the reaction was completed, the reaction mixture was extracted with methylene chloride, added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 5: 1 (v / v)) to obtain 5- (dibenzo [b, d] furan- Yield: 76%).
1H-NMR: δ 6.45 (d, 1H), 7.27-7.38 (m, 4H), 7.66-7.89 (m, 7H), 10.1 (b, 1H) 1 H-NMR: δ 6.45 ( d, 1H), 7.27-7.38 (m, 4H), 7.66-7.89 (m, 7H), 10.1 (b, 1H)
<단계 2> 5-(dibenzo[b,d]furan-4-yl)-1-(9,9-dimethyl-9H-fluoren-3-yl)-1H-indole의 합성Synthesis of dibenzo [b, d] furan-4-yl) -1- (9,9-dimethyl-9H-fluoren-3-yl)
질소 기류 하에서 5-(dibenzo[b,d]furan-4-yl)-1H-indole (94.6 g, 333.8 mmol), 3-bromo-9,9-dimethyl-9H-fluorene (109.4 g, 400.5 mmol), Cu (10.6 g, 166.9 mmol), K2CO3 (92.3 g, 667.6 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 6:1 (v/v))로 정제하여 5-(dibenzo[b,d]furan-4-yl)-1-(9,9-dimethyl-9H-fluoren-3-yl)-1H-indole (117.5 g, 수율 74%)을 얻었다.3-bromo-9,9-dimethyl-9H-fluorene (109.4 g, 400.5 mmol) was added to a solution of 5- (dibenzo [b, d] furan- , Cu (10.6 g, 166.9 mmol), K 2 CO 3 (92.3 g, 667.6 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (hexane: EA = 6: 1 (v / v)) to obtain 5- (dibenzo [b, -yl) -1- (9,9-dimethyl-9H-fluoren-3-yl) -1H-indole (117.5 g, yield 74%).
1H-NMR: δ 1.72 (s, 6H), 6.52 (d, 1H), 7.06-7.07 (m, 2H), 7.17 (dd, 1H), 7.32-7.38 (m, 5H), 7.60-7.66 (m, 3H), 7.77-7.89 (m, 5H), 8.00 (d, 1H), 8.18 (d, 1H) 1 H-NMR: δ 1.72 ( s, 6H), 6.52 (d, 1H), 7.06-7.07 (m, 2H), 7.17 (dd, 1H), 7.32-7.38 (m, 5H), 7.60-7.66 (m , ≪ / RTI > 3H), 7.77-7.89 (m, 5H)
<단계 3> AzC-10의 합성<Step 3> Synthesis of AzC-10
질소 기류 하에서 5-(dibenzo[b,d]furan-4-yl)-1-(9,9-dimethyl-9H-fluoren-3-yl)-1H-indole (117.5 g, 247.0 mmol), polyphosphoric acid (587.3 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-10 (34.1 g, 수율 29%)를 얻었다.(Dibenzo [b, d] furan-4-yl) -1- (9,9-dimethyl-9H-fluoren-3-yl) -1H- indole (117.5 g, 247.0 mmol), polyphosphoric acid (587.3 g) were mixed and stirred at 100 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted from water and then filtered to obtain Compound AzC-10 (34.1 g, yield 29%).
1H-NMR: δ 1.72 (s, 6H), 6.69 (d, 1H), 6.99-7.04 (m, 3H), 7.28-7.38 (m, 6H), 7.46 (s, 1H), 7.55 (d, 1H), 7.66 (d, 1H), 7.81-7.89 (m, 5H), 8.42 (b, 1H)
1 H-NMR:? 1.72 (s, 6H), 6.69 (d, 1H), 6.99-7.04 (m, 3H), 7.28-7.38 ), 7.66 (d, 1 H), 7.81-7.89 (m, 5H), 8.42 (b,
[준비예 25] AzC-11의 합성[Preparation Example 25] Synthesis of AzC-11
<단계 1> 1-(dibenzo[b,d]furan-2-yl)-5-(dibenzo[b,d]furan-4-yl)-1H-indole의 합성Synthesis of dibenzo [b, d] furan-2-yl) -5- (dibenzo [b, d] furan-4-yl)
질소 기류 하에서 5-(dibenzo[b,d]furan-4-yl)-1H-indole (80.0 g, 282.4 mmol), 2-bromodibenzo[b,d]furan (83.7 g, 338.8 mmol), Cu (9.0 g, 141.2 mmol), K2CO3 (78.1 g, 564.7 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 4:1 (v/v))로 정제하여 1-(dibenzo[b,d]furan-2-yl)-5-(dibenzo[b,d]furan-4-yl)-1H-indole (100.3 g, 수율 79%)을 얻었다.Dibenzo [b, d] furan-4-yl) -1H-indole (80.0 g, 282.4 mmol), 2-bromodibenzo [b, d] furan (83.7 g, 338.8 mmol), Cu g, 141.2 mmol), K 2 CO 3 (78.1 g, 564.7 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 4: 1 (v / v)) to obtain 1- (dibenzo [b, -yl) -5- (dibenzo [b, d] furan-4-yl) -1H-indole (100.3 g, yield 79%).
1H-NMR: δ 6.52 (d, 1H), 7.32-7.38 (m, 5H), 7.50 (d, 1H), 7.60-7.66 (m, 4H), 7.77-7.89 (m, 6H), 8.00 (d, 1H), 8.18 (d, 1H) 1 H-NMR: δ 6.52 ( d, 1H), 7.32-7.38 (m, 5H), 7.50 (d, 1H), 7.60-7.66 (m, 4H), 7.77-7.89 (m, 6H), 8.00 (d , ≪ / RTI > 1H), 8.18 (d, 1H)
<단계 2> AzC-11의 합성<Step 2> Synthesis of AzC-11
질소 기류 하에서 1-(dibenzo[b,d]furan-2-yl)-5-(dibenzo[b,d]furan-4-yl)-1H-indole (100.3 g, 223.1 mmol), polyphosphoric acid (501.3 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-11 (31.1 g, 수율 31%)을 얻었다.Dibenzo [b, d] furan-2-yl) -5- (dibenzo [b, d] furan-4-yl) -1H- indole (100.3 g, 223.1 mmol), polyphosphoric acid g) were mixed and stirred at 100 占 폚 for 12 hours. After completion of the reaction, the reaction product was extracted with water and then filtered to obtain a compound AzC-11 (31.1 g, yield: 31%).
1H-NMR: δ 6.69 (d, 1H), 6.99-7.00 (m, 2H), 7.32-7.38 (m, 7H), 7.65-7.66 (m, 3H), 7.81-7.89 (m, 5H), 8.42 (b, 1H)
1 H-NMR: δ 6.69 ( d, 1H), 6.99-7.00 (m, 2H), 7.32-7.38 (m, 7H), 7.65-7.66 (m, 3H), 7.81-7.89 (m, 5H), 8.42 (b, 1H)
[준비예 26] AzC-12의 합성[Preparation Example 26] Synthesis of AzC-12
<단계 1> 5-(dibenzo[b,d]furan-4-yl)-1-(dibenzo[b,d]thiophen-2-yl)-1H-indole의 합성Synthesis of dibenzo [b, d] furan-4-yl) -1- (dibenzo [b, d] thiophen-2-yl)
질소 기류 하에서 5-(dibenzo[b,d]furan-4-yl)-1H-indole (80.0 g, 282.4 mmol), 2-bromodibenzo[b,d]thiophene (89.2 g, 338.8 mmol), Cu (9.0 g, 141.2 mmol), K2CO3 (78.1 g, 564.7 mmol) 및 nitrobenzene (2000 ml)를 혼합하고 210℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 5-(dibenzo[b,d]furan-4-yl)-1-(dibenzo[b,d]thiophen-2-yl)-1H-indole (97.3 g, 수율 74%)을 얻었다.Dibenzo [b, d] furan-4-yl) -1H-indole (80.0 g, 282.4 mmol), 2-bromodibenzo [b, d] thiophene (89.2 g, 338.8 mmol), Cu g, 141.2 mmol), K 2 CO 3 (78.1 g, 564.7 mmol) and nitrobenzene (2000 ml) were mixed and stirred at 210 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 5- (dibenzo [b, -yl) -1- (dibenzo [b, d] thiophen-2-yl) -1H-indole (97.3 g, yield 74%).
1H-NMR: δ 6.52 (d, 1H), 7.38-7.66 (m, 8H), 7.77-8.00 (m, 8H), 8.18 (d, 1H), 8.45 (d, 1H) 1 H-NMR: δ 6.52 ( d, 1H), 7.38-7.66 (m, 8H), 7.77-8.00 (m, 8H), 8.18 (d, 1H), 8.45 (d, 1H)
<단계 2> AzC-12의 합성<Step 2> Synthesis of AzC-12
질소 기류 하에서 5-(dibenzo[b,d]furan-4-yl)-1-(dibenzo[b,d]thiophen-2-yl)-1H-indole (97.3 g, 209.0 mmol), polyphosphoric acid (486.4 g)를 혼합하고 100℃에서 12시간 동안 교반하였다. 반응이 종결된 후 물에서 추출한 다음 여과하여 화합물 AzC-12 (35.0 g, 수율 36%)을 얻었다.Dibenzo [b, d] furan-4-yl) -1- (dibenzo [b, d] thiophen-2-yl) -1H- indole (97.3 g, 209.0 mmol), polyphosphoric acid g) were mixed and stirred at 100 占 폚 for 12 hours. After completion of the reaction, the reaction product was extracted from water and then filtered to obtain a compound AzC-12 (35.0 g, yield 36%).
1H-NMR: δ 6.69 (d, 1H), 6.99-7.00 (m, 2H), 7.32-7.40 (m, 5H), 7.50-7.52 (m, 2H), 7.66 (d, 1H), 7.77-7.89 (m, 5H), 7.98 (d, 1H), 8.42 (b, 1H), 8.50 (d, 1H)
1 H-NMR: δ 6.69 ( d, 1H), 6.99-7.00 (m, 2H), 7.32-7.40 (m, 5H), 7.50-7.52 (m, 2H), 7.66 (d, 1H), 7.77-7.89 (m, 5H), 7.98 (d, IH), 8.42 (b, IH), 8.50
[합성예 1] A-1의 합성[Synthesis Example 1] Synthesis of A-1
질소 기류 하에서 IIC-1 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-1 (3.7 g, 65 %)을 얻었다.(3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t- Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the title compound A-1 (3.7 g, 65 %).
Mass (이론치: 587.71 g/mol, 측정치: 587 g/mol)Mass (theory: 587.71 g / mol, measurement: 587 g / mol)
[합성예 2] A-2의 합성[Synthesis Example 2] Synthesis of A-2
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물 A-2 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-2 , Yield: 71%).
Mass (이론치: 588.70 g/mol, 측정치: 588 g/mol)Mass (theory: 588.70 g / mol, measurement: 588 g / mol)
[합성예 3] A-3의 합성[Synthesis Example 3] Synthesis of A-3
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물 A-3 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 1 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective Compound A-3 (4.5 g, yield 78%) was obtained.
Mass (이론치: 589.69 g/mol, 측정치: 589 g/mol)Mass (theory: 589.69 g / mol, measurement: 589 g / mol)
[합성예 4] A-4의 합성[Synthesis Example 4] Synthesis of A-4
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물 A-4 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine, 4 (3.9 g, yield 60%).
Mass (이론치: 664.79 g/mol, 측정치: 664 g/mol)Mass (theory: 664.79 g / mol, measurement: 664 g / mol)
[합성예 5] A-5의 합성[Synthesis Example 5] Synthesis of A-5
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물 A-5 (4.3 g, 수율 66 %)를 얻었다.Was prepared in the same manner as in Synthesis Example 1, except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine To obtain the target compound A-5 (4.3 g, yield 66%).
Mass (이론치: 665.78 g/mol, 측정치: 665 g/mol)Mass (calculated: 665.78 g / mol, measured: 665 g / mol)
[합성예 6] A-6의 합성[Synthesis Example 6] Synthesis of A-6
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물 A-6 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-6 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 1.
Mass (이론치: 741.88 g/mol, 측정치: 741 g/mol)Mass (theory: 741.88 g / mol, measured: 741 g / mol)
[합성예 7] A-7의 합성[Synthesis Example 7] Synthesis of A-7
질소 기류 하에서 IIC-2 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-7 (3.7 g, 65 %)을 얻었다.(3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t- Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the title compound A-7 (3.7 g, 65 %).
Mass (이론치: 587.71 g/mol, 측정치: 587 g/mol)Mass (theory: 587.71 g / mol, measurement: 587 g / mol)
[합성예 8] A-8의 합성[Synthesis Example 8] Synthesis of A-8
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 7과 동일한 과정을 수행하여 목적 화합물 A-8 (4.1 g, 수율 71 %)를 얻었다.The same procedure as in Synthesis Example 7 was carried out except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine, , Yield: 71%).
Mass (이론치: 588.70 g/mol, 측정치: 588 g/mol)Mass (theory: 588.70 g / mol, measurement: 588 g / mol)
[합성예 9] A-9의 합성[Synthesis Example 9] Synthesis of A-9
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 7과 동일한 과정을 수행하여 목적 화합물 A-9 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 7 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective Compound A-9 (4.5 g, yield 78%) was obtained.
Mass (이론치: 589.69 g/mol, 측정치: 589 g/mol)Mass (theory: 589.69 g / mol, measurement: 589 g / mol)
[합성예 10] A-10의 합성[Synthesis Example 10] Synthesis of A-10
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 7과 동일한 과정을 수행하여 목적 화합물 A-10 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthetic Example 7 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine. 10 (3.9 g, yield 60%).
Mass (이론치: 664.79 g/mol, 측정치: 664 g/mol)Mass (theory: 664.79 g / mol, measurement: 664 g / mol)
[합성예 11] A-11의 합성[Synthesis Example 11] Synthesis of A-11
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 7과 동일한 과정을 수행하여 목적 화합물 A-11 (4.3 g, 수율 66 %)를 얻었다.(3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the title compound A-11 (4.3 g, yield 66%).
Mass (이론치: 665.78 g/mol, 측정치: 665 g/mol)Mass (calculated: 665.78 g / mol, measured: 665 g / mol)
[합성예 12] A-12의 합성[Synthesis Example 12] Synthesis of A-12
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 7과 동일한 과정을 수행하여 목적 화합물 A-12 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-12 (5.3 g, yield 73%) was obtained by carrying out the same procedure as in Synthesis Example 7.
Mass (이론치: 741.88 g/mol, 측정치: 741 g/mol)Mass (theory: 741.88 g / mol, measured: 741 g / mol)
[합성예 13] A-13의 합성[Synthesis Example 13] Synthesis of A-13
질소 기류 하에서 IIC-3 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-13 (3.7 g, 65 %)을 얻었다.(3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t-Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-13 (3.7 g, 65 %).
Mass (이론치: 587.71 g/mol, 측정치: 587 g/mol)Mass (theory: 587.71 g / mol, measurement: 587 g / mol)
[합성예 14] A-14의 합성[Synthesis Example 14] Synthesis of A-14
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 13과 동일한 과정을 수행하여 목적 화합물 A-14 (4.1 g, 수율 71 %)를 얻었다.The same procedure as in Synthesis Example 13 was carried out except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine, , Yield: 71%).
Mass (이론치: 588.70 g/mol, 측정치: 588 g/mol)Mass (theory: 588.70 g / mol, measurement: 588 g / mol)
[합성예 15] A-15의 합성[Synthesis Example 15] Synthesis of A-15
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 13과 동일한 과정을 수행하여 목적 화합물 A-15 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 13 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The target compound A-15 (4.5 g, yield 78%) was obtained.
Mass (이론치: 589.69 g/mol, 측정치: 589 g/mol)Mass (theory: 589.69 g / mol, measurement: 589 g / mol)
[합성예 16] A-16의 합성[Synthesis Example 16] Synthesis of A-16
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 13과 동일한 과정을 수행하여 목적 화합물 A-16 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 13 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6- 16 (3.9 g, yield 60%).
Mass (이론치: 664.79 g/mol, 측정치: 664 g/mol)Mass (theory: 664.79 g / mol, measurement: 664 g / mol)
[합성예 17] A-17의 합성[Synthesis Example 17] Synthesis of A-17
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 13과 동일한 과정을 수행하여 목적 화합물 A-17 (4.3 g, 수율 66 %)를 얻었다.Was obtained in the same manner as in Synthesis Example 13 except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine (4.3 g, yield 66%) of the target compound A-17 was obtained.
Mass (이론치: 665.78 g/mol, 측정치: 665 g/mol)Mass (calculated: 665.78 g / mol, measured: 665 g / mol)
[합성예 18] A-18의 합성[Synthesis Example 18] Synthesis of A-18
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 13과 동일한 과정을 수행하여 목적 화합물 A-18 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-18 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 13.
Mass (이론치: 741.88 g/mol, 측정치: 741 g/mol)Mass (theory: 741.88 g / mol, measured: 741 g / mol)
[합성예 19] A-19의 합성[Synthesis Example 19] Synthesis of A-19
질소 기류 하에서 IIC-4 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-19 (3.7 g, 65 %)을 얻었다.(3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t-Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-19 (3.7 g, 65 %).
Mass (이론치: 587.71 g/mol, 측정치: 587 g/mol)Mass (theory: 587.71 g / mol, measurement: 587 g / mol)
[합성예 20] A-20의 합성[Synthesis Example 20] Synthesis of A-20
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 19와 동일한 과정을 수행하여 목적 화합물 A-20 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 19 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-20 , Yield: 71%).
Mass (이론치: 588.70 g/mol, 측정치: 588 g/mol)Mass (theory: 588.70 g / mol, measurement: 588 g / mol)
[합성예 21] A-21 의 합성[Synthesis Example 21] Synthesis of A-21
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 19와 동일한 과정을 수행하여 목적 화합물 A-21 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 19 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective compound A-21 (4.5 g, yield 78%) was obtained.
Mass (이론치: 589.69 g/mol, 측정치: 589 g/mol)Mass (theory: 589.69 g / mol, measurement: 589 g / mol)
[합성예 22] A-22의 합성[Synthesis Example 22] Synthesis of A-22
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 19와 동일한 과정을 수행하여 목적 화합물 A-22 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 19 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine, 22 (3.9 g, yield 60%).
Mass (이론치: 664.79 g/mol, 측정치: 664 g/mol)Mass (theory: 664.79 g / mol, measurement: 664 g / mol)
[합성예 23] A-23의 합성[Synthesis Example 23] Synthesis of A-23
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 19와 동일한 과정을 수행하여 목적 화합물 A-23 (4.3 g, 수율 66 %)를 얻었다.The same procedure as in Synthesis Example 19 was repeated, except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine To obtain the target compound A-23 (4.3 g, yield 66%).
Mass (이론치: 665.78 g/mol, 측정치: 665 g/mol)Mass (calculated: 665.78 g / mol, measured: 665 g / mol)
[합성예 24] A-24의 합성[Synthesis Example 24] Synthesis of A-24
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 19와 동일한 과정을 수행하여 목적 화합물 A-24 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-24 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 19.
Mass (이론치: 741.88 g/mol, 측정치: 741 g/mol)Mass (theory: 741.88 g / mol, measured: 741 g / mol)
[합성예 25] A-25의 합성[Synthesis Example 25] Synthesis of A-25
질소 기류 하에서 IIC-5 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-25 (3.7 g, 65 %)을 얻었다.(3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t-Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-25 (3.7 g, 65 %).
Mass (이론치: 587.71 g/mol, 측정치: 587 g/mol)Mass (theory: 587.71 g / mol, measurement: 587 g / mol)
[합성예 26] A-26의 합성[Synthesis Example 26] Synthesis of A-26
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 25와 동일한 과정을 수행하여 목적 화합물 A-26 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 25 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-26 , Yield: 71%).
Mass (이론치: 588.70 g/mol, 측정치: 588 g/mol)Mass (theory: 588.70 g / mol, measurement: 588 g / mol)
[합성예 27] A-27의 합성[Synthesis Example 27] Synthesis of A-27
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 25와 동일한 과정을 수행하여 목적 화합물 A-27 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 25 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective compound A-27 (4.5 g, yield 78%) was obtained.
Mass (이론치: 589.69 g/mol, 측정치: 589 g/mol)Mass (theory: 589.69 g / mol, measurement: 589 g / mol)
[합성예 28] A-28의 합성[Synthesis Example 28] Synthesis of A-28
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 25와 동일한 과정을 수행하여 목적 화합물 A-28 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 25 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6- 28 (3.9 g, yield 60%).
Mass (이론치: 664.79 g/mol, 측정치: 664 g/mol)Mass (theory: 664.79 g / mol, measurement: 664 g / mol)
[합성예 29] A-29의 합성[Synthesis Example 29] Synthesis of A-29
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 25와 동일한 과정을 수행하여 목적 화합물 A-29 (4.3 g, 수율 66 %)를 얻었다.Was obtained in the same manner as in Synthesis Example 25 except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine To obtain the target compound A-29 (4.3 g, yield 66%).
Mass (이론치: 665.78 g/mol, 측정치: 665 g/mol)Mass (calculated: 665.78 g / mol, measured: 665 g / mol)
[합성예 30] A-30의 합성[Synthesis Example 30] Synthesis of A-30
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 25와 동일한 과정을 수행하여 목적 화합물 A-30 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-30 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 25.
Mass (이론치: 741.88 g/mol, 측정치: 741 g/mol)Mass (theory: 741.88 g / mol, measured: 741 g / mol)
[합성예 31] A-31의 합성[Synthesis Example 31] Synthesis of A-31
질소 기류 하에서 IIC-6 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-31 (3.7 g, 65 %)을 얻었다.(3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-31 (3.7 g, 65 %).
Mass (이론치: 587.71 g/mol, 측정치: 587 g/mol)Mass (theory: 587.71 g / mol, measurement: 587 g / mol)
[합성예 32] A-32의 합성[Synthesis Example 32] Synthesis of A-32
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물 A-32 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 31 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-32 , Yield: 71%).
Mass (이론치: 588.70 g/mol, 측정치: 588 g/mol)Mass (theory: 588.70 g / mol, measurement: 588 g / mol)
[합성예 33] A-33의 합성[Synthesis Example 33] Synthesis of A-33
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물 A-33 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 31 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine To obtain the title compound A-33 (4.5 g, yield 78%).
Mass (이론치: 589.69 g/mol, 측정치: 589 g/mol)Mass (theory: 589.69 g / mol, measurement: 589 g / mol)
[합성예 34] A-34의 합성[Synthesis Example 34] Synthesis of A-34
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물 A-34 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 31 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine, 34 (3.9 g, yield 60%).
Mass (이론치: 664.79 g/mol, 측정치: 664 g/mol)Mass (theory: 664.79 g / mol, measurement: 664 g / mol)
[합성예 35] A-35의 합성[Synthesis Example 35] Synthesis of A-35
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물 A-35 (4.3 g, 수율 66 %)를 얻었다.(3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the target compound A-35 (4.3 g, yield 66%).
Mass (이론치: 665.78 g/mol, 측정치: 665 g/mol)Mass (calculated: 665.78 g / mol, measured: 665 g / mol)
[합성예 36] A-36의 합성[Synthesis Example 36] Synthesis of A-36
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 31과 동일한 과정을 수행하여 목적 화합물 A-36 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-36 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 31.
Mass (이론치: 741.88 g/mol, 측정치: 741 g/mol)Mass (theory: 741.88 g / mol, measured: 741 g / mol)
[합성예 37] A-37의 합성[Synthesis Example 37] Synthesis of A-37
질소 기류 하에서 IIC-7 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-37 (3.7 g, 65 %)을 얻었다.(3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-37 (3.7 g, 65 %).
Mass (이론치: 528.66 g/mol, 측정치: 528 g/mol)Mass (theory: 528.66 g / mol, measurement: 528 g / mol)
[합성예 38] A-38의 합성[Synthesis Example 38] Synthesis of A-38
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 과정을 수행하여 목적 화합물 A-38 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 37 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-38 , Yield: 71%).
Mass (이론치: 529.65 g/mol, 측정치: 529 g/mol)Mass (theory: 529.65 g / mol, measurement: 529 g / mol)
[합성예 39] A-39의 합성[Synthesis Example 39] Synthesis of A-39
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 과정을 수행하여 목적 화합물 A-39 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 37 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective compound A-39 (4.5 g, yield 78%) was obtained.
Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)Mass (theory: 530.64 g / mol, measured: 530 g / mol)
[합성예 40] A-40의 합성[Synthesis Example 40] Synthesis of A-40
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 과정을 수행하여 목적 화합물 A-40 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 37 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine, 40 (3.9 g, yield 60%).
Mass (이론치: 605.75 g/mol, 측정치: 605 g/mol)Mass (theory: 605.75 g / mol, measurement: 605 g / mol)
[합성예 41] A-41의 합성[Synthesis Example 41] Synthesis of A-41
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 과정을 수행하여 목적 화합물 A-41 (4.3 g, 수율 66 %)를 얻었다.(3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine To obtain the target compound A-41 (4.3 g, yield 66%).
Mass (이론치: 606.74 g/mol, 측정치: 665 g/mol)Mass (theory: 606.74 g / mol, measurement: 665 g / mol)
[합성예 42] A-42의 합성[Synthesis Example 42] Synthesis of A-42
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 37과 동일한 과정을 수행하여 목적 화합물인 A-42 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-42 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 37.
Mass (이론치: 682.83 g/mol, 측정치: 682 g/mol)Mass (theory: 682.83 g / mol, measured: 682 g / mol)
[합성예 43] A-43의 합성[Synthesis Example 43] Synthesis of A-43
질소 기류 하에서 IIC-8 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-43 (3.7 g, 65 %)을 얻었다.(3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t-Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-43 (3.7 g, 65 %).
Mass (이론치: 528.66 g/mol, 측정치: 528 g/mol)Mass (theory: 528.66 g / mol, measurement: 528 g / mol)
[합성예 44] A-44의 합성[Synthesis Example 44] Synthesis of A-44
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 과정을 수행하여 목적 화합물 A-44 (4.1 g, 수율 71 %)를 얻었다.The same procedure as in Synthesis Example 43 was carried out except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the target compound A-44 , Yield: 71%).
Mass (이론치: 529.65 g/mol, 측정치: 529 g/mol)Mass (theory: 529.65 g / mol, measurement: 529 g / mol)
[합성예 45] A-45의 합성[Synthesis Example 45] Synthesis of A-45
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 과정을 수행하여 목적 화합물 A-45 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 43 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective compound A-45 (4.5 g, yield 78%) was obtained.
Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)Mass (theory: 530.64 g / mol, measured: 530 g / mol)
[합성예 46] A-46의 합성[Synthesis Example 46] Synthesis of A-46
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 과정을 수행하여 목적 화합물 A-46 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 43 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine, 46 (3.9 g, yield 60%).
Mass (이론치: 605.75 g/mol, 측정치: 605 g/mol)Mass (theory: 605.75 g / mol, measurement: 605 g / mol)
[합성예 47] A-47의 합성[Synthesis Example 47] Synthesis of A-47
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 과정을 수행하여 목적 화합물 A-47 (4.3 g, 수율 66 %)를 얻었다.Except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the target compound A-47 (4.3 g, yield 66%).
Mass (이론치: 606.74 g/mol, 측정치: 665 g/mol)Mass (theory: 606.74 g / mol, measurement: 665 g / mol)
[합성예 48] A-48의 합성[Synthesis Example 48] Synthesis of A-48
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 43과 동일한 과정을 수행하여 목적 화합물 A-48 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-48 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 43.
Mass (이론치: 682.83 g/mol, 측정치: 682 g/mol)Mass (theory: 682.83 g / mol, measured: 682 g / mol)
[합성예 49] A-49의 합성[Synthesis Example 49] Synthesis of A-49
질소 기류 하에서 IIC-9 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-49 (3.7 g, 65 %)을 얻었다.(3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t-Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-49 (3.7 g, 65 %).
Mass (이론치: 528.66 g/mol, 측정치: 528 g/mol)Mass (theory: 528.66 g / mol, measurement: 528 g / mol)
[합성예 50] A-50의 합성[Synthesis Example 50] Synthesis of A-50
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 49와 동일한 과정을 수행하여 목적 화합물 A-50 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthetic Example 49 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-50 , Yield: 71%).
Mass (이론치: 529.65 g/mol, 측정치: 529 g/mol)Mass (theory: 529.65 g / mol, measurement: 529 g / mol)
[합성예 51] A-51의 합성[Synthesis Example 51] Synthesis of A-51
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 49와 동일한 과정을 수행하여 목적 화합물 A-51 (4.5 g, 수율 78 %)를 얻었다.The procedure of Synthesis Example 49 was repeated except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The target compound A-51 (4.5 g, yield 78%) was obtained.
Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)Mass (theory: 530.64 g / mol, measured: 530 g / mol)
[합성예 52] A-52의 합성[Synthesis Example 52] Synthesis of A-52
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 49와 동일한 과정을 수행하여 목적 화합물 A-52 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthetic Example 49 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine, 52 (3.9 g, yield 60%).
Mass (이론치: 605.75 g/mol, 측정치: 605 g/mol)Mass (theory: 605.75 g / mol, measurement: 605 g / mol)
[합성예 53] A-53의 합성[Synthesis Example 53] Synthesis of A-53
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 49와 동일한 과정을 수행하여 목적 화합물 A-53 (4.3 g, 수율 66 %)를 얻었다.Except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine (4.3 g, yield 66%) of the desired compound A-53.
Mass (이론치: 606.74 g/mol, 측정치: 665 g/mol)Mass (theory: 606.74 g / mol, measurement: 665 g / mol)
[합성예 54] A-54의 합성[Synthesis Example 54] Synthesis of A-54
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 49와 동일한 과정을 수행하여 목적 화합물 A-54 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-54 (5.3 g, yield 73%) was obtained in the same manner as in Synthetic Example 49.
Mass (이론치: 682.83 g/mol, 측정치: 682 g/mol)Mass (theory: 682.83 g / mol, measured: 682 g / mol)
[합성예 55] A-55의 합성[Synthesis Example 55] Synthesis of A-55
질소 기류 하에서 IIC-10 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-55 (3.7 g, 65 %)을 얻었다.(3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t-Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-55 (3.7 g, 65 %).
Mass (이론치: 528.66 g/mol, 측정치: 528 g/mol)Mass (theory: 528.66 g / mol, measurement: 528 g / mol)
[합성예 56] A-56의 합성[Synthesis Example 56] Synthesis of A-56
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 55와 동일한 과정을 수행하여 목적 화합물 A-56 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 55 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-56 , Yield: 71%).
Mass (이론치: 529.65 g/mol, 측정치: 529 g/mol)Mass (theory: 529.65 g / mol, measurement: 529 g / mol)
[합성예 57] A-57의 합성[Synthesis Example 57] Synthesis of A-57
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 55와 동일한 과정을 수행하여 목적 화합물 A-57 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 55 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective compound A-57 (4.5 g, yield 78%) was obtained.
Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)Mass (theory: 530.64 g / mol, measured: 530 g / mol)
[합성예 58] A-58의 합성[Synthesis Example 58] Synthesis of A-58
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 55와 동일한 과정을 수행하여 목적 화합물 A-58 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthetic Example 55 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine, 58 (3.9 g, yield 60%).
Mass (이론치: 605.75 g/mol, 측정치: 605 g/mol)Mass (theory: 605.75 g / mol, measurement: 605 g / mol)
[합성예 59] A-59의 합성[Synthesis Example 59] Synthesis of A-59
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 55와 동일한 과정을 수행하여 목적 화합물 A-59 (4.3 g, 수율 66 %)를 얻었다.Was prepared in the same manner as in Synthesis Example 55 except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the target compound A-59 (4.3 g, yield 66%).
Mass (이론치: 606.74 g/mol, 측정치: 665 g/mol)Mass (theory: 606.74 g / mol, measurement: 665 g / mol)
[합성예 60] A-60의 합성[Synthesis Example 60] Synthesis of A-60
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 55와 동일한 과정을 수행하여 목적 화합물 A-60 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-60 (5.3 g, yield 73%) was obtained by carrying out the same procedure as in Synthesis Example 55.
Mass (이론치: 682.83 g/mol, 측정치: 682 g/mol)Mass (theory: 682.83 g / mol, measured: 682 g / mol)
[합성예 61] A-61의 합성[Synthesis Example 61] Synthesis of A-61
질소 기류 하에서 IIC-11 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-61 (3.7 g, 65 %)을 얻었다.(3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t-Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-61 (3.7 g, 65 %).
Mass (이론치: 528.66 g/mol, 측정치: 528 g/mol)Mass (theory: 528.66 g / mol, measurement: 528 g / mol)
[합성예 62] A-62의 합성[Synthesis Example 62] Synthesis of A-62
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 과정을 수행하여 목적 화합물 A-62 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 61 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-62 , Yield: 71%).
Mass (이론치: 529.65 g/mol, 측정치: 529 g/mol)Mass (theory: 529.65 g / mol, measurement: 529 g / mol)
[합성예 63] A-63의 합성[Synthesis Example 63] Synthesis of A-63
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 과정을 수행하여 목적 화합물 A-63 (4.5 g, 수율 78 %)를 얻었다.The procedure of Synthesis Example 61 was repeated except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective Compound A-63 (4.5 g, yield 78%) was obtained.
Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)Mass (theory: 530.64 g / mol, measured: 530 g / mol)
[합성예 64] A-64의 합성[Synthesis Example 64] Synthesis of A-64
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 과정을 수행하여 목적 화합물 A-64 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 61 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine, 64 (3.9 g, yield 60%).
Mass (이론치: 605.75 g/mol, 측정치: 605 g/mol)Mass (theory: 605.75 g / mol, measurement: 605 g / mol)
[합성예 65] A-65의 합성[Synthesis Example 65] Synthesis of A-65
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 과정을 수행하여 목적 화합물 A-65 (4.3 g, 수율 66 %)를 얻었다.Was obtained in the same manner as in Synthesis Example 61, except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the target compound A-65 (4.3 g, yield 66%).
Mass (이론치: 606.74 g/mol, 측정치: 665 g/mol)Mass (theory: 606.74 g / mol, measurement: 665 g / mol)
[합성예 66] A-66의 합성[Synthesis Example 66] Synthesis of A-66
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 61과 동일한 과정을 수행하여 목적 화합물 A-66 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-66 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 61.
Mass (이론치: 682.83 g/mol, 측정치: 682 g/mol)Mass (theory: 682.83 g / mol, measured: 682 g / mol)
[합성예 67] A-67의 합성[Synthesis Example 67] Synthesis of A-67
질소 기류 하에서 IIC-12 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-67 (3.7 g, 65 %)을 얻었다.2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t- Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-67 (3.7 g, 65 %).
Mass (이론치: 528.66 g/mol, 측정치: 528 g/mol)Mass (theory: 528.66 g / mol, measurement: 528 g / mol)
[합성예 68] A-68의 합성[Synthesis Example 68] Synthesis of A-68
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 과정을 수행하여 목적 화합물 A-68 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 67 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-68 , Yield: 71%).
Mass (이론치: 529.65 g/mol, 측정치: 529 g/mol)Mass (theory: 529.65 g / mol, measurement: 529 g / mol)
[합성예 69] A-69의 합성[Synthesis Example 69] Synthesis of A-69
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 과정을 수행하여 목적 화합물 A-69 (4.5 g, 수율 78 %)를 얻었다.The same procedure was followed as in Synthesis Example 67 except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective compound A-69 (4.5 g, yield 78%) was obtained.
Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)Mass (theory: 530.64 g / mol, measured: 530 g / mol)
[합성예 70] A-70의 합성[Synthesis Example 70] Synthesis of A-70
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 과정을 수행하여 목적 화합물 A-70 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 67 was repeated except for using 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) instead of 2-chloro-4,6-diphenylpyridine, 70 (3.9 g, yield 60%).
Mass (이론치: 605.75 g/mol, 측정치: 605 g/mol)Mass (theory: 605.75 g / mol, measurement: 605 g / mol)
[합성예 71] A-71의 합성[Synthesis Example 71] Synthesis of A-71
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 과정을 수행하여 목적 화합물 A-71 (4.3 g, 수율 66 %)를 얻었다.Was obtained in the same manner as in Synthesis Example 67 except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the target compound A-71 (4.3 g, yield 66%).
Mass (이론치: 606.74 g/mol, 측정치: 665 g/mol)Mass (theory: 606.74 g / mol, measurement: 665 g / mol)
[합성예 72] A-72의 합성[Synthesis Example 72] Synthesis of A-72
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 67과 동일한 과정을 수행하여 목적 화합물 A-72 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-72 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 67.
Mass (이론치: 682.83 g/mol, 측정치: 682 g/mol)Mass (theory: 682.83 g / mol, measured: 682 g / mol)
[합성예 73] A-73의 합성[Synthesis Example 73] Synthesis of A-73
질소 기류 하에서 IIC-13 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-73 (3.7 g, 65 %)을 얻었다.(3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t- Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-73 (3.7 g, 65 %).
Mass (이론치: 512.60 g/mol, 측정치: 512 g/mol)Mass (theory: 512.60 g / mol, measurement: 512 g / mol)
[합성예 74] A-74의 합성[Synthesis Example 74] Synthesis of A-74
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 과정을 수행하여 목적 화합물 A-74 (4.1 g, 수율 71 %)를 얻었다.The same procedure as in Synthesis Example 73 was carried out, except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine, , Yield: 71%).
Mass (이론치: 513.59 g/mol, 측정치: 513 g/mol)Mass (theory: 513.59 g / mol, measurement: 513 g / mol)
[합성예 75] A-75의 합성[Synthesis Example 75] Synthesis of A-75
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 과정을 수행하여 목적 화합물 A-75 (4.5 g, 수율 78 %)를 얻었다.The same procedure was followed as in Synthesis Example 73 except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective compound A-75 (4.5 g, yield 78%) was obtained.
Mass (이론치: 514.58 g/mol, 측정치: 514 g/mol)Mass (theory: 514.58 g / mol, measurement: 514 g / mol)
[합성예 76] A-76의 합성[Synthesis Example 76] Synthesis of A-76
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 과정을 수행하여 목적 화합물 A-76 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthetic Example 73 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6- 76 (3.9 g, yield 60%).
Mass (이론치: 589.68 g/mol, 측정치: 589 g/mol)Mass (theory: 589.68 g / mol, measurement: 589 g / mol)
[합성예 77] A-77의 합성[Synthesis Example 77] Synthesis of A-77
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 과정을 수행하여 목적 화합물 A-77 (4.3 g, 수율 66 %)를 얻었다.Except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the target compound A-77 (4.3 g, yield 66%).
Mass (이론치: 590.67 g/mol, 측정치: 590 g/mol)Mass (calculated: 590.67 g / mol, measured: 590 g / mol)
[합성예 78] A-78의 합성[Synthesis Example 78] Synthesis of A-78
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 73과 동일한 과정을 수행하여 목적 화합물 A-78 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-78 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 73.
Mass (이론치: 666.77 g/mol, 측정치: 666 g/mol)Mass (theory: 666.77 g / mol, measurement: 666 g / mol)
[합성예 79] A-79의 합성[Synthesis Example 79] Synthesis of A-79
질소 기류 하에서 IIC-14 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-79 (3.7 g, 65 %)을 얻었다.(3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-79 (3.7 g, 65 %).
Mass (이론치: 512.60 g/mol, 측정치: 512 g/mol)Mass (theory: 512.60 g / mol, measurement: 512 g / mol)
[합성예 80] A-80의 합성[Synthesis Example 80] Synthesis of A-80
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 79와 동일한 과정을 수행하여 목적 화합물 A-80 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 79 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-80 , Yield: 71%).
Mass (이론치: 513.59 g/mol, 측정치: 513 g/mol)Mass (theory: 513.59 g / mol, measurement: 513 g / mol)
[합성예 81] A-81의 합성[Synthesis Example 81] Synthesis of A-81
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 79와 동일한 과정을 수행하여 목적 화합물 A-81 (4.5 g, 수율 78 %)를 얻었다.The procedure of Synthesis Example 79 was repeated except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective compound A-81 (4.5 g, yield 78%) was obtained.
Mass (이론치: 514.58 g/mol, 측정치: 514 g/mol)Mass (theory: 514.58 g / mol, measurement: 514 g / mol)
[합성예 82] A-82의 합성[Synthesis Example 82] Synthesis of A-82
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 79와 동일한 과정을 수행하여 목적 화합물 A-82 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthetic Example 79 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine. 82 (3.9 g, yield 60%).
Mass (이론치: 589.68 g/mol, 측정치: 589 g/mol)Mass (theory: 589.68 g / mol, measurement: 589 g / mol)
[합성예 83] A-83의 합성[Synthesis Example 83] Synthesis of A-83
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 79와 동일한 과정을 수행하여 목적 화합물 A-83 (4.3 g, 수율 66 %)를 얻었다.Was obtained in the same manner as in Synthesis Example 79 except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the target compound A-83 (4.3 g, yield 66%).
Mass (이론치: 590.67 g/mol, 측정치: 590 g/mol)Mass (calculated: 590.67 g / mol, measured: 590 g / mol)
[합성예 84] A-84의 합성[Synthesis Example 84] Synthesis of A-84
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 79와 동일한 과정을 수행하여 목적 화합물 A-84 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-84 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 79.
Mass (이론치: 666.77 g/mol, 측정치: 666 g/mol)Mass (theory: 666.77 g / mol, measurement: 666 g / mol)
[합성예 85] A-85의 합성[Synthesis Example 85] Synthesis of A-85
질소 기류 하에서 IIC-15 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-85 (3.7 g, 65 %)을 얻었다.(3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-85 (3.7 g, 65 %).
Mass (이론치: 512.60 g/mol, 측정치: 512 g/mol)Mass (theory: 512.60 g / mol, measurement: 512 g / mol)
[합성예 86] A-86의 합성[Synthesis Example 86] Synthesis of A-86
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 85와 동일한 과정을 수행하여 목적 화합물 A-86 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthetic Example 85 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-86 , Yield: 71%).
Mass (이론치: 513.59 g/mol, 측정치: 513 g/mol)Mass (theory: 513.59 g / mol, measurement: 513 g / mol)
[합성예 87] A-87의 합성[Synthesis Example 87] Synthesis of A-87
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 85와 동일한 과정을 수행하여 목적 화합물 A-87 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 85 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective Compound A-87 (4.5 g, yield 78%) was obtained.
Mass (이론치: 514.58 g/mol, 측정치: 514 g/mol)Mass (theory: 514.58 g / mol, measurement: 514 g / mol)
[합성예 88] A-88의 합성[Synthesis Example 88] Synthesis of A-88
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 85와 동일한 과정을 수행하여 목적 화합물 A-88 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 85 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6- 88 (3.9 g, yield 60%).
Mass (이론치: 589.68 g/mol, 측정치: 589 g/mol)Mass (theory: 589.68 g / mol, measurement: 589 g / mol)
[합성예 89] A-89의 합성[Synthesis Example 89] Synthesis of A-89
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 85와 동일한 과정을 수행하여 목적 화합물 A-89 (4.3 g, 수율 66 %)를 얻었다.Was obtained in the same manner as in Synthesis Example 85 except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was carried out to obtain the target compound A-89 (4.3 g, yield 66%).
Mass (이론치: 590.67 g/mol, 측정치: 590 g/mol)Mass (calculated: 590.67 g / mol, measured: 590 g / mol)
[합성예 90] A-90의 합성[Synthesis Example 90] Synthesis of A-90
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 85와 동일한 과정을 수행하여 목적 화합물 A-90 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-90 (5.3 g, yield 73%) was obtained by carrying out the same procedure as in Synthesis Example 85.
Mass (이론치: 666.77 g/mol, 측정치: 666 g/mol)Mass (theory: 666.77 g / mol, measurement: 666 g / mol)
[합성예 91] A-91의 합성[Synthesis Example 91] Synthesis of A-91
질소 기류 하에서 IIC-16 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-91 (3.7 g, 65 %)을 얻었다.(3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t-Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-91 (3.7 g, 65 %).
Mass (이론치: 512.60 g/mol, 측정치: 512 g/mol)Mass (theory: 512.60 g / mol, measurement: 512 g / mol)
[합성예 92] A-92의 합성[Synthesis Example 92] Synthesis of A-92
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 91과 동일한 과정을 수행하여 목적 화합물 A-92 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 91 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain target compound A-92 , Yield: 71%).
Mass (이론치: 513.59 g/mol, 측정치: 513 g/mol)Mass (theory: 513.59 g / mol, measurement: 513 g / mol)
[합성예 93] A-93의 합성[Synthesis Example 93] Synthesis of A-93
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 91과 동일한 과정을 수행하여 목적 화합물 A-93 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 91 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective compound A-93 (4.5 g, yield 78%) was obtained.
Mass (이론치: 514.58 g/mol, 측정치: 514 g/mol)Mass (theory: 514.58 g / mol, measurement: 514 g / mol)
[합성예 94] A-94의 합성[Synthesis Example 94] Synthesis of A-94
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 91과 동일한 과정을 수행하여 목적 화합물 A-94 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 91 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine, 94 (3.9 g, yield 60%).
Mass (이론치: 589.68 g/mol, 측정치: 589 g/mol)Mass (theory: 589.68 g / mol, measurement: 589 g / mol)
[합성예 95] A-95의 합성[Synthesis Example 95] Synthesis of A-95
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 91과 동일한 과정을 수행하여 목적 화합물 A-95 (4.3 g, 수율 66 %)를 얻었다.Was obtained in the same manner as in Synthesis Example 91 except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the title compound A-95 (4.3 g, yield 66%).
Mass (이론치: 590.67 g/mol, 측정치: 590 g/mol)Mass (calculated: 590.67 g / mol, measured: 590 g / mol)
[합성예 96] A-96의 합성[Synthesis Example 96] Synthesis of A-96
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 91과 동일한 과정을 수행하여 목적 화합물 A-96 (5.3 g, 수율 73%)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-96 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 91.
Mass (이론치: 666.77 g/mol, 측정치: 666 g/mol)Mass (theory: 666.77 g / mol, measurement: 666 g / mol)
[합성예 97] A-97의 합성[Synthesis Example 97] Synthesis of A-97
질소 기류 하에서 IIC-17 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-97 (3.7 g, 65 %)을 얻었다.(3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t- Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. Extracted with ethyl acetate. After the reaction was terminated, and then, dried with MgSO 4 and purified by column chromatography to obtain the target compound A-97 (3.7 g, 65 %).
Mass (이론치: 512.60 g/mol, 측정치: 512 g/mol)Mass (theory: 512.60 g / mol, measurement: 512 g / mol)
[합성예 98] A-98의 합성[Synthesis Example 98] Synthesis of A-98
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 97과 동일한 과정을 수행하여 목적 화합물 A-98 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 97 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-98 , Yield: 71%).
Mass (이론치: 513.59 g/mol, 측정치: 513 g/mol)Mass (theory: 513.59 g / mol, measurement: 513 g / mol)
[합성예 99] A-99의 합성[Synthesis Example 99] Synthesis of A-99
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 97과 동일한 과정을 수행하여 목적 화합물 A-99 (4.5 g, 수율 78 %)를 얻었다.The procedure of Synthesis Example 97 was repeated except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective Compound A-99 (4.5 g, yield 78%) was obtained.
Mass (이론치: 514.58 g/mol, 측정치: 514 g/mol)Mass (theory: 514.58 g / mol, measurement: 514 g / mol)
[합성예 100] A-100의 합성[Synthesis Example 100] Synthesis of A-100
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 97과 동일한 과정을 수행하여 목적 화합물 A-100 (3.9 g, 수율 60 %)를 얻었다.The procedure of Synthesis Example 97 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine, 100 (3.9 g, yield 60%).
Mass (이론치: 589.68 g/mol, 측정치: 589 g/mol)Mass (theory: 589.68 g / mol, measurement: 589 g / mol)
[합성예 101] A-101의 합성[Synthesis Example 101] Synthesis of A-101
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 97과 동일한 과정을 수행하여 목적 화합물 A-101 (4.3 g, 수율 66 %)를 얻었다.Was prepared in the same manner as in Synthesis Example 97, except that 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine Was performed to obtain the target compound A-101 (4.3 g, yield 66%).
Mass (이론치: 590.67 g/mol, 측정치: 590 g/mol)Mass (calculated: 590.67 g / mol, measured: 590 g / mol)
[합성예 102] A-102의 합성[Synthesis Example 102] Synthesis of A-102
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 97과 동일한 과정을 수행하여 목적 화합물 A-102 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-102 (5.3 g, yield 73%) was obtained by carrying out the same procedure as in Synthesis Example 97.
Mass (이론치: 666.77 g/mol, 측정치: 666 g/mol)Mass (theory: 666.77 g / mol, measurement: 666 g / mol)
[합성예 103] A-103의 합성[Synthesis Example 103] Synthesis of A-103
질소 기류 하에서 IIC-18 (3.5 g, 9.76 mmol), 2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd(OAc)2 (110 mg, 0.488 mmol), NaO(t-Bu) (1.9 g, 19.5 mmol), P(t-Bu)3 (50wt%) (395 mg, 0.976 mmol) 및 Toluene (35 ml)를 혼합하고 110℃에서 12시간 동안 교반하였다. 반응이 종결된 후 에틸아세테이트로 추출한 다음, MgSO4로 수분을 제거하고, 컬럼크로마토그래피로 정제하여 목적 화합물 A-103 (3.7 g, 65 %)을 얻었다.2-chloro-4,6-diphenylpyridine (3.1 g, 11.7 mmol), Pd (OAc) 2 (110 mg, 0.488 mmol), NaO (t- Bu) (1.9 g, 19.5 mmol), P (t-Bu) 3 (50 wt%) (395 mg, 0.976 mmol) and Toluene (35 ml) were mixed and stirred at 110 ° C for 12 hours. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, and then water was removed with MgSO 4. The residue was purified by column chromatography to obtain the desired compound A-103 (3.7 g, 65%).
Mass (이론치: 512.60 g/mol, 측정치: 512 g/mol)Mass (theory: 512.60 g / mol, measurement: 512 g / mol)
[합성예 104] A-104의 합성[Synthesis Example 104] Synthesis of A-104
2-chloro-4,6-diphenylpyridine 대신 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 103과 동일한 과정을 수행하여 목적 화합물 A-104 (4.1 g, 수율 71 %)를 얻었다.The procedure of Synthesis Example 103 was repeated except that 4-chloro-2,6-diphenylpyrimidine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine to obtain the desired compound A-104 , Yield: 71%).
Mass (이론치: 513.59 g/mol, 측정치: 513 g/mol)Mass (theory: 513.59 g / mol, measurement: 513 g / mol)
[합성예 105] A-105의 합성[Synthesis Example 105] Synthesis of A-105
2-chloro-4,6-diphenylpyridine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 103과 동일한 과정을 수행하여 목적 화합물 A-105 (4.5 g, 수율 78 %)를 얻었다.The same procedure as in Synthesis Example 103 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (3.1 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine The objective Compound A-105 (4.5 g, yield 78%) was obtained.
Mass (이론치: 514.58 g/mol, 측정치: 514 g/mol)Mass (theory: 514.58 g / mol, measurement: 514 g / mol)
[합성예 106] A-106의 합성[Synthesis Example 106] Synthesis of A-106
2-chloro-4,6-diphenylpyridine 대신 4-(3-chlorophenyl)-2,6-diphenylpyrimidine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 103과 동일한 과정을 수행하여 목적 화합물 A-106 (3.9 g, 수율 60%)를 얻었다.The procedure of Synthesis Example 103 was repeated except that 4- (3-chlorophenyl) -2,6-diphenylpyrimidine (4.0 g, 11.7 mmol) was used instead of 2-chloro-4,6-diphenylpyridine, 106 (3.9 g, yield 60%).
Mass (이론치: 589.68 g/mol, 측정치: 589 g/mol)Mass (theory: 589.68 g / mol, measurement: 589 g / mol)
[합성예 107] A-107의 합성[Synthesis Example 107] Synthesis of A-107
2-chloro-4,6-diphenylpyridine 대신 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 103과 동일한 과정을 수행하여 목적 화합물 A-107 (4.3 g, 수율 66 %)를 얻었다.(3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.0 g, 11.7 mmol) was used in place of 2-chloro-4,6-diphenylpyridine The desired compound A-107 (4.3 g, yield 66%) was obtained.
Mass (이론치: 590.67 g/mol, 측정치: 590 g/mol)Mass (calculated: 590.67 g / mol, measured: 590 g / mol)
[합성예 108] A-108의 합성[Synthesis Example 108] Synthesis of A-108
2-chloro-4,6-diphenylpyridine 대신 2-(3'-chloro-[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol)을 사용하는 것을 제외하고는 합성예 103과 동일한 과정을 수행하여 목적 화합물 A-108 (5.3 g, 수율 73 %)를 얻었다.(3'-chloro- [1,1'-biphenyl] -3-yl) -4,6-diphenyl-1,3,5-triazine (4.9 g, 11.7 mmol), the target compound A-108 (5.3 g, yield 73%) was obtained in the same manner as in Synthesis Example 103.
Mass (이론치: 666.77 g/mol, 측정치: 666 g/mol)Mass (theory: 666.77 g / mol, measurement: 666 g / mol)
[합성예 109] B-1의 합성[Synthesis Example 109] Synthesis of B-1
질소 기류 하에서 AzC-1 (3.7 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 B-1 (3.5 g, 수율 66 %)을 얻었다.4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and purified by column chromatography to obtain the desired compound B-1 (3.5 g, yield 66%).
Mass (이론치: 780.33, 측정치: 780 g/mol)Mass (theory value: 780.33, measurement value: 780 g / mol)
[합성예 110] B-2의 합성[Synthesis Example 110] Synthesis of B-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 109와 동일한 과정을 수행하여 목적 화합물 B-2 (3.4 g, 수율 65 %)를 얻었다.The same procedure as in Synthesis Example 109 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound B-2 (3.4 g, yield 65%).
Mass (이론치: 781.32, 측정치: 781 g/mol)Mass (theory: 781.32, measurement: 781 g / mol)
[합성예 111] B-3의 합성[Synthesis Example 111] Synthesis of B-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 109와 동일한 과정을 수행하여 목적 화합물 B-3 (3.7 g, 수율 64 %)을 얻었다.Was obtained in the same manner as in Synthesis Example 109 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound B-3 (3.7 g, yield 64%).
Mass (이론치: 857.35, 측정치: 857 g/mol)Mass (theory: 857.35, measured: 857 g / mol)
[합성예 112] B-4의 합성[Synthesis Example 112] Synthesis of B-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 109와 동일한 과정을 수행하여 목적 화합물 B-4 (3.5 g, 수율 70%)를 얻었다.The procedure of Synthesis Example 109 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain the desired compound B-4 70%).
Mass (이론치: 754.31, 측정치: 754 g/mol)Mass (theory: 754.31, measurement: 754 g / mol)
[합성예 113] B-5의 합성[Synthesis Example 113] Synthesis of B-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 109와 동일한 과정을 수행하여 목적 화합물 B-5 (3.7 g, 수율 62 %)를 얻었다.The same procedure as in Synthesis Example 109 was carried out except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound B-5 (3.7 g, yield 62%).
Mass (이론치: 880.36, 측정치: 880 g/mol)Mass (theory value: 880.36, measurement value: 880 g / mol)
[합성예 114] B-6의 합성[Synthesis Example 114] Synthesis of B-6
질소 기류 하에서 AzC-2 (2.0 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 B-6 (3.2 g, 수율 64 %)을 얻었다.(2.0 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol) and 1,10-phenanthroline mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and purified by column chromatography to obtain the target compound B-6 (3.2 g, yield 64%).
Mass (이론치: 754.27, 측정치: 754 g/mol)Mass (theory: 754.27, found: 754 g / mol)
[합성예 115] B-7의 합성[Synthesis Example 115] Synthesis of B-7
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 114와 동일한 과정을 수행하여 목적 화합물 B-7 (3.5 g, 수율 69 %)를 얻었다.The same procedure was followed as in Synthesis Example 114 except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound B-7 (3.5 g, yield 69%).
Mass (이론치: 755.27, 측정치: 755 g/mol)Mass (theory: 755.27, measurement: 755 g / mol)
[합성예 116] B-8의 합성[Synthesis Example 116] Synthesis of B-8
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 114와 동일한 과정을 수행하여 목적 화합물 B-8 (3.4 g, 수율 61%)을 얻었다.The same procedure as in Preparation Example 114 was repeated, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine. To obtain the desired compound B-8 (3.4 g, yield 61%).
Mass (이론치: 831.30, 측정치: 831 g/mol)Mass (theory: 831.30, measurement: 831 g / mol)
[합성예 117] B-9의 합성[Synthesis Example 117] Synthesis of B-9
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 114와 동일한 과정을 수행하여 목적 화합물 B-9 (3.1 g, 수율 63 %)를 얻었다.The procedure of Synthesis Example 114 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain 3.1 g 63%).
Mass (이론치: 728.26, 측정치: 728 g/mol)Mass (theory: 728.26, measurement: 728 g / mol)
[합성예 118] B-10의 합성[Synthesis Example 118] Synthesis of B-10
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 114와 동일한 과정을 수행하여 목적 화합물 B-10 (3.8 g, 수율 66 %)를 얻었다.The procedure of Synthesis Example 114 was repeated except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the title compound B-10 (3.8 g, yield 66%).
Mass (이론치: 854.30, 측정치: 854 g/mol)Mass (theory: 854.30, measurement: 854 g / mol)
[합성예 119] C-1의 합성[Synthesis Example 119] Synthesis of C-1
질소 기류 하에서 AzC-3 (3.6 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 C-1 (3.3 g, 수율 63 %)을 얻었다.(3.6 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and purified by column chromatography to obtain the target compound C-1 (3.3 g, yield 63%).
Mass (이론치: 770.25, 측정치: 770 g/mol) Mass (theory: 770.25, measurement: 770 g / mol)
[합성예 120] C-2의 합성[Synthesis Example 120] Synthesis of C-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 119와 동일한 과정을 수행하여 목적 화합물 C-2 (3.6 g, 수율 70 %)를 얻었다.The same procedure was followed as in Synthesis Example 119 except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine To obtain the aimed compound C-2 (3.6 g, yield 70%).
Mass (이론치: 771.25, 측정치: 771 g/mol)Mass (theory: 771.25, measurement: 771 g / mol)
[합성예 121] C-3의 합성[Synthesis Example 121] Synthesis of C-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 119와 동일한 과정을 수행하여 목적 화합물 C-3 (3.7 g, 수율 65 %)을 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound C-3 (3.7 g, yield 65%).
Mass (이론치: 847.28, 측정치: 847 g/mol)Mass (theory: 847.28, measurement: 847 g / mol)
[합성예 122] C-4의 합성[Synthesis Example 122] Synthesis of C-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 119와 동일한 과정을 수행하여 목적 화합물 C-4 (3.1 g, 수율 63 %)를 얻었다.The procedure of Synthesis Example 119 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain 3.1 g 63%).
Mass (이론치: 744.23, 측정치: 744 g/mol)Mass (calcd.: 744.23, found: 744 g / mol)
[합성예 123] C-5의 합성[Synthesis Example 123] Synthesis of C-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 119와 동일한 과정을 수행하여 목적 화합물 C-5 (3.8 g, 수율 66 %)를 얻었다.The same procedure as in Synthesis Example 119 was performed except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the aimed compound C-5 (3.8 g, yield 66%).
Mass (이론치: 870.28, 측정치: 870 g/mol)Mass (theory: 870.28, measured: 870 g / mol)
[합성예 124] D-1의 합성[Synthesis Example 124] Synthesis of D-1
질소 기류 하에서 AzC-4 (3.7 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 D-1 (3.2 g, 수율 61 %)을 얻었다.4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and purified by column chromatography to obtain the desired compound D-1 (3.2 g, yield 61%).
Mass (이론치: 780.33, 측정치: 780 g/mol) Mass (theory value: 780.33, measurement value: 780 g / mol)
[합성예 125] D-2의 합성[Synthesis Example 125] Synthesis of D-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 124와 동일한 과정을 수행하여 목적 화합물 D-2 (3.4 g, 수율 65 %)를 얻었다.The same procedure as in Synthesis Example 124 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound D-2 (3.4 g, yield 65%).
Mass (이론치: 781.32, 측정치: 781 g/mol)Mass (theory: 781.32, measurement: 781 g / mol)
[합성예 126] D-3의 합성[Synthesis Example 126] Synthesis of D-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 124와 동일한 과정을 수행하여 목적 화합물 D-3 (3.6 g, 수율 63 %)을 얻었다.Was obtained in the same manner as in Synthesis Example 124 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound D-3 (3.6 g, yield 63%).
Mass (이론치: 857.35, 측정치: 857 g/mol)Mass (theory: 857.35, measured: 857 g / mol)
[합성예 127] D-4의 합성[Synthesis Example 127] Synthesis of D-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 124와 동일한 과정을 수행하여 목적 화합물 D-4 (3.1 g, 수율 62 %)를 얻었다.The procedure of Synthesis Example 124 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain the desired compound D-4 62%).
Mass (이론치: 754.31, 측정치: 754 g/mol)Mass (theory: 754.31, measurement: 754 g / mol)
[합성예 128] D-5의 합성[Synthesis Example 128] Synthesis of D-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 124와 동일한 과정을 수행하여 목적 화합물 D-5 (4.0 g, 수율 68 %)를 얻었다.The same procedure as in Synthesis Example 124 was carried out except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound D-5 (4.0 g, yield 68%).
Mass (이론치: 880.36, 측정치: 880 g/mol)Mass (theory value: 880.36, measurement value: 880 g / mol)
[합성예 129] E-1의 합성[Synthesis Example 129] Synthesis of E-1
질소 기류 하에서 AzC-5 (2.0 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 E-1 (3.3 g, 수율 65 %)을 얻었다.(2.0 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and purified by column chromatography to obtain the target compound E-1 (3.3 g, yield 65%).
Mass (이론치: 754.27, 측정치: 754 g/mol) Mass (theory: 754.27, found: 754 g / mol)
[합성예 130] E-2의 합성[Synthesis Example 130] Synthesis of E-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 129와 동일한 과정을 수행하여 목적 화합물 E-2 (3.2 g, 수율 63 %)를 얻었다.The procedure of Synthesis Example 129 was repeated except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine The objective Compound E-2 (3.2 g, yield 63%) was obtained.
Mass (이론치: 755.27, 측정치: 755 g/mol)Mass (theory: 755.27, measurement: 755 g / mol)
[합성예 131] E-3의 합성[Synthesis Example 131] Synthesis of E-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 129와 동일한 과정을 수행하여 목적 화합물 E-3 (3.7 g, 수율 67 %)을 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound E-3 (3.7 g, yield 67%).
Mass (이론치: 831.30, 측정치: 831 g/mol)Mass (theory: 831.30, measurement: 831 g / mol)
[합성예 132] E-4의 합성[Synthesis Example 132] Synthesis of E-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 129와 동일한 과정을 수행하여 목적 화합물 E-4 (3.4 g, 수율 70 %)를 얻었다.The procedure of Synthesis Example 129 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain the desired compound E-4 (3.4 g, yield 70%).
Mass (이론치: 728.26, 측정치: 728 g/mol)Mass (theory: 728.26, measurement: 728 g / mol)
[합성예 133] E-5의 합성[Synthesis Example 133] Synthesis of E-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 129와 동일한 과정을 수행하여 목적 화합물 E-5 (4.2 g, 수율 73 %)를 얻었다.The same procedure as in Synthesis Example 129 was performed except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound E-5 (4.2 g, yield 73%).
Mass (이론치: 854.30, 측정치: 854 g/mol)Mass (theory: 854.30, measurement: 854 g / mol)
[합성예 134] F-1의 합성[Synthesis Example 134] Synthesis of F-1
질소 기류 하에서 AzC-6 (3.6 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 F-1 (3.3 g, 수율 64%)을 얻었다.(3.6 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol) and 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain the desired compound F-1 (3.3 g, yield 64%).
Mass (이론치: 770.25, 측정치: 770 g/mol)Mass (theory: 770.25, measurement: 770 g / mol)
[합성예 135] F-2의 합성[Synthesis Example 135] Synthesis of F-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 134와 동일한 과정을 수행하여 목적 화합물 F-2 (3.3 g, 수율 63 %)를 얻었다.The same procedure as in Synthesis Example 134 was performed except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine To obtain the aimed compound F-2 (3.3 g, yield 63%).
Mass (이론치: 771.25, 측정치: 771 g/mol)Mass (theory: 771.25, measurement: 771 g / mol)
[합성예 136] F-3의 합성[Synthesis Example 136] Synthesis of F-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 134와 동일한 과정을 수행하여 목적 화합물 F-3 (3.8 g, 수율 67%)을 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound F-3 (3.8 g, yield 67%).
Mass (이론치: 847.28, 측정치: 847 g/mol)Mass (theory: 847.28, measurement: 847 g / mol)
[합성예 137] F-4의 합성[Synthesis Example 137] Synthesis of F-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 134와 동일한 과정을 수행하여 목적 화합물 F-4 (3.1 g, 수율 62 %)를 얻었다.The procedure of Synthesis Example 134 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine to obtain 3.1 g 62%).
Mass (이론치: 744.23, 측정치: 744 g/mol)Mass (calcd.: 744.23, found: 744 g / mol)
[합성예 138] F-5의 합성[Synthesis Example 138] Synthesis of F-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 134와 동일한 과정을 수행하여 목적 화합물 F-5 (3.8 g, 수율 66 %)를 얻었다.The same procedure as in Synthesis Example 134 was repeated, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound F-5 (3.8 g, yield 66%).
Mass (이론치: 870.28, 측정치: 870 g/mol)Mass (theory: 870.28, measured: 870 g / mol)
[합성예 139] G-1의 합성[Synthesis Example 139] Synthesis of G-1
질소 기류 하에서 AzC-7 (4.0 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 G-1 (3.9 g, 수율 71 %)을 얻었다.4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain the desired compound G-1 (3.9 g, yield 71%).
Mass (이론치: 829.32, 측정치: 829 g/mol) Mass (theory: 829.32, measurement: 829 g / mol)
[합성예 140] G-2의 합성[Synthesis Example 140] Synthesis of G-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 139와 동일한 과정을 수행하여 목적 화합물 G-2 (4.1 g, 수율 73 %)를 얻었다.The same procedure as in Synthesis Example 139 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound G-2 (4.1 g, yield 73%).
Mass (이론치: 830.32, 측정치: 830 g/mol)Mass (theory: 830.32, measurement: 830 g / mol)
[합성예 141] G-3의 합성[Synthesis Example 141] Synthesis of G-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 139와 동일한 과정을 수행하여 목적 화합물 G-3 (3.9 g, 수율 64 %)을 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound G-3 (3.9 g, yield 64%).
Mass (이론치: 905.35, 측정치: 905 g/mol)Mass (theory: 905.35, measurement: 905 g / mol)
[합성예 142] G-4의 합성[Synthesis Example 142] Synthesis of G-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 139와 동일한 과정을 수행하여 목적 화합물 G-4 (3.4 g, 수율 64 %)를 얻었다.The procedure of Synthesis Example 139 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain the desired compound G-4 (3.4 g, 64%).
Mass (이론치: 803.30, 측정치: 803 g/mol)Mass (theory: 803.30, measurement: 803 g / mol)
[합성예 143] G-5의 합성[Synthesis Example 143] Synthesis of G-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 139와 동일한 과정을 수행하여 목적 화합물 G-5 (4.1 g, 수율 66 %)를 얻었다.The same procedure as in Synthesis Example 139 was carried out except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound G-5 (4.1 g, yield 66%).
Mass (이론치: 929.35, 측정치: 929 g/mol)Mass (theory: 929.35, found: 929 g / mol)
[합성예 144] H-1의 합성[Synthesis Example 144] Synthesis of H-1
질소 기류 하에서 AzC-8 (4.0 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 H-1 (3.6 g, 수율 64 %)을 얻었다.To a solution of AzC-8 (4.0 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain the desired compound H-1 (3.6 g, yield 64%).
Mass (이론치: 829.32, 측정치: 829 g/mol) Mass (theory: 829.32, measurement: 829 g / mol)
[합성예 145] H-2의 합성[Synthesis Example 145] Synthesis of H-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 144와 동일한 과정을 수행하여 목적 화합물 H-2 (3.9 g, 수율 70 %)를 얻었다.The same procedure was followed as in Synthesis Example 144 except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound H-2 (3.9 g, yield 70%).
Mass (이론치: 830.32, 측정치: 830 g/mol)Mass (theory: 830.32, measurement: 830 g / mol)
[합성예 146] H-3의 합성[Synthesis Example 146] Synthesis of H-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 144와 동일한 과정을 수행하여 목적 화합물 H-3 (4.3 g, 수율 71%)을 얻었다.The same procedure as in Synthesis Example 144 was repeated, except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the target compound H-3 (4.3 g, yield 71%).
Mass (이론치: 905.35, 측정치: 905 g/mol)Mass (theory: 905.35, measurement: 905 g / mol)
[합성예 147] H-4의 합성[Synthesis Example 147] Synthesis of H-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 144와 동일한 과정을 수행하여 목적 화합물 H-4 (3.5 g, 수율 65 %)를 얻었다.The procedure of Synthesis Example 144 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain the desired compound H-4 (3.5 g, yield 65%).
Mass (이론치: 803.95, 측정치: 803 g/mol)Mass (theory: 803.95, measurement: 803 g / mol)
[합성예 148] H-5의 합성[Synthesis Example 148] Synthesis of H-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 144와 동일한 과정을 수행하여 목적 화합물 H-5 (3.7 g, 수율 60%)를 얻었다.The same procedure as in Synthesis Example 144 was carried out except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain objective compound H-5 (3.7 g, yield 60%).
Mass (이론치: 929.35, 측정치: 929 g/mol)Mass (theory: 929.35, found: 929 g / mol)
[합성예 149] I-1의 합성[Synthesis Example 149] Synthesis of I-1
질소 기류 하에서 AzC-9 (3.5 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 I-1 (3.2 g, 수율 63%)을 얻었다.(3.5 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and purified by column chromatography to obtain the desired compound I-1 (3.2 g, yield 63%).
Mass (이론치: 754.27, 측정치: 754 g/mol) Mass (theory: 754.27, found: 754 g / mol)
[합성예 150] I-2의 합성[Synthesis Example 150] Synthesis of I-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 149와 동일한 과정을 수행하여 목적 화합물 I-2 (3.4 g, 수율 67 %)를 얻었다.The same procedure as in Preparation Example 149 was repeated but using 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) instead of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound I-2 (3.4 g, yield 67%).
Mass (이론치: 755.27, 측정치: 755 g/mol)Mass (theory: 755.27, measurement: 755 g / mol)
[합성예 151] I-3의 합성[Synthesis Example 151] Synthesis of I-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 149와 동일한 과정을 수행하여 목적 화합물 I-3 (3.4 g, 수율 61 %)을 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound I-3 (3.4 g, yield 61%).
Mass (이론치: 830.30, 측정치: 830 g/mol)Mass (theory: 830.30, measured: 830 g / mol)
[합성예 152] I-4의 합성[Synthesis Example 152] Synthesis of I-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 149와 동일한 과정을 수행하여 목적 화합물 I-4 (3.4 g, 수율 70 %)를 얻었다.The same procedure as in Synthesis Example 149 was repeated but using 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) instead of 4-bromo-2,6-diphenylpyrimidine to obtain the desired compound I- 70%).
Mass (이론치: 728.26, 측정치: 728 g/mol)Mass (theory: 728.26, measurement: 728 g / mol)
[합성예 153] I-5의 합성[Synthesis Example 153] Synthesis of I-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 149와 동일한 과정을 수행하여 목적 화합물 I-5 (4.2 g, 수율 73 %)를 얻었다.The same procedure as in Preparation Example 149 was repeated, except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound I-5 (4.2 g, yield 73%).
Mass (이론치: 854.30, 측정치: 854 g/mol)Mass (theory: 854.30, measurement: 854 g / mol)
[합성예 154] J-1의 합성[Synthesis Example 154] Synthesis of J-1
질소 기류 하에서 AzC-10 (3.2 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 J-1 (3.0 g, 수율 64%)을 얻었다.(3.2 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain the desired compound J-1 (3.0 g, yield 64%).
Mass (이론치: 705.28, 측정치: 705 g/mol) Mass (theory: 705.28, measured: 705 g / mol)
[합성예 155] J-2의 합성[Synthesis Example 155] Synthesis of J-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 154와 동일한 과정을 수행하여 목적 화합물 J-2 (3.4 g, 수율 71 %)를 얻었다.The same procedure as in Synthesis Example 154 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine To obtain the title compound J-2 (3.4 g, yield 71%).
Mass (이론치: 706.27, 측정치: 706 g/mol)Mass (theory: 706.27, measurement: 706 g / mol)
[합성예 156] J-3의 합성[Synthesis Example 156] Synthesis of J-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 154와 동일한 과정을 수행하여 목적 화합물 J-3 (3.7 g, 수율 70 %)을 얻었다.Except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound J-3 (3.7 g, yield 70%).
Mass (이론치: 782.30, 측정치: 782 g/mol)Mass (theory: 782.30, measured: 782 g / mol)
[합성예 157] J-4의 합성[Synthesis Example 157] Synthesis of J-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 154와 동일한 과정을 수행하여 목적 화합물 J-4 (2.9 g, 수율 63 %)를 얻었다.The procedure of Synthesis Example 154 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain the desired compound J-4 (2.9 g, 63%).
Mass (이론치: 679.26, 측정치: 679 g/mol)Mass (theory: 679.26, found: 679 g / mol)
[합성예 158] J-5의 합성[Synthesis Example 158] Synthesis of J-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 154와 동일한 과정을 수행하여 목적 화합물 J-5 (3.6 g, 수율 66 %)를 얻었다.The same procedure as in Synthesis Example 154 was performed except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound J-5 (3.6 g, yield 66%).
Mass (이론치: 805.31, 측정치: 805 g/mol)Mass (theory: 805.31, measurement: 805 g / mol)
[합성예 159] K-1의 합성[Synthesis Example 159] Synthesis of K-1
질소 기류 하에서 AzC-11 (3.0 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 K-1 (3.0 g, 수율 67 %)을 얻었다.(3.0 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and then purified by column chromatography to obtain the desired compound K-1 (3.0 g, yield 67%).
Mass (이론치: 679.23, 측정치: 679 g/mol) Mass (theory: 679.23, measurement: 679 g / mol)
[합성예 160] K-2의 합성[Synthesis Example 160] Synthesis of K-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 159와 동일한 과정을 수행하여 목적 화합물 K-2 (2.9 g, 수율 64 %)를 얻었다.The same procedure as in Synthesis Example 159 was carried out except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound K-2 (2.9 g, yield 64%).
Mass (이론치: 680.22, 측정치: 680 g/mol)Mass (theory: 680.22, measurement: 680 g / mol)
[합성예 161] K-3의 합성[Synthesis Example 161] Synthesis of K-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 159와 동일한 과정을 수행하여 목적 화합물 K-3 (3.2 g, 수율 63 %)을 얻었다.The same procedure as in Preparation Example 159 was repeated but using 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) instead of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound K-3 (3.2 g, yield 63%).
Mass (이론치: 756.25, 측정치: 756 g/mol)Mass (theory: 756.25, measurement: 756 g / mol)
[합성예 162] K-4의 합성[Synthesis Example 162] Synthesis of K-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 159와 동일한 과정을 수행하여 목적 화합물 K-4 (2.9 g, 수율 67 %)를 얻었다.The procedure of Synthesis Example 159 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain the desired compound K-4 (2.9 g, 67%).
Mass (이론치: 653.21, 측정치: 653 g/mol)Mass (theory: 653.21, found: 653 g / mol)
[합성예 163] K-5의 합성[Synthesis Example 163] Synthesis of K-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 159와 동일한 과정을 수행하여 목적 화합물 K-5 (3.2 g, 수율 61 %)를 얻었다.The same procedure as in Synthesis Example 159 was repeated but using 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) instead of 4-bromo-2,6-diphenylpyrimidine To obtain the aimed compound K-5 (3.2 g, yield 61%).
Mass (이론치: 779.26, 측정치: 779 g/mol)Mass (theory: 779.26, measurement: 779 g / mol)
[합성예 164] L-1의 합성[Synthesis Example 164] Synthesis of L-1
질소 기류 하에서 AzC-12 (3.1 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 L-1 (2.9 g, 수율 63%)을 얻었다.(3.1 g, 6.7 mmol), 4-bromo-2,6-diphenylpyrimidine (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred at 210 ° C for 3 hours. After completion of the reaction, the solid salt was filtered and purified by column chromatography to obtain the desired compound L-1 (2.9 g, yield 63%).
Mass (이론치: 695.20, 측정치: 695 g/mol) Mass (theory: 695.20, measurement: 695 g / mol)
[합성예 165] L-2의 합성[Synthesis Example 165] Synthesis of L-2
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 164와 동일한 과정을 수행하여 목적 화합물 L-2 (2.8 g, 수율 61 %)를 얻었다.The same procedure was followed as in Synthesis Example 164 except that 2-chloro-4,6-diphenyl-1,3,5-triazine (2.14 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound L-2 (2.8 g, yield 61%).
Mass (이론치: 696.20, 측정치: 696 g/mol)Mass (theory: 696.20, measurement: 696 g / mol)
[합성예 166] L-3의 합성[Synthesis Example 166] Synthesis of L-3
4-bromo-2,6-diphenylpyrimidine 대신 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 164와 동일한 과정을 수행하여 목적 화합물 L-3 (3.5 g, 수율 67 %)을 얻었다.Was obtained in the same manner as in Preparation Example 164 except that 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (3.1 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound L-3 (3.5 g, yield 67%).
Mass (이론치: 777.23, 측정치: 777 g/mol)Mass (theory: 777.23, measurement: 777 g / mol)
[합성예 167] L-4의 합성[Synthesis Example 167] Synthesis of L-4
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 164와 동일한 과정을 수행하여 목적 화합물 L-4 (2.8 g, 수율 62 %)를 얻었다.The procedure of Synthetic Example 164 was repeated except that 2-chloro-4-phenylquinazoline (1.9 g, 8.0 mmol) was used instead of 4-bromo-2,6-diphenylpyrimidine to obtain the desired compound L-4 (2.8 g, 62%).
Mass (이론치: 669.19, 측정치: 669 g/mol)Mass (theory: 669.19, found: 669 g / mol)
[합성예 168] L-5의 합성[Synthesis Example 168] Synthesis of L-5
4-bromo-2,6-diphenylpyrimidine 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline (2.9 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 164와 동일한 과정을 수행하여 목적 화합물 L-5 (3.8 g, 수율 71 %)를 얻었다.The same procedure as in Synthesis Example 164 was carried out except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline (2.9 g, 8.0 mmol) was used in place of 4-bromo-2,6-diphenylpyrimidine To obtain the desired compound L-5 (3.8 g, yield 71%).
Mass (이론치: 795.23, 측정치: 795 g/mol)Mass (theory: 795.23, measured: 795 g / mol)
[합성예 169] M-1의 합성[Synthesis Example 169] Synthesis of M-1
질소 기류 하에서 AzC-1 (3.7 g, 6.7 mmol), 5'-bromo-(1,1',3',1")terphenyl (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 M-1 (3.4 g, 수율 65 %)을 얻었다.(2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1 ' -bromo- (1, 1 ', 3 ', 1 ") terphenyl (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred for 3 hours at 210 ° C. After completion of the reaction, , And then purified by column chromatography to obtain the title compound M-1 (3.4 g, yield 65%).
Mass (이론치: 778.33, 측정치: 778 g/mol) Mass (theory: 778.33, measurement: 778 g / mol)
[합성예 170] M-2의 합성[Synthesis Example 170] Synthesis of M-2
5'-bromo-(1,1',3',1")terphenyl 대신 4-bromobiphenyl (1.90 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 169와 동일한 과정을 수행하여 목적 화합물 M-2 (3.1 g, 수율 66 %)를 얻었다.The procedure of Synthesis Example 169 was repeated except that 4-bromobiphenyl (1.90 g, 8.0 mmol) was used instead of 5'-bromo- (1,1 ', 3', 1 " (3.1 g, yield 66%).
Mass (이론치: 702.30, 측정치: 702 g/mol)Mass (theory: 702.30, measurement: 702 g / mol)
[합성예 171] M-3의 합성[Synthesis Example 171] Synthesis of M-3
5'-bromo-(1,1',3',1")terphenyl 대신 2-bromo-9,9-dimethyl-9H-fluorene (2.18 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 169와 동일한 과정을 수행하여 목적 화합물 M-3 (3.1 g, 수율 63 %)을 얻었다.Except that 2-bromo-9,9-dimethyl-9H-fluorene (2.18 g, 8.0 mmol) was used instead of 5'-bromo- (1,1 ', 3' The same procedure was followed to obtain the title compound M-3 (3.1 g, yield 63%).
Mass (이론치: 742.33, 측정치: 742 g/mol)Mass (theory: 742.33, measurement: 742 g / mol)
[합성예 172] N-1의 합성[Synthesis Example 172] Synthesis of N-1
질소 기류 하에서 AzC-4 (3.7 g, 6.7 mmol), 5'-bromo-(1,1',3',1")terphenyl (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 N-1 (3.4 g, 수율 66 %)을 얻었다.(2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1 ' -bromo- (1,1 ', 3 ', 1 ") terphenyl (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred for 3 hours at 210 ° C. After completion of the reaction, , And then purified by column chromatography to obtain the title compound N-1 (3.4 g, yield 66%).
Mass (이론치: 778.33, 측정치: 778 g/mol)Mass (theory: 778.33, measurement: 778 g / mol)
[합성예 173] N-2의 합성[Synthesis Example 173] Synthesis of N-2
5'-bromo-(1,1',3',1")terphenyl 대신 4-bromobiphenyl (1.90 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 172와 동일한 과정을 수행하여 목적 화합물 N-2 (3.1 g, 수율 66 %)를 얻었다.The procedure of Synthesis Example 172 was repeated except that 4-bromobiphenyl (1.90 g, 8.0 mmol) was used instead of 5'-bromo- (1,1 ', 3', 1 " (3.1 g, yield 66%).
Mass (이론치: 702.30, 측정치: 702 g/mol)Mass (theory: 702.30, measurement: 702 g / mol)
[합성예 174] N-3의 합성[Synthesis Example 174] Synthesis of N-3
5'-bromo-(1,1',3',1")terphenyl 대신 2-bromo-9,9-dimethyl-9H-fluorene (2.18 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 172와 동일한 과정을 수행하여 목적 화합물 N-3 (3.0 g, 수율 60 %)을 얻었다.Except that 2-bromo-9,9-dimethyl-9H-fluorene (2.18 g, 8.0 mmol) was used instead of 5'-bromo- (1,1 ', 3' The objective compound N-3 (3.0 g, yield 60%) was obtained by carrying out the same procedure.
Mass (이론치: 742.33, 측정치: 742 g/mol)Mass (theory: 742.33, measurement: 742 g / mol)
[합성예 175] O-1의 합성[Synthesis Example 175] Synthesis of O-1
질소 기류 하에서 AzC-5 (3.5 g, 6.7 mmol), 5'-bromo-(1,1',3',1")terphenyl (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 O-1 (3.2 g, 수율 64%)을 얻었다.(3.5 g, 6.7 mmol), 5'-bromo- (1,1 ', 3', 1 ") terphenyl (2.5 g, 8.0 mmol), CuI (0.13 g, (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred for 3 hours at 210 ° C. After completion of the reaction, , And then purified by column chromatography to obtain the desired compound O-1 (3.2 g, yield 64%).
Mass (이론치: 752.28, 측정치: 752 g/mol)Mass (theory: 752.28, measured: 752 g / mol)
[합성예 176] O-2의 합성[Synthesis Example 176] Synthesis of O-2
5'-bromo-(1,1',3',1")terphenyl 대신 4-bromobiphenyl (1.90 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 175와 동일한 과정을 수행하여 목적 화합물 O-2 (3.1 g, 수율 68 %)를 얻었다.The procedure of Synthesis Example 175 was repeated except that 4-bromobiphenyl (1.90 g, 8.0 mmol) was used instead of 5'-bromo- (1,1 ', 3', 1 " (3.1 g, yield 68%).
Mass (이론치: 675.26, 측정치: 675 g/mol)Mass (theory: 675.26, measured: 675 g / mol)
[합성예 177] O-3의 합성[Synthesis Example 177] Synthesis of O-3
5'-bromo-(1,1',3',1")terphenyl 대신 2-bromo-9,9-dimethyl-9H-fluorene (2.18 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 175와 동일한 과정을 수행하여 목적 화합물 O-3 (3.0 g, 수율 63 %)을 얻었다.Except that 2-bromo-9,9-dimethyl-9H-fluorene (2.18 g, 8.0 mmol) was used instead of 5'-bromo- (1,1 ', 3' The same procedure was followed to obtain the desired compound O-3 (3.0 g, yield 63%).
Mass (이론치: 716.28, 측정치: 716 g/mol)Mass (theory: 716.28, measurement: 716 g / mol)
[합성예 178] P-1의 합성[Synthesis Example 178] Synthesis of P-1
질소 기류 하에서 AzC-10 (3.2 g, 6.7 mmol), 5'-bromo-(1,1',3',1")terphenyl (2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1,10-phenanthroline (0.24 g, 1.34 mmol), Cs2CO3 (4.37 g, 13.4 mmol) 및 nitrobenzene (25 ml)를 혼합하고 210℃에서 3시간 동안 교반하였다. 반응이 종결된 후 고체염을 filter한 후, 컬럼크로마토그래피로 정제하여 목적 화합물 P-1 (3.2 g, 수율 67 %)을 얻었다.(2.5 g, 8.0 mmol), CuI (0.13 g, 0.67 mmol), 1 ' -bromo- (1,1 ', 3 ', 1 ") terphenyl (0.24 g, 1.34 mmol), Cs 2 CO 3 (4.37 g, 13.4 mmol) and nitrobenzene (25 ml) were mixed and stirred for 3 hours at 210 ° C. After completion of the reaction, , And then purified by column chromatography to obtain the target compound P-1 (3.2 g, yield 67%).
Mass (이론치: 703.29, 측정치: 703 g/mol)Mass (theory: 703.29, measured: 703 g / mol)
[합성예 179] P-2의 합성[Synthesis Example 179] Synthesis of P-2
5'-bromo-(1,1',3',1")terphenyl 대신 4-bromobiphenyl (1.90 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 178과 동일한 과정을 수행하여 목적 화합물 P-2 (2.9 g, 수율 70%)를 얻었다.The procedure of Synthesis Example 178 was repeated except that 4-bromobiphenyl (1.90 g, 8.0 mmol) was used instead of 5'-bromo- (1,1 ', 3', 1 " (2.9 g, yield 70%).
Mass (이론치: 627.26, 측정치: 627 g/mol)Mass (theory: 627.26, found: 627 g / mol)
[합성예 180] P-3의 합성[Synthesis Example 180] Synthesis of P-3
5'-bromo-(1,1',3',1")terphenyl 대신 2-bromo-9,9-dimethyl-9H-fluorene (2.18 g, 8.0 mmol)을 사용하는 것을 제외하고는 합성예 178과 동일한 과정을 수행하여 목적 화합물 P-3 (3.4 g, 수율 76 %)을 얻었다.Except that 2-bromo-9,9-dimethyl-9H-fluorene (2.18 g, 8.0 mmol) was used instead of 5'-bromo- (1,1 ', 3' The same procedure was followed to obtain the desired compound P-3 (3.4 g, yield 76%).
Mass (이론치: 667.29, 측정치: 667 g/mol)
Mass (theory: 667.29, found: 667 g / mol)
[실시예 1 내지 144] 녹색 유기 전계 발광 소자의 제조[Examples 1 to 144] Preparation of green organic electroluminescent device
합성예에서 합성한 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 소자를 제조하였다.Compounds synthesized in Synthesis Examples were subjected to high purity sublimation purification by a conventionally known method, and devices were manufactured according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수로 초음파 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium Tin Oxide) with a thickness of 1500 Å was ultrasonically washed with distilled water. After the distilled water was washed, the substrate was ultrasonically cleaned with a solvent such as isopropyl alcohol, acetone, and methanol, dried and transferred to a UV OZONE cleaner (Power Sonic 405, Hoshin Tech), the substrate was cleaned using UV for 5 minutes, The substrate was transferred.
이렇게 준비된 ITO 투명 기판(전극) 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ 90% 하기 표 1의 호스트 화합물 + 10 % Ir(ppy)3 (30 nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 소자를 제조하였다.
M-MTDATA (60 nm) / TCTA (80 nm) / 90% on the prepared ITO transparent substrate (electrode) + host compound + 10% Ir (ppy) 3 (30 nm) / BCP Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) in this order.
[비교예 1] 녹색 유기 전계 발광 소자의 제조[Comparative Example 1] Production of green organic electroluminescent device
발광층 형성시 발광 호스트 물질로서 화합물 A-1 대신 CBP를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 소자를 제조하였다.
The device was fabricated in the same manner as in Example 1, except that CBP was used instead of Compound A-1 as a luminescent host material in forming the light emitting layer.
상기 실시예 1 내지 144 및 비교예 1에서 사용된 m-MTDATA, TCTA, Ir(ppy)3, BCP 및 CBP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , BCP and CBP used in Examples 1 to 144 and Comparative Example 1 are as follows.
[평가예 1][Evaluation Example 1]
실시예 1 내지 144 및 비교예 1에서 제조한 각각의 녹색 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 전류효율 및 발광피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.The driving voltage, the current efficiency and the emission peak at the current density of 10 mA / cm 2 were measured for each of the green organic electroluminescent devices prepared in Examples 1 to 144 and Comparative Example 1, and the results are shown in the following Table 1 .
상기 표1에 나타낸 바와 같이, 본 발명에 따른 화합물을 녹색 유기 전계 발광 소자의 발광층에 사용한 경우(실시예 1 내지 144)가 종래 CBP를 녹색 유기 전계 발광 소자의 발광층에 사용한 경우(비교예 1)보다 효율 및 구동전압이 우수한 것을 확인할 수 있었다.
As shown in Table 1, when the compound according to the present invention was used for the light emitting layer of the green organic electroluminescent device (Examples 1 to 144), the conventional CBP was used for the light emitting layer of the green organic electroluminescent device (Comparative Example 1) It was confirmed that the efficiency and the driving voltage were superior.
[실시예 145 내지 168] 적색 유기 전계 발광 소자의 제조[Examples 145 to 168] Preparation of red organic electroluminescent device
합성예에서 합성한 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 적색 유기 전계 발광 소자를 제작하였다.The compound synthesized in Synthesis Example was subjected to high purity sublimation purification by a conventionally known method, and a red organic electroluminescent device was fabricated according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수로 초음파 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium Tin Oxide) with a thickness of 1500 Å was ultrasonically washed with distilled water. After the distilled water was washed, the substrate was ultrasonically cleaned with a solvent such as isopropyl alcohol, acetone, and methanol, dried and transferred to a UV OZONE cleaner (Power Sonic 405, Hoshin Tech), the substrate was cleaned using UV for 5 minutes, The substrate was transferred.
이렇게 준비된 ITO 투명 기판(전극) 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ 90% 하기 표 2의 호스트 화합물 + 10 % (piq)2Ir(acac) (30 nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 소자를 제조하였다.
M-MTDATA (60 nm) / TCTA (80 nm) / 90% on the prepared ITO transparent substrate (electrode) + host compound + 10% (piq) 2 Ir (acac) (30 nm) / BCP nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm).
[비교예 2][Comparative Example 2]
발광층 형성시 발광 호스트 물질로서 화합물 B-4 대신 CBP를 사용하는 것을 제외하고는 실시예 145와 동일한 과정으로 소자를 제조하였다.
A device was fabricated in the same manner as in Example 145 except that CBP was used instead of Compound B-4 as a luminescent host material in forming the light emitting layer.
상기 실시예 145 내지 168 및 비교예 2에서 사용된 m-MTDATA, TCTA, BCP 및 CBP의 구조는 상기와 같고, (piq)2Ir(acac)의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, BCP and CBP used in Examples 145 to 168 and Comparative Example 2 are as described above, and the structure of (piq) 2 Ir (acac) is as follows.
[평가예 2][Evaluation Example 2]
실시예 145 내지 168 및 비교예 2에서 제조한 각각의 적색 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압 및 전류효율을 측정하고, 그 결과를 하기 표 2에 나타내었다.The driving voltage and the current efficiency at the current density of 10 mA / cm 2 were measured for each red organic electroluminescent device manufactured in Examples 145 to 168 and Comparative Example 2, and the results are shown in Table 2 below.
상기 표 2에 나타낸 바와 같이, 본 발명의 화합물을 적색 유기 전계 발광 소자의 발광층에 사용한 경우(실시예 145 내지 168)가 종래 CBP를 적색 유기 전계 발광 소자의 발광층에 사용한 경우(비교예 2)보다 효율 및 구동전압이 우수한 것을 확인할 수 있었다.
As shown in Table 2, when the compound of the present invention was used for the light emitting layer of the red organic electroluminescent device (Examples 145 to 168), the conventional CBP was used for the light emitting layer of the red organic electroluminescent device (Comparative Example 2) It was confirmed that the efficiency and the driving voltage were excellent.
[실시예 169 내지 180] 청색 유기 전계 발광 소자의 제조[Examples 169 to 180] Preparation of blue organic electroluminescent device
합성예에서 합성한 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 청색 유기 전계 발광 소자를 제작하였다.The compound synthesized in Synthesis Example was subjected to high purity sublimation purification by a conventionally known method, and a blue organic electroluminescent device was fabricated according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500Å 두께로 박막 코팅된 유리 기판을 증류수로 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with ITO (Indium tin oxide) thin film having a thickness of 1500 Å was ultrasonically washed with distilled water. After the distilled water was washed, the substrate was ultrasonically washed with a solvent such as isopropyl alcohol, acetone, or methanol, dried and transferred to a UV OZONE cleaner (Power Sonic 405, Hoshin Tech), the substrate was cleaned using UV for 5 minutes, The substrate was transferred.
상기와 같이 준비된 ITO 투명 전극 위에, DS-205 (두산社) (80 nm)/NPB (15 nm)/하기 표 3 각각의 화합물 (15 nm)/ADN + 5 % DS-405 (두산社) (300nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다. 이때, 하기 표 3의 화합물들은 발광 보조층의 재료로 사용되었으며, BCP의 구조는 상기와 같고 ADN 및 NPB의 구조는 하기와 같다. (15 nm) / ADN + 5% DS-405 (Doosan) (manufactured by Doosan Heavy Industries, Ltd.) on the ITO transparent electrode prepared above 300 nm) / BCP (10 nm) / Alq3 (30 nm) / LiF (1 nm) / Al (200 nm) were stacked in this order to fabricate an organic electroluminescent device. At this time, the compounds shown in the following Table 3 were used as materials for the light emission-assisting layer, the structure of BCP was as described above, and the structures of ADN and NPB were as follows.
[비교예 3] 청색 유기 전계 발광 소자의 제작[Comparative Example 3] Fabrication of blue organic electroluminescent device
발광층 형성시 발광 보조층 물질로서 화합물 M-1을 사용하지 않는 것을 제외하고는, 실시예 169와 동일하게 수행하여 청색 유기 전계 발광 소자를 제조하였다.
A blue organic electroluminescent device was produced in the same manner as in Example 169 except that the compound M-1 was not used as the luminescent auxiliary layer material in the luminescent layer formation.
[평가예 3][Evaluation Example 3]
실시예 169 내지 180 및 비교예 3에서 제조한 각각의 청색 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압 및 전류효율을 측정하고, 그 결과를 하기 표 3에 나타내었다.The driving voltage and current efficiency at the current density of 10 mA / cm 2 were measured for each of the blue organic electroluminescent devices manufactured in Examples 169 to 180 and Comparative Example 3, and the results are shown in Table 3 below.
상기 표 3에 나타낸 바와 같이, 본 발명의 화합물을 청색 유기 전계 발광 소자의 발광 보조층에 사용한 경우(실시예 169 내지 180)가 종래의 청색 유기 전계 발광 소자(비교예 3)보다 효율 및 구동전압이 우수한 것을 확인할 수 있었다.As shown in Table 3, when the compound of the present invention was used for the light-emission-assisting layer of the blue organic electroluminescent device (Examples 169 to 180), the efficiency and the driving voltage of the blue organic electroluminescent device .
Claims (11)
[화학식 1]
상기 화학식 1에서,
X1은 O, S 및 N(Ar1)으로 이루어진 군에서 선택되고,
Ar1은 C6~C15의 아릴기이고,
R1과 R2, R2와 R3 및 R3와 R4 중 적어도 하나는 하기 화학식 2로 표시되는 축합 고리를 형성하고,
[화학식 2]
상기 화학식 2에서,
점선은 상기 화학식 1과 축합이 이루어지는 부분이고,
X2는 N(R31)이며,
상기 화학식 2의 축합고리를 형성하지 않는 R1 내지 R4와; R5 내지 R14는 각각 독립적으로 수소이며,
R31은 C6~C12의 아릴기 및 핵원자수 5 내지 10의 헤테로아릴기로 이루어진 군에서 선택되며,
상기 R31의 아릴기 및 헤테로아릴기는 각각 C6의 아릴기, 및 핵원자수 5 내지 6의 헤테로아릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있으며,
상기 헤테로아릴기는 1 내지 3개의 헤테로원자를 포함하며, 이때 헤테로원자는 N, O, 및 S로 이루어진 군에서 선택된 1종 이상이다.A compound represented by the following formula (1):
[Chemical Formula 1]
In Formula 1,
X 1 is selected from the group consisting of O, S and N (Ar 1 )
Ar 1 is a C 6 to C 15 aryl group,
At least one of R 1 and R 2 , R 2 and R 3, and R 3 and R 4 forms a condensed ring represented by the following formula (2)
(2)
In Formula 2,
The dotted line is a moiety which is condensed with the above-mentioned formula (1)
X 2 is N (R 31 )
R 1 to R 4 which do not form a condensed ring of Formula 2; R 5 to R 14 are each independently hydrogen,
R 31 is selected from the group consisting of a C 6 to C 12 aryl group and a heteroaryl group having 5 to 10 nuclear atoms,
The aryl group and the heteroaryl group of R 31 may be substituted or unsubstituted with at least one substituent selected from the group consisting of C 6 aryl group and heteroaryl group having 5 to 6 nuclear atoms,
The heteroaryl group contains 1 to 3 heteroatoms, wherein the heteroatom is at least one selected from the group consisting of N, O and S.
상기 화학식 1 로 표시되는 화합물이 하기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택되는 화합물:
[화학식 1a]
[화학식 1b]
[화학식 1c]
[화학식 1d]
[화학식 1e]
[화학식 1f]
상기 화학식 1a 내지 1f에서,
X1, X2, R1 내지 R14는 제1항에서 정의한 바와 같다.The method according to claim 1,
Wherein the compound represented by the formula (1) is selected from the group consisting of compounds represented by the following formulas (1a) to (1f):
[Formula 1a]
[Chemical Formula 1b]
[Chemical Formula 1c]
≪ RTI ID = 0.0 &
[Formula 1e]
(1f)
In the above general formulas (1a) to (1f)
X 1 , X 2 , R 1 to R 14 are as defined in claim 1.
[화학식 1]
상기 화학식 1에서,
X1은 N(Ar1)이고,
Ar1은 C6~C15의 아릴기 및 핵원자수 5 내지 10의 헤테로아릴기로 이루어진 군에서 선택되고,
R2와 R3는 하기 화학식 2로 표시되는 축합 고리를 형성하고,
[화학식 2]
상기 화학식 2에서,
점선은 상기 화학식 1과 축합이 이루어지는 부분이고,
X2는 O, S, N(R31) 및 C(R32)(R33)로 이루어진 군에서 선택되며,
R1, R4 내지 R7, R9 내지 R10, 및 R11 내지 R14는 각각 독립적으로 수소이며,
R31은 C6~C12의 아릴기 및 핵원자수 5 내지 10의 헤테로아릴기이며,
R32 내지 R33은 각각 독립적으로 C1의 알킬기이며,
상기 화학식 1에서 R8은 하기 화학식 3으로 표시되며,
[화학식 3]
상기 화학식 3에서,
*는 화학식 1과 연결되는 부위이고,
L1은 단일결합이고,
R21 내지 R28 중 하나는 화학식 1과 연결되고, 상기 L1과 연결되지 않는 R21 내지 R28은 각각 독립적으로 수소이고,
X3는 O 및 N(R31)로 이루어진 군에서 선택되며,
R31은 C6~C12의 아릴기 및 핵원자수 5 내지 10의 헤테로아릴기이며,
상기 Ar1의 아릴기 및 헤테로아릴기는 각각 독립적으로 C6~C10의 아릴기, 및 핵원자수 5 내지 6의 헤테로아릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있으며,
상기 헤테로아릴기는 각각 독립적으로 1 내지 3개의 헤테로원자를 포함하며, 이때 헤테로원자는 N, O, 및 S로 이루어진 군에서 선택된 1종 이상이다.A compound represented by the following formula (1):
[Chemical Formula 1]
In Formula 1,
X 1 is N (Ar 1 )
Ar 1 is selected from the group consisting of a C 6 to C 15 aryl group and a heteroaryl group having 5 to 10 nuclear atoms,
R 2 and R 3 form a condensed ring represented by the following formula (2)
(2)
In Formula 2,
The dotted line is a moiety which is condensed with the above-mentioned formula (1)
X 2 is selected from the group consisting of O, S, N (R 31 ) and C (R 32 ) (R 33 )
R 1 , R 4 to R 7 , R 9 to R 10 , and R 11 to R 14 are each independently hydrogen,
R 31 is a C 6 to C 12 aryl group and a heteroaryl group having 5 to 10 nuclear atoms,
R 32 to R 33 are each independently a C 1 alkyl group,
In Formula 1, R 8 is represented by the following Formula 3,
(3)
In Formula 3,
* Is a moiety connected to the formula (1)
L < 1 > is a single bond,
One of R 21 to R 28 is connected to the formula (1), and each of R 21 to R 28, which is not connected to L 1 , is independently hydrogen,
X 3 is selected from the group consisting of O and N (R 31 )
R 31 is a C 6 to C 12 aryl group and a heteroaryl group having 5 to 10 nuclear atoms,
The aryl group of said Ar 1 and heteroaryl groups are each independently C 6 ~ C 10 aryl group, and the number of nuclear atoms which may be unsubstituted or substituted by one substituent at least one selected from the group consisting of a heteroaryl group of from 5 to 6,
The heteroaryl groups each independently have 1 to 3 heteroatoms, wherein the heteroatom is at least one selected from the group consisting of N, O, and S.
상기 Ar1 및 R31이 각각 독립적으로 페닐기인 화합물.The method according to claim 1 or 3,
Wherein Ar 1 and R 31 are each independently a phenyl group.
상기 Ar1 및 R31이 각각 독립적으로 하기 A1 내지 A10으로 표시되는 구조로 이루어진 군에서 선택되는 화합물.
상기 A1 내지 A10에서,
L2는 단일결합 및 C6~C12의 아릴렌기로 이루어진 군에서 선택되고,
R15는 각각 독립적으로 수소, 및 C6의 아릴기로 이루어진 군에서 선택되고,
R41은 수소이며, n은 1 내지 4의 정수이며,
상기 R15의 아릴기는 각각 독립적으로 C6~C10의 아릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환 또는 비치환될 수 있다.The method according to claim 1 or 3,
Wherein Ar 1 and R 31 are each independently selected from the group consisting of the structures represented by the following formulas A1 to A10.
In the above-mentioned A1 to A10,
L 2 is selected from the group consisting of a single bond and a C 6 to C 12 arylene group,
R 15 is selected from the group consisting of hydrogen, and a group of C 6 aryl, each independently,
R 41 is hydrogen, n is an integer of 1 to 4,
Wherein R 15 is an aryl group may be unsubstituted or substituted by one substituent at least one selected from the group consisting of each independently an aryl group of C 6 ~ C 10.
상기 1층 이상의 유기물층 중에서 적어도 하나는 제1항 또는 제3항에 기재된 화합물을 포함하는 유기 전계 발광 소자.An organic electroluminescent device comprising an anode, a cathode, and at least one organic material layer interposed between the anode and the cathode,
Wherein at least one of the one or more organic layers includes the compound according to any one of claims 1 to 3.
상기 화합물을 포함하는 유기물층이 정공 주입층, 정공 수송층, 전자수송층 및 발광층으로 이루어진 군에서 선택되는 유기 전계 발광 소자.10. The method of claim 9,
Wherein the organic compound layer containing the compound is selected from the group consisting of a hole injecting layer, a hole transporting layer, an electron transporting layer, and a light emitting layer.
상기 화합물을 포함하는 유기물층이 인광 발광층인 유기 전계 발광 소자.10. The method of claim 9,
Wherein the organic compound layer containing the compound is a phosphorescent light-emitting layer.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140025643A KR101729373B1 (en) | 2014-03-04 | 2014-03-04 | Organic compound and organic electroluminescent device comprising the same |
PCT/KR2015/002070 WO2015133807A1 (en) | 2014-03-04 | 2015-03-04 | Organic compound and organic electroluminescent element comprising same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140025643A KR101729373B1 (en) | 2014-03-04 | 2014-03-04 | Organic compound and organic electroluminescent device comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150103948A KR20150103948A (en) | 2015-09-14 |
KR101729373B1 true KR101729373B1 (en) | 2017-04-21 |
Family
ID=54055550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140025643A KR101729373B1 (en) | 2014-03-04 | 2014-03-04 | Organic compound and organic electroluminescent device comprising the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101729373B1 (en) |
WO (1) | WO2015133807A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101742359B1 (en) * | 2013-12-27 | 2017-05-31 | 주식회사 두산 | Organic electro luminescence device |
KR102642199B1 (en) * | 2016-04-07 | 2024-03-05 | 삼성디스플레이 주식회사 | Organic light emitting device |
WO2019190212A1 (en) * | 2018-03-30 | 2019-10-03 | 에스케이머티리얼즈 주식회사 | Compound, organic electroluminescent diode and display device |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6620529B1 (en) | 1999-10-27 | 2003-09-16 | Fuji Photo Film Co., Ltd. | Materials for light emitting devices and light emitting devices using the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201103608A (en) * | 2009-07-31 | 2011-02-01 | Performax Golf & Composite Inc | Golf club head with double-layered wire trenches |
KR101559430B1 (en) * | 2012-02-22 | 2015-10-13 | 주식회사 엠비케이 | Organic light compound and organic light device using the same |
-
2014
- 2014-03-04 KR KR1020140025643A patent/KR101729373B1/en active IP Right Grant
-
2015
- 2015-03-04 WO PCT/KR2015/002070 patent/WO2015133807A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6620529B1 (en) | 1999-10-27 | 2003-09-16 | Fuji Photo Film Co., Ltd. | Materials for light emitting devices and light emitting devices using the same |
Also Published As
Publication number | Publication date |
---|---|
KR20150103948A (en) | 2015-09-14 |
WO2015133807A1 (en) | 2015-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6735753B2 (en) | Organic compound and organic electroluminescent device including the same | |
KR102487503B1 (en) | Organic compound and organic electroluminescent device using the same | |
KR101614599B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
JP2022064995A (en) | Organic light-emitting compound and organic electroluminescent device including the same | |
JP7071404B2 (en) | Organic compounds and organic electroluminescent devices containing them | |
KR20190045435A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20160066339A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR102499850B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20160079415A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101729372B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR20150047858A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20190076375A (en) | Organic compounds and organic electro luminescence device comprising the same | |
JP6039078B2 (en) | Novel compound and organic electroluminescence device containing the same | |
KR20230078604A (en) | Organic compounds and organic electro luminescence device comprising the same | |
JP6991254B2 (en) | Organic compounds and organic electroluminescent devices containing them | |
KR20190045436A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20170074649A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101729373B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR101603384B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101622822B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20150103968A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR102360504B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR101762482B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20180064861A (en) | Organic compound and organic electroluminescent device using the same | |
KR102444781B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
AMND | Amendment | ||
AMND | Amendment | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |